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Abstract 
 
Tauopathies are progressive neurodegenerative diseases characterised by the aggregation 
of hyperphosphorylated tau protein into neurofibrillary tangles (NFTs). To date, the majority 
of research has focused on NFT formation and neuronal death. However, mounting 
evidence suggests that clinical symptoms precede aggregate formation and cell loss. Thus, a 
period of cellular dysfunction precedes cell death. For further understanding, robust animal 
models of tau-mediated neuronal dysfunction are urgently required. In this thesis, I 
successfully model the early stages of tauopathies in Drosophila.  
 
First, I show tau-mediated neuronal dysfunction (progressive loss of the ERG response and 
abnormal visual behaviour in the flight simulator system) and neuronal death (progressive 
loss of the photoreceptor rhabdomeres) are temporally separable in a Drosophila eye 
model. I demonstrate isoform-specific effects of different 4r tau proteins in my model. For 
example, lGMR>2n4r tau, but not lGMR>0n4r tau, expression causes age-related 
progressive structural degeneration. I further suggest a role for PAR1 phosphorylation in 
tau-mediated neuronal dysfunction and show Aβ42 potently exacerbates tau-mediated 
neuronal dysfunction.  
 
Circadian rhythm disruption is common in tauopathies, such as Alzheimer’s disease (AD). I 
show Drosophila expressing human tau, recapitulate many of the features of circadian 
dysfunction found in AD, including elevated night-time activity, gains in daytime sleep and 
night-time sleep loss and in LD, and progressive behavioural arrhythmicity in DD. I show that 
distinct subsets of clock neurons mediate different tau-evoked circadian rhythm 
disturbances. Tau expression in the PDF neurons, which are considered to be the master 
pacemaker, prolongs the free-running period and causes hyperactivity, but is insufficient to 
induce progressive behavioural arrhythmia in DD. All clock neurons is the most clock-
restricted domain required to produce behavioural arrhythmicity. The tau species and 
extent of tau expression affects the circadian behavioural deficits. I find no loss of PDF 
neurons in flies expressing tau in the clock system. Taken together, these results show in 
independent neuronal populations tau-mediated neuronal dysfunction is separable from
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 neuronal death. Collectively, these results suggest circadian dysfunction in AD is not due to 
neuronal death in the master pacemaker, but neuronal dysfunction throughout the clock 
system. In this thesis, I present parallel studies that provide a platform for the future 
dissection of the mechanisms underlying progressive functional and structural 
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Chapter 1:   General Introduction 
 
1.1   Tauopathies 
 
Tauopathies are a collection of neurodegenerative diseases characterised 
neuropathologically by the aggregation of abnormally hyperphosphorylated tau into 
neurofibrillary tangles (NFTs). At a neuropathological level, tauopathies contain only tau 
aggregates (frontotemporal dementia (FTD), Picks Disease (PiD), cortical basal degeneration 
(CBD) and progressive supranuclear palsy (PSP)) or the tau aggregates coexist with amyloid 
aggregates (Alzheimer’s Disease (AD); initially described by Alzheimer (Alzheimer, 1907)) or 
α-synuclein aggregates (Parkinson’s disease (PD)). Tau, which was first discovered in 1975, 
binds to and stabilises microtubules in a phospho-dependent manner (Weingarten et al., 
1975). Tau also promotes microtubule assembly. Mutations in the tau gene have been 
causally linked to FTD (Spillantini et al., 1998; Ghetti et al., 2015). Tau haplotypes driving 
slightly higher tau expression are linked to AD (Allen et al., 2014) and PD (Kwok et al., 2004; 
Tobin et al., 2008; Refenes et al., 2009). Thus, tau abnormalities are sufficient to cause 
neurodegeneration.  
 
There are a range of tauopathies with overlapping, but distinct, clinical symptoms and 
neuropathological features. In different tauopathies, the aggregates deposit in distinct brain 
regions including the hippocampus/entorhinal cortex, cortical regions and mid/hindbrain. 
The aggregates also consist of different tau proteins. In different tauopathies, the clinical 
symptoms range from cognitive to motor deficits. However, common to all tauopathies are 
aggregates of hyperphosphorylated and misfolded tau (Goedert et al., 1989; Weaver et al., 
2000). In tauopathies, an increase in tau phosphorylation reduces microtubule binding 
leading to destabilisation of the microtubule network and axonal transport defects 
(Mandelkow et al., 2003; Dixit et al., 2008). Detached soluble tau missorts to the 
somatodendritic compartment and self-aggregates into oligomers and higher order 
aggregates in a series of steps (Maeda et al., 2007; Sahara et al., 2008). FTD-causing 
mutations often increase tau phosphorylation and thereby reduce microtubule binding 






Petrucelli, 2009). It is currently unclear whether tau-mediated neurodegeneration is due to 
loss-of-function or toxic gain-of-toxic function (Trojanowski and Lee, 2005; Iqbal et al., 
2009).  
 
AD is the most common tauopathy. AD is clinically characterised by cognitive deficits (Burns 
and Iliffe, 2009). AD is neuropathologically characterised by slow and progressive 
neurodegeneration and tau aggregates in the cortical regions (Kumar et al., 2015). Mounting 
evidence suggests neuronal and synaptic dysfunction often precedes neurodegeneration in 
AD (Palop and Mucke, 2010; Marcello et al., 2012). As well as the cognitive deficits, a 
substantial proportion of AD patients exhibit circadian rhythm disruption characterised by 
daytime drowsiness and night-time restlessness (Witting et al., 1990; Satlin et al., 1995; 
Volicer, 2001). Circadian dysfunction have also been reported in other tauopathies such as 
FTD (Anderson et al., 2009) and PD (Videnovic and Golombek, 2013; Videnovic and 
Golombek, 2017). The circadian disturbances appear at an early stage in the disease process 
and may even precede the onset of cognitive abnormalities. Recent evidence suggests 
circadian dysfunction may directly influence AD pathogenesis (Maywood et al., 2006; 
Hastings and Goedert, 2013; Musiek and Holtzan, 2016). Therefore, targeting sleep and 
circadian alterations provides a promising opportunity to slow down or even halt disease 
progression. So further understanding of circadian dysfunction in tauopathies may have 
wide ranging implications that extend far beyond circadian biology. Because, currently there 
is no effective disease modifying therapies for any tauopathies (Coughlin and Irwin, 2017). 
 
 Although tau is best known as a microtubule stabilising protein, mounting evidence has 
shown that tau has additional physiological roles in the neuron including synaptic plasticity, 
regulation of genomic stability and cell signalling. This opens up the intriguing possibility 
that multiple mechanisms mediate tau toxicity in tauopathies. However, despite much 
research effort both the physiological and pathological roles of tau remain poorly 
understood (Wang and Mandelkow, 2016; Guo et al., 2017). For further understanding of 
neuronal dysfunction in tauopathies, robust animal models are needed that recapitulate the 
early stages of the disease process. The development of such animal models would provide 






melanogaster are well suited to model tauopathies because of the powerful genetic tools 
available (Bilen and Bonini et al., 2005; Marsh and Thompson, 2006; Prussing et al., 2013).  
 
1.2   Tau protein structure 
 
Tau is encoded by the MAPT gene, located on chromosome 17 in humans. The tau primary 
transcript is composed of 16 exons, the majority of which are constitutively expressed, while 
exons 2, 3 and 10 are alternatively spliced. In the human CNS, alternative splicing produces 
six tau isoforms that vary in length from 352 to 441 amino acids. Exons 2 and 3 each encode 
an insert of 29 amino acids in the amino (N)-terminal region of tau. Alternative splicing 
produces tau isoforms that contain no N-terminal inserts (0n), one N-terminal insert (1n, 
exon 2) or two N-terminal inserts (2n, exons 2 and 3). Exons 9, 10, 11 and 12 each encode a 
30-31 amino acid highly conserved imperfect repeat in the carboxyl (C)-terminal half of tau. 
These C-terminal repeats comprise the microtubule binding domain of tau. Exon 10 is 
alternatively spliced producing tau isoforms that contain three (3r) or four (4r) C-terminal 
repeats (Figure 1.1). Tau expression is developmentally regulated. For example, in the adult 
human brain all six isoforms are expressed, whereas in the foetal brain only 0n4r tau is 
expressed (Sergeant et al., 2005; Llorens-Martin et al., 2012). In the cerebral cortex of 
healthy adults, the ratio of 3r to 4r tau is approximately 1:1 (Buee et al., 2000; Takuma et al., 
2003). Differential splicing of exons 2 and 3 results in the amount of the 2n tau isoform 
(~9%) being much less than the 0n (~37%) and 1n (~54%) tau isoforms in the human brain 
(Deshpande et al., 2008). Tau expression also varies in different brain regions. For example, 
the overall amount of tau is much higher in the neocortex than in the white matter and 
cerebellum (Trabzuni et al., 2012). Splicing of the MAPT gene also varies in different brain 
regions. For example, On3r tau levels are lower in the cerebellum than in other brain 
regions (Trabzuni et al., 2012). These differences in tau expression in specific brain regions 
most likely contribute to the region specific effects of distinct tauopathies.  
 
Biophysical studies have revealed that tau is prototypically a ‘natively unfolded’ protein 
(Gamblin, 2005). Tau is composed of four domains. First, the N-terminal acidic projection 






which contains the proline-rich domain. Third, the microtubule binding domain in the C-
terminal half of tau, which is comprised of three or four C-terminal repeats. And finally, the 
C-terminal basic tail (Figure 1.1). 
 
The N-terminal projection domain of tau projects away from the microtubule surface and 
can interact with other cytoskeletal elements, cytoplasmic organelles and the neural plasma 
membrane (Buee et al., 2000). The N-terminal domain of tau regulates the distance 
between the axonal microtubules and thereby can increase the axon diameter (Chen et al., 
1992). The interaction of the N-terminal domain with other cytoskeletal elements, like 
microfilaments, regulates the flexibility of microtubule lattices. The extreme N-terminal 
region of tau plays a role in a signalling cascade that regulates axonal transport (Kanaan et 
al., 2011). However, the specific function of the N-terminal inserts is not well known. In 
vitro, in the mouse brain different 4r tau isoforms show specific subcellular distributions (Liu 
and Gotz, 2013). Thus, the N-terminal inserts seem to influence the subcellular distribution 
of tau. Additionally, the N-terminal inserts also seem to affect tau protein-protein 
interactions, because different 4r tau isoforms show different protein interaction partners. 
For example, β-synuclein binds 0n rather than 1n or 2n tau isoforms. In contrast, 
apolipoprotein A1 only binds to 2n tau isoforms (Liu et al., 2016). Moreover, in vitro the N-
terminal inserts also affect tau’s ability to aggregate. The inclusion of one N-terminal inserts 
promotes tau aggregation, whereas the inclusion of two N-terminal inserts suppresses tau 
aggregation (Zhong et al., 2012) 
 
Tau binds through the proline rich domain to SH3-containing proteins, including Fyn, in a 
phospho-dependent manner (Lee et al., 1998). Microtubule binding is mediated by the 
microtubule binding domain, located in the C-terminal half of tau. 4r tau isoforms binds 
more effectively than 3r tau isoforms, which is probably because of variation in the C-
terminal repeats (Butner and Kirschner, 1991; Lu and Kosik, 2001). Tauopathies can be 
grouped according to the tau isoform found in the tau deposits: 4r-tauopathies (including 
PSP and CBD), 3r–tauopathies (such as PiD), and 3r+4r-tauopathies (such as AD) (Irwin, 











Figure 1.1: Isoforms of tau in the human brain. Six isoforms of tau are produced in the human CNS by 
alternative splicing of the MAPT gene. Different tau isoforms contain zero, one or two N-terminal inserts and 
three or four C-terminal repeats. Tau is made up of the N-terminal region, the proline-rich domain (PRD), 
microtubule binding domain (MTBD) and C-terminal tail. 
 
1.3   Tau phosphorylation  
 
The longest human CNS tau isoform (2n4r, 441aa) contains 85 putative phosphorylation 
sites (80 serines and threonines in addition to five tyrosine residues) (Hanger et al., 2009). 
Because of the large number of phosphorylation sites, it is to be expected phosphorylation 
will have a major effect on tau function. More than 39 of these sites are often 
phosphorylated in NFTs (Buee et al., 2000). The overall phosphorylation status of tau is 
tightly regulated by the combined balanced activity of various kinases and photospheres. 
Phosphorylation levels of tau are dramatically higher (> fourfold) in brains from AD patients 
than in brains from healthy controls (Kopke et al., 1993). Tau is phosphorylated at certain 
sites in both normal and AD brains, whereas it is phosphorylated at others in only AD brains 
(Sergeant et al., 2008). Under pathological conditions, tau phosphorylation increases, which 






phosphorylation at specific residues in the C-terminal-repeats (including Ser262, Ser293, 
Ser323 and Ser356) substantially reduces tau microtubule binding affinity (Drewers et al., 
1995). Detached soluble tau then mislocalises to the somatodendritic compartment and 
forms aggregates of increasing complexity in a series of steps. Currently, it is unknown the 
order in which specific residues are phosphorylated in tauopathies. Both in vitro and in vivo 
studies have identified several kinases that phosphorylate tau (for a complete list see recent 
review by Guo et al., 2017). Intriguingly, the majority of these kinases have been shown to 
phosphorylate tau in both physiological and pathological conditions. 
 
Glycogen synthase kinase (GSK) has been shown to phosphorylate approximately half of the 
tau phosphorylation sites, with the majority of them being phosphorylated in AD brains 
(Hanger et al., 2007). The amount and activity of GSK in AD brains correlates well with 
neurodegeneration and aggregate formation (Rankin et al., 2007). In mice, overexpressing 
human tau, treatment with a GSK inhibitor reduces tau phosphorylation and rescues 
neuronal death (Sereno et al., 2009). Tau phosphorylation by the tyrosine kinase Fyn (at 
Tyr18) has been shown to regulate axonal transport (Cox et al., 2016). In mice, expressing 
human tau, an increase in overall Tyr phosphorylation coincides with aggregate formation. 
Thus, overall Tyr phosphorylation levels may contribute to aggregate formation. In vitro 
studies have shown protein phosphatase 1 (PP1), PP2A, PP2B, and PP2C dephosphorylate 
tau (Avila et al., 2004; Braithwaite et al., 2012). Activity of PP2A the main phosphatase 
(accounts for the majority of cellular phosphatase activity in the human brain) is reduced by 
~50 % in the brain of individuals with AD (Gong et al., 1993; Liu et al., 2005). Tau is also 
subject to other post-translational modifications (PTMs), including acetylation, which 
regulate tau function in both physiological and pathological conditions (Min et al., 2010; 












1.4   Physiological function 
 
1.4.1   Microtubule-related axonal transport 
 
Tau is best known as a microtubule associated protein (MAP). In adult neurons, the majority 
of tau localises to the axons, where it binds with the microtubules, the tracks for the 
intracellular transport of organelles, proteins and mRNA, through the microtubule binding 
domain. Thus, tau stabilises the microtubules and promotes microtubule assembly. The 
ability of tau to bind microtubules is regulated by phosphorylation. The phosphorylation 
state of tau is highly dynamic and regulated by various kinases and phosphatases. Tau 
considerably increases microtubule polymerisation and reduces microtubule 
depolymerisation in vitro (Drechsel et al., 1992). In normal neurons, the amount of tau 
greatly exceeds the amount of tubulin (~tenfold), therefore nearly all tau is microtubule 
bound in the cell (Iqbal et al., 2009). Tau is also able to bind actin through the N-terminal 
domain and cross-link microtubules to microfilaments and thereby stabilise, regulate and 
allow reorganisation of the cytoskeleton. This cross-linking is disrupted in tauopathies (Fulga 
et al., 2007). 
 
In addition to regulating microtubule dynamics, tau can regulate axonal transport by 
influencing the function of the motor proteins, dynein and kinesin. Dynein transports cargo 
in a retrograde direction (towards the cell body), whereas kinesin transports cargo in an 
anterograde direction (towards the axon terminus). Tau can influence the binding of motor 
proteins to both microtubules and cargo (Seitz et al., 2002; Vershinin et al., 2007). 
Additionally, tau controls the release of cargo vesicles from kinesin chains by activating a 
GSK signalling cascade via its extreme N-terminal domain (Kanaan et al., 2011). 
Furthermore, tau can facilitate dynein-mediated transport by binding to its cofactor 
dynactin, and thereby stabilising the interaction of dynein with the microtubules (Magnani 
et al., 2007). However, because all of these studies were done in vitro or in cultured cells 
and tau knockout mice show no obvious defects in axonal transport (Yuan et al., 2008), it is 







1.4.2   Function of dendritic and nuclear tau  
 
A tiny amount of tau localises to the nucleus. Nuclear tau can bind to DNA through the 
proline rich and microtubule binding domain (Camero et al., 2014). Tau 
hyperphosphorylation compromises the ability of tau to enter the nucleus and bind to DNA. 
Thus, tau hyperphosphorylation substantially reduces both microtubule and DNA binding 
(Qi et al., 2015). Nuclear tau contributes to DNA protection in both physiological and 
hypothermic stress conditions (Sultan et al., 2011; Violet et al., 2014). Furthermore, nuclear 
tau also been reported to be involved in the DNA repair mechanism (Rossi et al., 2013; 
Violet et al., 2014). Nuclear tau has also been shown to regulate gene expression. Via the 
proline-rich and microtubule binding domain, tau binds to the AT rich minor grove of DNA 
causing a conformational change. The altered DNA conformation affects the activity of 
multi-protein DNA complexes that control gene transcription (Sultan et al., 2011; Rossi et 
al., 2013; Qi et al., 2015). In support of this, ~20 genes have been identified whose 
transcription is altered in a tau knockout mice (Gomez de Barreda et al., 2010). Finally, 
nuclear tau has also been reported to be involved in chromosome stability and 
processing/silencing of rRNA (Rossi et al., 2013). A tiny amount of tau localises to the 
dendrites and dendritic spines (Ittner et al., 2010). In cell culture, pharmacological synaptic 
activation causes endogenous tau to translocate from the dendritic spines into the 
excitatory postsynaptic compartment. These results suggest a role for dendritic tau in 
synaptic plasticity, however the precise mechanisms are as of yet unclear (Frandemiche et 
al., 2014).  
 
1.4.3   Other functions of tau  
 
Tau has been shown to play critical roles in synaptic plasticity and neurogenesis. For 
example, tau knockout mice show defective long-term depression (LTD) in the hippocampus 
(Kimura et al., 2014). Concurrently, a different study has shown tau knockout mice show 
defective long-term potentiation (LTP) in the hippocampus (Ahmed et al., 2014). Tau has 
been reported to be involved in neurogenesis and neuronal migration (Hong et al., 2010; 






granule formation and trafficking (Vanderweyde et al., 2016). Many studies have noted the 
role of tau in mediating network hyperactivity in disease models. Knocking out tau rescues 
the excitotoxicity produced by Aβ in mice overexpressing either human APP or human APP 
and PS1 (Roberson et al., 2007; Ittner et al., 2010). Similarly, reduction of endogenous tau 
with antisense oligonucleotides (ASO) suppresses seizures in chemically induced seizure 
models (DeVos et al., 2013). These studies suggest a role for tau in mediating pathological 
network hyperactivity, however, it is currently unknown whether tau is involved in 
regulating physiological network activity. A recent study has shown that tau modulates 
cellular iron export. The interaction of APP with ferroportin at the cell surface is essential for 
iron export and tau is involved in the trafficking of APP to the cell surface. In aged tau 
knockout mice, iron accumulation results in neuronal death in the substantia nigra. In 
tauopathies, there is an accumulation of iron in brain regions with reduced soluble tau such 
as the cortex in AD (Lei et al., 2014). A small amount of tau localises to glial cells, but the 
role of tau in glia is as of yet unknown (Muller et al., 1997). Despite a vast amount of 
research the physiological role of tau remains poorly understood.  
 
1.5   Pathological function  
 
Currently, the underlying mechanisms of tau-induced neurodegeneration are poorly 
understood (despite a vast amount of research). Abnormal tau modifications including mis-
splicing, various PTMs including phosphorylation and aggregation convert physiological tau 
species into pathological tau species. In familial tauopathies (<5 % of cases), mutations in 
the MAPT gene cause tau pathology, whereas in sporadic tauopathies, the cause of tau 
pathology is unknown. It is unclear whether pathological tau causes neurodegeneration by 
loss-of-function or toxic gain-of-function (for recent indepth reviews see Wang and 
Mandelkow, 2016 and Guo et al., 2017).  
 
1.5.1   Tau mutations  
 
Currently, around 80 mutations have been identified in the MAPT gene. These mutations 






Coppola et al., 2012). They are either missense or splicing mutations. Missense mutations 
tend to be located in the C-terminal half of tau (for example P301L, V337M or R406W) and 
result in tau protein with reduced affinity for microtubules and increased propensity to 
aggregate (Hong et al., 1998; Barghorn et al., 2000). Splicing mutations tend to promote the 
inclusion of exon 10 and thereby increase the 4r-3r tau ratio. It is unknown how altering the 
3r-4r ratio triggers aggregation; it might be due to the different microtubule binding abilities 
and phosphorylation susceptibilities of 3r and 4r tau.  
 
1.5.2   Loss–of-function 
 
Even though tau function to a certain extent can be compensated by MAP1A and MAP2, 
aged (12-month old) tau knockout mice show behavioural impairments. Thus, tau is 
required for normal functioning of the brain (Lei et al., 2014). Furthermore, dementia 
lacking distinctive histopathology (DLDH), which is characterised by neuronal loss in the 
absence of any brain lesions, is caused by reduced tau levels (Zhukareva et al., 2001). 
Hyperphosphorylation of tau substantially reduces microtubule binding, which leads to 
cytoskeleton destabilisation. Tau aggregation reduces the amount of soluble functional tau, 
which also reduces microtubule binding and leads to cytoskeleton destabilisation. Thus, tau 
loss-of-function due to either hyperphosphorylation or aggregation can lead to a damaged 
microtubule network. An intact microtubule network is needed for efficient axonal 
transport. Often in tauopathies, cargo accumulates in both the axons and cell body leading 
to ‘traffic jams’ (Millecamps and Julien, 2013). Thus, axonal transport defects may 
contribute to disease pathogenesis. In support of this, one of the earliest abnormalities in 
several animal models of tauopathies are defects in axonal transport (for review see 
Ballatore et al., 2007). For example, human tau expression in Drosophila larval motor 
neurons disrupts axonal transport as evidenced by overaccumulation of transport vesicles in 
the motor neuron axon (Mudher et al., 2004; Chee et al., 2005). Additionally, K3 mice, which 
express human tau with the K389I mutation, show impaired anterograde axonal transport of 







Pathological tau disrupts axonal transport by interfering with the function of the motor 
proteins, dynein and kinesin. Overexpression of tau inhibits access of the motor proteins to 
the microtubule tracks (Seitz et al., 2002). In vitro, tau is capable of reducing the velocity of 
kinesin-mediated retrograde transport (Dixit et al., 2008). Overexpression of tau reduces the 
amount of cargo bound to motor proteins by sequestering available motors (Vershinin et al., 
2007). Protein levels of the components of the dynein and kinesin complexes are reduced in 
brains from AD patients compared with brains from healthy controls (Seward et al., 2013). 
Tau overexpression causes selective inhibition of kinesin-mediated anterograde transport, 
resulting in an accumulation of cargo, such as mitochondria, endoplasmic reticulum (ER) and 
synaptic proteins in the cell body. Depletion of mitochondria and ER in the axon produces a 
decrease in glucose and lipid metabolism and ATP synthesis that results in energy 
deprivation and oxidative stress, which leads to ‘dying back’ axonal degeneration. For 
example, human tau overexpression in the Drosophila larval motor neurons causes 
morphological changes and perturbs synaptic transmission as a result of impaired axonal 
transport of mitochondria (Chee et al., 2005). Disruption of any of the various processes 
that tau is involved in, including, neuronal activity, synaptic plasticity, DNA protection and 
iron export may play a part in the neurodegenerative process.  
 
In post mortem brain tissue from individuals with AD tau in NFTs is always 
hyperphosphorylated, and tau hyperphosphorylation precedes aggregation (Braak et al., 
1994). However, whether tau hyperphosphorylation drives aggregation remains disputed. In 
vitro, hyperphosphorylated tau isolated from AD patient brains forms aggregates (Alonso et 
al., 2001). However, tau hyperphosphorylation is not necessarily toxic as it occurs during 
animal hypothermia and anaesthesia-induced hypothermia (Arendt et al., 2003), and may 
even have a protective effect (Schneider et al., 1999). Therefore, tau hyperphosphorylation 
is not sufficient to cause aggregation in all circumstances. Furthermore, in vitro tau 
hyperphosphorylation is not necessary for aggregate formation, (Goedert et al., 1996).  
 
The ability of hyperphosphorylated tau to enter the nucleus and bind to DNA is 
compromised (Camero et al., 2014). The lack of nuclear tau results in stress-induced DNA 






which is fatal to differentiated neurons (Seward et al., 2013). Loss of tau function in the 
nucleus can also lead to altered gene expression, which in turn causes altered protein 
synthesis (Frost et al., 2014; Hernandez-Ortefa et al., 2016). However, it is also possible 
hyperphosphorylated tau in the nucleus has a toxic gain-of-function. Rod-like tau aggregates 
have been found in neuronal nuclei in tauopathies such as AD, FTD and HD (Metuzals et al., 
1988; Fernandez-Nogales et al., 2014). Although the consequences of harbouring tau 
aggregates in the nucleus are, as of yet, unidentified. 
 
1.5.3   Neurotoxic toxic gain-of-function 
 
In AD brains, the region distribution of NFTs correlates well with cognitive deficits. So 
initially the NFTs were thought to cause neurodegeneration. However, recent findings have 
shown NFT formation is not required for, or sufficient to cause, neurodegeneration. In post 
mortem brain tissue from AD patients, the number of NFTs greatly exceeds neuron loss, 
indicating that most neurons die without having formed NFTs (Gomez-Isla et al., 1997). 
Additionally, neurons containing NFTs in AD can survive for up to 20 years (Morsch et al., 
1999). In mice overexpressing human wild-type or mutant tau, neuronal death does not 
coincide with tau aggregation. Neurons can die without forming aggregates and neurons 
which contain aggregates do not die and appear functional (Andorfer et al., 2005). 
Additionally, mice overexpressing human wild-type or mutant show cognitive deficits, 
impaired synaptic transmission and synapse loss before or without aggregation formation. 
For example, Tg4510 mice, which overexpress inducible human tau with P301L mutation, 
develop age-related NFTs, neuronal loss and cognitive abnormalities. Switching off tau 
expression rescues the cognitive impairments even though the NFTs continue to form 
(Santacruz et al., 2005). Similarly, mice, which overexpress regulatable human tau with the 
ΔK280 mutation, show age-dependent aggregate formation, synapse loss, cognitive deficits 
and loss of LTP. When tau expression is switched off, memory and LTP recover, even though 
the aggregates remain (Sydow et al., 2011; Van der Jeugd et al., 2012). Furthermore, 
Drosophila overexpressing human wild-type or mutant tau show neuronal loss and 
behavioural impairments in the absence of aggregate formation (Wittmann et al., 2001; 






studies suggest that tau-mediated neuronal dysfunction and degeneration is caused by a 
soluble tau species, rather than NFTs. Different isoforms, mutations and PTMs lead to an 
enormous number of different tau species, which mostly likely contribute to the clinical and 
neuropathological heterogeneity found in tauopathies (Sanders et al., 2014). It has been 
proposed that NFT formation is a protective cellular response because the NFTs can 
scavenge toxic soluble tau species (Alonso Adel et al., 2006). Recent evidence shows that 
tau oligomers rather than NFTs are the toxic species in tauopathies. Levels of soluble tau 
oligomers are increased in brains from AD patients compared to brains from healthy 
controls (Lasagna-Reeves et al., 2012). Additionally, several studies have demonstrated 
soluble tau oligomers are toxic in cultured mouse neurons (Tian et al., 2013; Tepper et al., 
2014). 
 
Hyperphosphorylated tau is able to mediate its toxic effects independent of aggregation. 
For example, hyperphosphorylated tau interacts with the scaffolding protein, c-Jun N-
terminal kinase-interacting protein 1 (JIP1) and impairs formation of the kinesin complex, 
which thus disrupts axonal transport (Ittner et al., 2009). Additionally, in various animal 
models of tauopathy, hyperphosphorylated tau promotes neurodegeneration by causing 
aberrant alignment and accumulation of F-actin filaments (Fulga et al., 2007). 
Hyperphosphorylation of tau alters its degradation, through both the unfolded protein 
response (UPR) and autophagosome/lysosomal system. For example, tau phosphorylation at 
Ser262 and Ser356 interferes with the binding of the ubiquitin ligase, C-terminus of HSP70-
interacting-protein (CHIP), which therefore protects tau from proteasome-mediated 
degradation (Dickey et al., 2007).  
 
Under normal circumstances, only small amounts of tau localise to the dendrites. 
Mislocalisation of tau to the dendrites occurs at an early stage of the disease process. Tau 
modifications (PTMs and mutations) and increasing the level of tau can all lead to the 
mislocalisation of tau into the somatodendritic compartment. For example, transfection of 
tau in mature hippocampal neurons causes the redistribution of tau into the 
somatodendritic compartment, which coincides with loss of dendritic spines (Thies and 






accumulates in the somatodendritic compartment. Overaccumulation of tau in the 
dendrites interferes with the trafficking and anchoring of NMDA receptors to the post 
synaptic membrane, resulting in defective synaptic transmission (Hoover et al., 2010). 
Expression of the LRK2 kinase in adult dopaminergic neurons in Drosophila causes 
degeneration of the dendritic arborizations as a result of hyperphosphorylation and 
mislocalisation of endogenous tau into the somatodendritic compartment. LRK2-mediated 
dendritic degeneration is rescued by knockdown of endogenous tau (using RNAi) and 
enhanced by overexpression of human wild-type tau. Thus, hyperphosphorylation and 
subsequent mislocalisation of tau is enough to cause dendritic degeneration in Drosophila 
(Lin et al., 2010). Additionally, mislocalisation of tau to the somatodendritic compartment 
results in a reduction in the amount of soluble functional tau to bind to and stabilise axonal 
microtubules. The mechanisms of tau missorting are not well understood.  
 
Recent evidence has demonstrated dendritic tau is involved in amyloid-beta (Aβ)-induced 
neurotoxicity. For example, in cultured hippocampal neurons Aβ oligomers cause the 
mislocalisation of endogenous tau into the somatodendritic compartment, which leads to 
dendritic spine loss (Zempel et al., 2010). Dendritic tau recruits the FYN kinase to the 
postsynaptic compartment, where it phosphorylates the NDMA receptor subunit, 
NR2B/GluNRB, causing increased calcium conductance and thereby enhancing Aβ 
excitotoxicity (Roberson et al., 2007; Ittner et al., 2010). Tau also mediates Aβ-induced cell 
cycle re-entry. Exposure of cultured wild-type neurons to Aβ oligomers causes cell cycle re-
entry and activation of various kinases. In contrast, in cultured tau knockout neurons, Aβ 
oligomers are unable to trigger cell cycle re-entry (Seward et al., 2013).  
 
1.6   Modelling neurodegenerative disease in Drosophila 
 
Drosophila have been used to study biological questions for well over a 100 years. As such, 
Drosophila have contributed to our understanding of a wide number of processes including 
circadian rhythms, learning and memory and synaptic transmission (for a comprehensive 
review see Bellen et al., 2010 and Pandey and Nichols, 2011). The conservation of 






degree of conservation between the human and Drosophila genome (the majority of 
disease-linked genes have Drosophila orthologues), suggests we may be able to use 
Drosophila to investigate the underpinnings of mammalian disease (Bier, 2005). During the 
last decade, several Drosophila models of neurodegenerative disease (including AD, PD and 
HD) have been created (reviewed in Marsh and Thompson, 2006 and Iijima-Ando and 
Iijiama, 2010). It is possible to study circadian rhythms in Drosophila at both a cellular and 
circuit level. In Drosophila it is possible to assess the consequences of manipulating small 
groups of neurons or even individual neurons. Moreover, the anatomy and physiology of 
Drosophila are relatively well understood. Drosophila have a fully sequenced and highly 
annotated genome, ~13,600 protein coding genes located in only four chromosomes 
(Adams et al., 2000). There is less genetic redundancy in Drosophila than in humans. 
Drosophila are easy and inexpensive to maintain.  
 
Drosophila have been used to study circadian rhythms for nearly five decades (Konopka and 
Benzer, 1971). In Drosophila, circadian rhythms and sleep are studied by recording 
locomotor activity using the DAM system (TriKinetics, Walthman, MA). In the DAM system, 
individual flies are placed in glass tubes which are bisected by an infrared beam. When a fly 
is active it breaks the infrared beam and this activity is recorded. The DAM system is placed 
in light and temperature controlled incubators and activity is measured over several days 
(Chiu et al., 2010). In rodents, there are several different systems to monitor locomotor 
activity, including wheels, cages with infrared beams and piezoelectric systems, which may 
differentially influence circadian rhythms and sleep (Siepka and Takahashi, 2005; Bains et 
al., 2018). Additionally, the genetic background of transgenic mice has a profound effect on 
circadian behaviour and sleep (Banks et al., 2015). Thus, it is difficult to directly compare 
different studies because you don’t know if differences are real or contributed to by 
differing methodology or genetic background. Genetic background also has a major 
influence on sleep in Drosophila (Zimmerman et al., 2012). However, it is much quicker and 
easier to outcross into a common genetic background in Drosophila than in mice. Drosophila 
better recapitulate the sleep-wake cycle in humans than rodents. Mice are nocturnal and 
have fragmented sleep, whereas, Drosophila are diurnal and have a period of consolidated 






diseases, like AD, which are characterised by circadian rhythm and sleep disruption, in 
addition to cognitive deficits. It is possible to combine the tools to study circadian behaviour 
and model neurodegenerative disease in Drosophila to shed light on the circadian 
dysfunction in human tauopathies, such as AD (Chen et al., 2014; Long et al., 2014). There is 
a panoply of tools to monitor neuronal function and death in Drosophila (for review see 
Ugur et al., 2016). Drosophila have a short lifespan (2-3 months) and so are well suited to 
studying late-onset progressive neurodegenerative diseases. 
 
The main advantage of Drosophila is the extensive genetic toolkit (Adams and Sekelsky, 
2002). In Drosophila genetics, the Swiss army knife is the binary Gal4-UAS system. Gal4 is a 
yeast transcription factor that binds to Upstream Activation Sequences (UAS). Gal4 activates 
UAS-transgenes expression in all cells it is expressed in. Therefore, to produce tissue specific 
UAS-transgene expression, Gal4 is placed under the control of a tissue-specific promoter. 
There is a large collection of Gal4 drivers that express in single cells, groups of cells or entire 
tissues (Brandt and Perrimon, 1993). Frequently used are the GMR driver, inducing pan-
retina expression, and Elav driver, inducing pan-neuronal expression (Brand and Perrimon, 
1993). It is also possible to use the Gal4/UAS system to coexpress various different UAS-
transgenes in the same tissue. It is also possible to further restrict UAS-transgene expression 
to a smaller number of cells by using the Gal4 repressor, Gal80 (Suster et al., 2004). Both 
Gal4 and Gal80 are placed under the control of different tissue-specific promoters whose 
expression partially overlaps. Gal4 is only able to activate UAS-transgene expression in cells 
in which it is expressed in but Gal80 is not. 
 
Most commonly used Gal4 drivers activate UAS-transgene expression during development. 
When modelling adult-onset neurodegenerative disease it is often necessary to restrict 
expression to adulthood. Modifications of the Gal4/UAS system allows for combined spatial 
and temporal control of UAS transgene expression. The TARGET system (McGuire et al., 
2003) uses a temperature-sensitive variant of the Gal4 repressor, Gal80 (Gal80ts). At 18 °C 
(permissive temperature), Gal80ts is active and inhibit Gal4 activity. Whereas, after shifting 
the flies to 29-30 °C (restrictive temperature), Gal80ts becomes inactive and permits Gal4 






variant of Gal4 (Osterwalder et al., 2001). In the absence of RU458, RU486 sensitive Gal4 is 
unable to activate UAS-transgene expression. When RU458 is present it binds to RU458 
sensitive Gal4 and activates UAS-transgene expression. To activate RU458 sensitive Gal4 
driven UAS-transgene expression, RU458 is added to fly food. Drosophila are amenable to in 
vivo (genetic or pharmacological) medium to high-throughput enhancer/suppressor screens 
because of two main reasons. First, it is simple and inexpensive to set up 100s or even 1000s 
of fly crossings. Second, several robust readouts of neuronal degeneration and dysfunction 
exist in Drosophila (Ugur et al., 2016).  
 
1.7   Drosophila models of tauopathy  
 
1.7.1   Neuronal toxicity 
 
Tauopathies are neuropathologically characterised by brain deposits of aberrantly 
phosphorylated and misfolded wild-type or mutant tau. Consequently, to create Drosophila 
models of tauopathies the Gal4/UAS system has been used to overexpress wild-type or FTD-
linked mutant tau in particular neurons (or glia) in larval or adult Drosophila. The effects of 
overexpressing tau can be examined by studying neuronal death and neuronal function (for 
review see Papanikolopoulou and Skoulakis, 2011; Cowan et al., 2011; Gistelinck at al., 
2012). William et al. (2000) was the first anatomical study to show that tau expression 
causes neurotoxicity in Drosophila. The authors showed expression of bovine tau fused with 
GFP in larval sensory neurons causes axonal degeneration. 
 
Subsequently, many Drosophila models of human tauopathy were then created by 
transgenetically expressing human wild-type or FTD-linked mutant (R406W/V337M) tau. 
Human wild-type tau (0n4r isoform) expression throughout the CNS causes progressive age-
related neurodegeneration and vacuolisation in neurons throughout the brain (Wittmann et 
al., 2001; Nishimura et al., 2004). Tau-expressing flies also die a lot sooner than controls. 
This most likely represents bona fide degeneration, because it only seems to affect adult 
terminally differentiated neurons, because no neurodegeneration or vacuolisation was 






AD patients or in AD mouse models, however neurodegeneration in Drosophila is often 
accompanied by vacuolisation. Vacuolisation probably reflects the rapid tempo of 
neurodegeneration in flies. There is evidence of apoptosis in tau-expressing flies, as 
indicated by the presence of TUNEL-positive cells. Tau-mediated neurodegeneration 
coincides with a substantial increase in tau phosphorylation (including at the AT8 and AT100 
epitopes). No aggregates were detectable immunohistochemically in fly neurons, not even 
in old flies. Thus, aggregates are not needed to cause neuronal death in this model. 
Therefore, it appears soluble hyperphosphorylated tau species are intrinsically toxic. Thus, 
Drosophila models of tauopathy recapitulate the early pre-aggregate events of tau-
associated neurodegeneration. FTD-linked mutant tau precipitates a more severe 
pathological phenotype than wild-type tau. Increasing tau dosage also enhances the severity 
of the pathological phenotype. Tau expression throughout the CNS preferentially targets 
cholinergic neurons. This model successfully recapitulates many features of human 
tauopathies, such as AD.  
 
Tau expression throughout the CNS also dramatically affects the mushroom bodies (MBs). 
The MBs are composed of ~2,000 neurons and play an essential role in learning and memory 
(functionally analogous to the hippocampus) (for review see Heisenberg, 2003). Pan-
neuronal tau expression (0n4r or 2n4r isoform) throughout development results in nearly 
complete ablation of the MBs (other brain structures are unaffected) (Kosmidis et al., 2010). 
This was due to the toxic effect of hyperphosphorylated tau on the MB neuroblasts that 
develop into MB neurons. Therefore, it does not reflect bona fide degeneration because tau 
interferes with the development of MB neurons rather than causes the loss of extant adult 
MB neurons. Tau-mediated MB ablation requires tau phosphorylation. Expression of mutant 
tau with a reduced ability to be phosphorylated does not cause MB ablation. In contrast, 
expression of pseudophosphorylated tau has a more dramatic effect on the MBs than wild-
type tau. The selective loss of MB neurons in flies pan-neuronally expressing tau, 
demonstrates the differential susceptibility of different neuronal types to tau pathology. 
2n4r tau produces a more severe effect on the MB neuroblasts than 0n4r tau. Whereas, 
FTD-linked mutant tau produces a weaker effect on the MB neuroblasts than wild-type tau, 






Glial cells are commonly affected in tauopathies (Ikeda et al., 1995; Berry et al., 2001; 
Ballatore et al., 2007). Inducible expression of human tau in adult glia results in 
neurodegeneration in both neurons and glia and decreased longevity. Tau becomes 
hyperphosphorylated at the AT8 and AT100 epitopes (via the JAK/STAT signalling pathway) 
and, in contrast to neurons, forms fibrillar glial aggregates, reminiscent of NFTs, and triggers 
apoptosis. However, switching-off tau expression results in a reduction in the number of 
apoptotic cells, without any concurrent change in the number of glial tangles. These results 
further suggest that soluble hyperphosphorylated tau species (rather than glial aggregates) 
mediate tau-linked neurodegeneration in Drosophila (Colodner and Feany, 2010).  
 
Tau expression in fly eye causes retinal toxicity, which manifests as a rough eye phenotype 
(REP), characterised by a reduced eye size and disrupted ommatidial organisation. The REP 
is also associated with degeneration and vacuolisation in the optic lobe. The adult fly retina 
is composed of ~800 identical units called ommatidia, arranged in a hexangular array. Each 
ommatidia contains eight photoreceptor neurons and twelve accessory cells (Ready et al., 
1976; Wolff and Ready, 1991). Expression of various tau isoforms and proteins using GMR-
Gal4, which is expressed throughout the eye, causes a REP (Jackson et al., 2002; 
Grammenoudi et al., 2008). However, an important note is that the Drosophila eye surface 
is formed during late larval and pupal stages in development (Moses et al., 1991; Ellis et al., 
1993). This combined with the fact that GMR-Gal4 is expressed during development, means 
that a REP in newborn adult flies is probably caused by tau-dependent toxicity during 
development (similar to the toxic effects of tau on the MB neuroblasts), rather than bona 
fide degeneration. 
 
Whether tau phosphorylation is required for tau toxicity has been extensively studied using 
the REP (Jackson et al., 2002; Nishimura et al., 2004; Steinhilb et al., 2007; Chatterjee et al., 
2009; Ambegaokar and Jackson, 2010). Jackson et al. (2002) demonstrated coexpression of 
the Shaggy (SGG, the fly homology of GSK3β) kinase enhanced the REP and precipitated the 
formation of large NFT-like aggregates in the optic lobe. To date no other study in 
Drosophila has reported NFT formation apart from in glia. This study linked tau 






though a series of elegant experiments that tau phosphorylation is critical in tau-mediated 
toxicity. They showed coexpression of the PAR1 kinase with human tau increases its 
phosphorylation at Ser262/Ser356 (12E site) and exacerbates the REP. In contrast, tau that 
is unable to be phosphorylated at the PAR1 phosphorylation sites (2n4r tauS2A; which has 
alanine substitutions at Ser262/Ser356) fails to cause a REP. Another study has shown that 
expression of a phosphomimetic tau mutant (0n4r tauE14) causes a more severe REP, whilst 
a nonphosphorylatable mutant (0n4r tauAP) fails to cause a REP (Fulga et al., 2007). The REP 
is frequently used in unbiased high-throughput enhancer/suppressor screens, because it is 
easily quantifiable and provides a robust readout of tau neurotoxicity. Several independent 
screens have successfully identified numerous modifiers of tau neurotoxicity, a number of 
which, perhaps unsurprisingly, were kinases (including SGG and PAR1) and phosphatases 
(such as PP2A). However, several other novel modifiers have been identified, including 
cytoskeleton proteins, molecular cochaperones, ion transporting ATPases, transcription 
cofactors and RNA binding proteins (Shulman and Feany, 2003; Blard et al., 2006; Blard et 
al., 2007; Ambegaokar and Jackson, 2011).  
 
1.7.2   Neuronal dysfunction 
 
Several Drosophila models have shown tau expression causes substantial neurotoxicity, 
however other Drosophila models have shown behavioural abnormalities without any 
apparent neuronal death. Cognitive deficits are a cardinal symptom of most tauopathies 
(Irwin, 2016). Additionally, the cognitive deficits may first appear prior to overt NFT 
formation and neuronal death (Oddo et al., 2003a; Oddo et al., 2003b). Mershin et al. (2004) 
investigated the effects of tau overexpression in adult MB neurons in Drosophila. The MBs 
are required for learning and memory in Drosophila. Human wild-type tau (0n4r or 2n4r 
isoform) or Drosophila tau expressed in adult MB neurons precipitates olfactory associative 
learning and memory deficits before or in the absence of obvious neurodegeneration 
(Kosmidis et al., 2010). Neurodegeneration was detected in no flies up to 45-days of age and 
in only a few flies over 45-days of age. Because the authors restricted tau expression to 
adulthood they were able to circumvent the toxic effects of tau on MB neuroblasts during 






dependent neuronal dysfunction, because they are not due to tau-mediated toxicity on the 
MB neuroblasts. No aggregates were detectable (neither biochemically nor 
immunohistochemically) in the tau-expressing flies. Thus, these results suggest soluble tau 
species mediate tau-dependent neuronal dysfunction in Drosophila. FTD-linked mutant tau 
precipitates a milder effect than wild-type tau on associative learning (Grammenoudi et al., 
2008). Similar findings were reported by Papanikolopoulou et al. (2010). The authors 
showed expression of human WT tau (0n4r or 2n4r isoform) in the adult CNS (using the 
TARGET system) impairs associative learning without affecting MB morphology. Collectively, 
these results suggest the impaired olfactory learning is due to toxic gain-of-function effects 
caused by tau overaccumulation in the adult MB neurons. Similar findings reported in a 
mice model of tauopathy. Mice overexpressing human wild-type tau (2n4r isoform) display 
cognitive impairments without any overt neuronal loss (Kimura et al., 2007). Collectively, 
these results show tau expression in the MBs produces temporally separable dysfunction 
and degeneration. Tau expression in MB neuroblasts is toxic, whereas tau expression in 
adult MB neurons causes neuronal dysfunction without neuronal death. 
 
Tau expression in the larval motor neurons also leads to neuronal dysfunction (Mudher et 
al., 2004; Chee et al., 2005; Ubhi et al., 2007). Mudher et al. (2004) showed expression of 
human wild-type tau (0n3r isoform) in larval motor neurons disrupts neuromuscular 
junction morphology and axonal transport, which causes obvious defects in larval locomotor 
function. Similarly, Chee et al. (2005) showed human wild-type tau (0n4r isoform) or 
Drosophila tau expression disrupts endo/exocytosis, resulting in dramatically reduced 
synaptic potentials. The synaptic transmission perturbations are due to axonal transport 
defects, resulting in a depletion of mitochondria in the presynaptic terminal. Behavioural 
abnormalities coincide with an increase in tau phosphorylation. Tau phosphorylation by SGG 
is important for tau-linked axonal transport defects. Reducing tau phosphorylation by LiCl 
treatment (SGG inhibitor) mostly rescued the behavioural impairments. In contrast, 
increasing tau phosphorylation by coexppression of SGG enhanced the behavioural 
impairments, as it does for retinal toxicity, suggesting a common pathogenic mechanism 
(Mudher et al., 2004). The authors found no detectable aggregates or cell loss in any of 






neuromuscular junction (NMJ) in Drosophila is caused by soluble hyperphosphorylated tau 
species. Collectively, this evidence from both the adult brain and larval neuromuscular 
junction suggests that tau-mediated neuronal dysfunction is separable from toxicity. 
 
1.8   Circadian rhythms  
 
Circadian rhythms are ~24 hour rhythms in behaviour and physiology. They are entrained by 
environmental cues (e.g. light and temperature) but persist or free run without these cues. 
Circadian rhythms are not passively driven by environmental cycles but generated by an 
endogenous timekeeping mechanism, called the circadian clock. The circadian clock allows 
organisms to adapt to and prepare for changes in the environment (e.g. the best time to 
find food or a mate) (Hut et al., 2012). The importance of the circadian clock is underscored 
by its ubiquity, clocks are present in organisms ranging from prokaryotes to mammals. In all 
organisms, circadian systems are composed of three parts: the timekeeper, input pathways 
(e.g. from the eye) and output pathways (e.g. to the motor centres). Circadian rhythms 
regulate a vast number of functions in the body, including sleep and wakefulness, body 
temperature and hormone production. Sleep-wake cycle and circadian rhythm disturbances 
often compromise health. Many studies have shown damage to the circadian system leads 
to accelerated aging (Kondratova and Kondratov, 2012). Furthermore, other studies in both 
mice and humans have shown sleep and circadian disturbances lead to neurodegenerative 
pathology, including AD (Kang et al., 2009). Finally, in humans the breakdown of daily 
circadian rhythms, induced by shift work or jetlag for example, is a risk factor for the 
development of cardiovascular disease, cancer and metabolic syndromes (Kondratov and 
Antoch, 2007; Takahashi et al., 2008; Sahar and Sassone-Corsi, 2009; Bass and Takahashi, 
2010).  
 
1.9   Molecular circadian clock  
 
In all organisms, circadian rhythms at a cellular and molecular level are controlled by 
interlocking autoregulatory transcription/translation feedback loops (TTLs) (Figure 1.2) (for 






the main TTL basic helix-loop-helix (bHLH)-PAS transcription factors, CLOCK (CLK) and 
BMAL1 heterodimerise and activate transcription of 100s of genes by binding E-boxes in 
their promoters, including period 1-3 (mPer), cryptochrome 1-2 (mCry). mPer and mCry are 
translated in the cytoplasm. PER and CRY heterodimerise. PER/CRY heterodimers 
accumulate in the cytoplasm. Following a delay, PER/CRY heterodimers enter the nucleus 
and inhibit CLK/BMAL1-mediated transcription. After another delay, PER/CRY heterodimers 
are degraded, which allows CLK/BMAL1 heterodimers to bind E-boxes and start a new cycle 
of transcription (Gekakis et al., 1998; Zheng et al., 1999; Shearman et al., 2000; Lee et al., 
2001). The timing of the nuclear entry of PER/CRY heterodimers is regulated by PER 
phosphorylation by glucose synthase kinase (GSK3) and casein kinase II (CKII). The stability 
of PER/CRY heterodimers is regulated by PER phosphorylation by casein kinase IƐ (CKI) and 
NEMO. PER is degraded via the proteasome following phosphorylation by CKI and 
ubiquitination by β-TrCP. In the SCN (master pacemaker), light from the retinohypothalamic 
tract (RHT) entrains the clock by activating transcription of mPer genes (Hankins et al., 
2008). 
 
In Drosophila, in the main TTL bHLH-PAS transcription factors, CLOCK (CLK) and CYCLE (CYC) 
heterodimerise and activate transcription of a vast number of genes by binding E-boxes in 
their promoters, including period (per) and timeless (tim). Per and tim are translated in the 
cytoplasm. PER and TIM heterodimerise. PER/TIM heterodimers accumulate in the 
cytoplasm. Following a delay, PER/TIM heterodimers enter the nucleus and inhibit CLK/CYC-
mediated transcription. After another delay, PER/TIM heterodimers are degraded, which 
allows CLK/CYC heterodimers to bind E-boxes and start a new cycle of transcription (Allada 
et al., 1998; Darlington 1998; Rutila et al., 1998) . The timing of the nuclear entry of PER/CRY 
heterodimers is regulated by PER phosphorylation by SHAGGY (SGG) and casein kinase II 
(CKII). The stability of PER/CRY heterodimers is regulated by PER phosphorylation by 
DOUBLETIME (DBT) and NEMO. PER is degraded via the proteasome following 
phosphorylation by DBT and ubiquitination by SLIMB. At a cellular level, Drosophila entrain 
the clock using the blue-light sensitive photoreceptor, CRYTOCHROME (CRY). Light-activated 
CRY promotes TIM degradation via the proteasome (which affects the stability of PER) (Koh 






A second interlocked TTL drives the cyclic expression of Bmal1 in mammals and Clk in 
Drosophila. In mammals, nuclear hormone receptors ROR α/β/γ and REVERB α/B bind Rev 
response elements (RREs) in the Bmal1 promoter to activate and repress Bmal1 
transcription, respectively (Guillaumond et al., 2005). In Drosophila, bZIP transcription 
factors PDP1 δ/Ɛ and VRILLE (VRI) bind D boxes in the Clk promotor to activate and repress 
Clk transcription, respectively (Cyran et al., 2003). Additionally, CLK/BMAL1 complexes in 
mammals and CLK/CYC complexes in Drosophila activate transcription of Dec1-2 and 
clockwork orange (cwo), respectively. DEC1-2 and CWO feedback to repress the activity of 
BMAL1 and CLK, respectively, by binding E boxes in their promoters (Honma et al., 2002; 

















Figure 1.2: Circadian molecular clock in Drosophila (A) and mammals (B). (A) In the main TTL, CLK/CYC 
heterodimers activate transcription of per and tim genes by binding to E boxes in their promoters. Per and tim 
are translated in the cytoplasm. PER and TIM form heterodimers. PER/TIM heterodimers accumulate in the 
cytoplasm and following a delay, enter the nucleus, and repress CLK/CYC-mediated transcription. CLK/CLK 
heterodimers also activate transcription of Pdp1 δ/Ɛ and vri genes by binding to E-boxes in their promoters. 
Clk expression is regulated by PDP1 δ/Ɛ and VRI which bind to a D-box in the Clk promoter. CLK and CYC are 
phosphorylated by DBT and SGG, which modulates the timing of nuclear entry and stability of CLK/CLK 
heterodimers. At the cellular level, the clock is entrained by the photoreceptor, CRY. Light-activated CRY 
promotes TIM degradation. (B) In the main TTL, BMAL1 and CLK heterodimers activate transcription of mPer 
and mCry genes by binding to E-boxes in their promoters. mPer and mCry are translated in the cytoplasm. PER 
and CRY form heterodimers. PER/CRY heterodimers accumulate in the cytoplasm and following a delay, enter 
the nucleus, and repress CLK/BMAL1-mediated transcription. PER/CRY heterodimers also activate transcription 
of Ror α/β/y and RevErb α/β genes by binding to E-boxes in their promoters. Bmal1 expression is regulated by 
ROR and REVERB which bind to a Ror-E in the Bmal1 promoter. PER and CRY are phosphorylated by GSK3 and 
CKI, which modulates the timing of nuclear entry and stability of PER/CRY heterodimers. In the SCN at the 
cellular level, the clock is entrained by light from the RHT, which activates transcription of mPer genes. 
Modified from Zordan and Sandrelli, 2015. 
 
1.10   Circadian clock at an organismal level 
 
In mammals, the vast majority of cells express a molecular clock. All the molecular clocks 
must be synchronised with each other and the environment for the circadian system to 
function properly. In mammals, the master pacemaker, the suprachiasmatic nucleus (SCN) is 
responsible for synchronising all the circadian oscillators. All neurons produce ~24 h 
oscillations in gene expression patterns. However, only SCN neurons receive photic input 
from the RHT. SCN neurons are electrically coupled (via gap junctions) to one another. They 
also generate rhythmic neuronal activity. Thus, SCN neurons entrain to light-dark (LD) cycles 
and then synchronise all the circadian oscillators in the body via various neuronal and 
humoral pathways. Furthermore, in constant darkness (DD) the SCN neurons, as a result of 
being coupled to one another, provide a circadian signal. This is required for normal 
behavioural and physiological rhythms in free-running conditions. The SCN is found in the 
hypothalamus just above the optic chiasma. The SCN is divided into several anatomical 
subdivisions that express distinct neuropeptides and receptors. The arginine vasopressin 






distinct subsets of SCN neurons, paracrinely synchronise the molecular oscillations of other 
cells (Welsh et al., 2010).  
 
Compared to mammals in which all neurons in the brain express a molecular clock, only 
~150 neurons express a molecular clock in Drosophila. These neurons make up a neural 
network that controls circadian behaviour. The ~150 neurons are subdivided into nine 
groups based on their anatomical position. There are five groups of lateral neurons and four 
groups of dorsal neurons. The ~150 neurons are comprised of eight large ventral lateral 
neurons (lLNvs), eight small ventral lateral neurons (sLNvs), two 5th sLNvs, ~eight lateral 
posterior neurons (LPNs), 12 dorsal lateral neurons (LNds), four anterior DN1 neurons 
(DN1as), ~32 posterior DN1 neurons (DN1ps), four DN2 neurons (DN2s), and ~80 DN3 
neurons (DN3s) (Figure 1.3). There is heterogeneity between groups and within groups, 
similar to the mammalian SCN. Distinct subsets of the ~150 neurons have different roles in 
circadian behaviour, driving activity at specific points in the LD cycle (reviewed in Allada and 
Chung, 2010; Peschel and Helfrich Forster, 2011; Muraro et al., 2013). 
 
In LD conditions, flies show two circadian clock-controlled peaks of activity, a morning 
activity peak around the time of lights-on and an evening activity peak around the time of 
lights-off. Flies anticipate the light transitions by gradually increasing their locomotor 
activity in advance of both lights-on and lights–off. Flies also exhibit non-circadian startle 
responses, substantial transient bursts of locomotor activity in response to the light 
transitions. In constant darkness (DD), the morning and evening activity peaks gradually 
merge into a single activity peak that reoccurs at roughly the same time every day (period 
~24 hours). This single activity peak in DD is normally slightly in advance of the evening 
activity peak in LD conditions (Figure 1.4).  
 
Molecular oscillations in the ~150 clock neurons are synchronised (Yoshii et al., 2009; 
Roberts et al., 2015). The clock cells exhibit cycling neuronal activity, peaks and troughs in 
neuronal activity occur at different times for distinct clock neurons (Cao and Nitabach, 2008; 






peak, are called morning (M) cells and the LNds and DNs, which control the evening activity 




Figure 1.3: Clock neurons and output neurons in the Drosophila brain. ~150 neurons express a molecular 
clock in the fly brain (blue circles). These ~150 neurons are divided into several groups based on their 
anatomical position. Distinct subsets of the ~150 neurons have different functional roles in circadian 
behaviour. All the LNvs except the 5th sLNv express the neuropeptide pigment dispersing factor (PDF), which 
paracrinely synchronises the molecular oscillations of clock neurons. DH44 and LHLK cells (green circles) do not 
express a molecular clock but exhibit cyclic neuronal activity, suggesting clock input. DH44 and LHLK cells 
express the neuropeptides Diuretic hormone 44 (DH44) and leuokinin (LK), respectively. DH44 and LK are 










Figure 1.4: Locomotor activity of a group of wild-type male flies in LD (A) or DD conditions (B) at 25 °C. (A) 
Average daily activity histogram for three days of 12/12 h LD cycles with abrupt LD transitions. Flies exhibit a 
morning activity peak around the time of lights-on (ZT0) and an evening activity peak around the time of lights-
off (ZT12). Flies anticipate lights-on and -off by gradually increasing their locomotor activity in advance of these 
transitions. Flies also exhibit non-circadian startle responses, transient bursts of locomotor activity in response 
to the light transitions. (B) Average daily activity histogram and double-plotted actogram for twelve days of 
constant darkness (DD). Flies exhibit a single peak of activity that reoccurs at roughly the same time each day. 
This activity peak is slightly in advance of the evening activity peak in LD conditions. 
 
The neuropeptide pigment dispersing factor (PDF), is expressed by all the LNvs, except the 
5th sLNv (~16 neurons). Ablation of the PDF neurons (using hid) or genetic deficiency in PDF 
or its receptors (pdf01 and pdfr, respectively) affects the timing of the activity peaks and 
anticipation in LD conditions and causes a rapid loss of behavioural rhythms in DD 
conditions. The loss of behavioural rhythms coincides with reduced amplitude and 
desynchronicity of molecular rhythms throughout the ~150 clock neurons (Renn et al., 1999; 
Lin et al., 2004; Mertens et al., 2005). Thus, PDF acts in both PDF and non-PDF clock 






established (Shafer et al., 2008). However, PDF has the ability either slow down or speed up 
molecular clocks (Yoshii et al., 2009). PDF neurons act on the LNds and a small number of 
the DN1s (E-cells) to affect the evening activity peak in LD and free-running period (Lear et 
al., 2009). Despite the fact both sLNvs and lLNvs express PDF, the sLNvs seem especially 
important for normal free-running rhythms. The sLNvs show strong molecular rhythms that 
persist for several days in DD (Stoleru et al., 2005). Speeding up the molecular clock (by 
overexpression of SGG) in only the sLNvs also speeds up the molecular clock in various other 
groups of clock neurons, including the LNds, DN1s and DN3s, and alters behavioural rhythms 
(Stoleru et al., 2005). The ability of the sLNvs to control behavioural and molecular rhythms 
is PDF dependent (Yao and Shafer, 2014). Because of the sLNvs ability to control the timings 
of both behavioural and molecular rhythms in free-running conditions, they are considered 
to be the master pacemaker in Drosophila (equivalent to the mammalian SCN). However, 
recent data indicates the entire clock network works collectively to generate strong activity 
rhythms in DD (Dissel et al., 2014; Yao and Shafer, 2014).  
 
How does the central clock talk to downstream brain regions to drive robust circadian 
locomotor behaviour? The DN1 neurons are connected to the sLNvs via synapses. DN1s play 
an essential role in generating robust behavioural rhythms in constant darkness. DN1s 
maintain rhythmic neuronal activity in DD conditions, despite a dampened molecular clock 
(Yoshii et al., 2009; Roberts et al., 2015). DN1s are connected via synapses to specific 
neurons in the pars intercerebralis (PI) (functionally analogous to the hypothalamus). These 
cells in the PI do not express molecular clocks, but exhibit rhythmic neuronal activity, 
suggesting that they receive time-of-day information from the clock system. Thus, DN1s 
connect the central clock with output neurons. PI cells secrete several neuropeptides, 
including Diuretic hormone 44 (DH44) (Drosophila homology of corticotrophin releasing 
hormone). DH44 is critical for the generation of strong behavioural rhythms in DD 
(Cavanaugh et al., 2014). DH44 receptors are expressed in various different brain regions, 
including the lateral protocerebrum. The lateral protocerebrum has been associated with 
stress-induced locomotor activity (Zhao et al., 2010). Moreover, stress glucocorticoids show 
circadian production and act to synchronise molecular clocks (Cavanaugh et al., 2014). 






(LK), which is necessary for the generation of robust behavioural rhythms. The LK-positive 
LH neurons exhibit rhythmic neuronal activity, suggesting that they receive time-of-day 
information from the clock system (most likely the sLNvs) (Cavey et al., 2016).  
 
A small subset of glia exhibit rhythmic expression of PER (Ewer et al., 1992). The close 
proximity of the PER-positive glial cells to the sLNvs indicates that they may interact to 
regulate activity rhythms (Helfrich-Forster, 1995; Suh and Jackson, 2007). It has been 
proposed glia regulate PDF transport and release (Ng et al., 2011). These studies suggest 
glia-to-neuron signalling plays an important role in circadian behaviour. A similar role for 
glial cells in circadian behaviour in mammals has been suggested (Slat et al., 2013).  
 
1.11   Sleep in Drosophila  
 
Drosophila has been used to study sleep for nearly 20 years (Hendricks et al., 2000; Shaw et 
al., 2000). During sleep, flies exhibit reduced activity/movement, sensory responsiveness 
and brain activity, and an increased arousal threshold. It is widely accepted that the 
underlying mechanisms of mammalian and Drosophila sleep are relatively similar (see for 
review Cirelli, 2009). Like circadian behaviour, sleep is studied using the DAM system. A fly is 
characterised as being asleep when it does not break the beam for at least five minutes. 
Both behaviourally and electrophysiologically fly sleep intensity varies over the course of 24 
hours. In laboratory LD conditions, wild-type flies have a midday nap and period of 
consolidated sleep at night (Figure 1.5).  
 
Both the circadian and homeostatic systems regulate sleep (for review see Cirelli and 
Bushey, 2008). Serotonergic and GABAergic signalling promotes sleep, whereas 
dopaminergic and octopaminergic signalling promotes arousal and wakefulness. Multiple 
brain regions have been shown to play a role in controlling sleep in Drosophila including the 
MBs (which harbours both wake- and sleep-promoting neurons), dorsal fan-shaped body, 
pars intercerebralis (PI) (which harbours both wake- and sleep-promoting neurons) and pars 









Some clock genes seem to have a role in sleep regulation. Compared to wild-type flies, sleep 
is reduced in Clk and Cyc mutant flies. Whereas, compared to wildtype flies, sleep is normal 
in tim mutant flies (Hendricks et al., 2000; Shaw et al., 2002; Hendricks et al., 2003). The 
clock circuitry also seems to play a role in sleep regulation. Distinct clock neurons promote 
sleep or wakefulness at specific times of the day. The lLNvs promote wakefulness at specific 
times of the day. The lLNvs neuronal activity fluctuates throughout the day and is reduced 
during the night (Cao and Nitabach, 2008; Parisky et al., 2008; Shang et al., 2008; Sheeba et 
al., 2008; Liu et al., 2014). Changes in neuronal activity are mediated by clock driven 
expression of wide awake, which interacts with the GABA-A receptor, Rdl, and thereby 
modulates inhibitory currents in the lLNvs (Liu et al., 2014). Activation of lLNvs disrupts 
nightime sleep, whereas silencing them increases night-time sleep (Sheeba et al., 2008; 
Parisky et al., 2008; Shang et al., 2008). lLNvs neurons also mediate their wake prompting 
effects via PDF expression. PDF has wide ranging effects in Drosophila because several brain 
areas express the PDF receptor. Of note, is the ellipsoid body (EB), which is involved in 
locomotion control (Parisky et al., 2008). The role of lLNvs in controlling sleep is 
independent from their role in the circadian system, since lLNvs maintain robust 
behavioural and molecular rhythms, despite genetic manipulations that affect sleep 
behaviour (Sheeba et al., 2008; Shang et al., 2013; Gmeiner et al., 2013). In contrast, the 
sLNvs are sleep-prompting neurons. The sLNVs promote sleep during the night via the 
expression of the neuropeptide short neuropeptide F (sNPF) (Shang et al., 2013). lLNvs 
express sNPF receptors, which are important for sLNv-lLNv coordination (Shang et al., 2013). 
The DN1 neurons promote wake in advance of lights-on (ZT21-24) via expression of the 
neuropeptide Diuretic hormone 31 (DH31). Knockdown of DH31 increases sleep, whereas 
Figure 1.5: Sleep of a group of wild-type male flies in 
LD conditions at 25 °C Average daily sleep profile for 
three days of 12/12 h LD cycles with abrupt LD 
transitions. Flies have a siesta in the middle of the day 







overexpression of DH31 decreases sleep specifically at the end of the night. The DN1 
neurons also promote wake in advance of lights-on in a PDF-dependent manner. Expression 
of tethered PDF in DN1s also reduces sleep specifically during ZT21-24 (Kunst et al., 2014). 
Intriguingly, the DN1 neurons also promote sleep at different times of the day via 
independent mechanisms. Because activating the DN1 neurons increases daytime sleep, 
while silencing them decreases night-time sleep (Guo et al., 2016).  
 
1.12   Circadian and sleep disturbances in tauopathies 
 
Memory deficits are the most common symptom of AD. However, the majority of AD 
patients also exhibit disturbances in the sleep-wake cycle and circadian rhythms. A 
substantial portion of AD patients display progressive disruption of the sleep-wake cycle, 
typified by increased daytime naps, reduced and fragmented nightime sleep and increased 
night-time wakefulness (for review see Musiek et al., 2015). Sleep disturbances are one of 
the earliest symptoms (prodrome) of AD and may even precede cognitive abnormalities. 
Similar fragmentation of the sleep-wake cycle has also been reported in FTD (Anderson et 
al., 2009). Additionally, in AD patients daily rhythms of activity and core body temperature 
show reduced amplitude and marked phase shifts. AD patients show reduced daytime 
activity (active phase) and increased night-time activity (inactive phase) compared to 
healthy controls. Furthermore, peaks in activity and core body temperature occur 
approximately four hours later in AD patients compared to healthy controls (Satlin et al., 
1995; Volicer et al., 2001; Harper et al., 2001; Tranah et al., 2011). Similar disruption in daily 
activity and body temperature rhythms has also been reported in FTD (Harper et al., 2001). 
Furthermore, many individuals with late/moderate AD display sundowning syndrome, which 
is an obvious increase in behavioural symptoms in the late afternoon/early evening (Volicer 
et al., 2001). Moreover, there is a strong link between sleep disorders and PD. For example, 
the vast majority of individuals diagnosed with a REM sleep behaviour disorder will 
subsequently develop tauopathies associated with tau and α-synuclein pathology (Boeve et 
al., 2011; Bjørnarå et al., 2018). Disruption of sleep and circadian rhythms pose a difficult 






patients and increased healthcare cost (the current global cost for caring for AD patients 
exceeds $800 billion annually see UsAgainstAlzheimer’s website). 
 
Circadian dysfunction is traditionally regarded as a downstream effect of tauopathies, but 
recent evidence has suggested it may in fact contribute to the disease process. For example, 
disrupted daily activity rhythms in cognitively normal adults increase the risk of developing 
AD in later life (Tranah et al., 2011). Furthermore, three independent studies have identified 
separate polymorphisms in the Clk gene that are a risk factor for AD (Chen et al. 2013; Chen 
et al., 2013; Yang et al., 2013). Collectively, these studies have established a link between 
the circadian clock and neurodegeneration. These studies open up the exciting possibility 
that treatment of the circadian and sleep disturbances in the early stages of tauopathies, 
such as AD, may slow down the progression of the disease or even stop it. Thus, a current 
priority is to develop therapeutics to target circadian misalignment and sleep disruption in 
AD. However, in spite of their serious consequences, sleep and circadian disturbances in 
tauopathies, such as AD, remain enigmatic. 
 
It is not known whether sleep and circadian disturbances in tauopathies are caused by 
damage to the central clock or by blocking its communication with output neurons. Several 
studies have suggested that degeneration of the SCN causes circadian dysfunction in AD. For 
example, there is substantial atrophy of the SCN in post mortem brains of AD patients 
(Swaab et al., 1985; Swaab et al., 1988; Zhou et al., 1995). There is a dramatic decrease in 
the number of VIP- and AVP-expressing neurons in the SCN of AD patients when compared 
with healthy controls. There is also a reduction in mRNA and protein levels of AVP and VIP in 
the brains of AD patients compared with healthy controls (Stopa et al., 1999; Wu et al., 
2007; Harper et al., 2008). However, amyloid plagues are not often found in the SCN ruling 
them out as the cause of neurodegeneration (Stopa et al., 1999). This suggests that that 
soluble Aβ and tau species may cause circadian dysfunction. In support of this, Tate et al. 
(1992) showed grafting of PC12 cells overexpressing disease linked variants of APP (but not 







However, other studies have suggested central clock output failure may cause circadian 
dysfunction. For example, clock gene expression in the pineal gland (downstream target of 
the SCN) is similar in post mortem brain tissue from AD patients and in rats in which the 
pineal gland has been derived of SCN control (Wu et al., 2006). Moreover, clock gene 
expression in various different clocks in post mortem brain tissue for AD patients is 
rhythmic, but there are marked phase shifts between the clock, suggesting changes in their 
relative synchronisation. The authors suggested that this failure to successfully synchronise 
the clocks is due to blocked communication between the clocks at a synaptic level 
(Cermakian et al., 2011). 
 
1.13   Animal models of AD-linked circadian and sleep disturbances 
 
1.13.1   β-amyloidosis  
 
To understand the mechanisms underlying the circadian and sleep disturbances in 
tauopathies, such as AD, and to try to develop ways to ameliorate these problems robust 
animal models are needed. Mouse models of β-amyloidosis have been created by a variety 
of different ways. One option is to express wild-type or mutant APP (amyloid β precursor 
protein). A second option is to coexpress wild-type or mutant APP and wild-type or mutant 
PS1 (presenilin 1). PS1 is a secretase that proteolytically cleaves APP to produce Aβ 
peptides. These mice models develop similar neuropathological and behavioural features to 
those observed in human AD. However, it is important to note that no one AD mice model 
fully recapitulates all the features of human AD.  
 
Mice overexpressing disease-linked variants of APP exhibit abnormalities in daily activity 
rhythms in LD conditions. PDAPP mice overexpressing human APP with the London 
mutation (717V→F), show increased cage activity during the active dark phase but not the 
inactive light phase pre-amyloid plaques (3-5 months old) but not post-amyloid plaques (22 
months old) (Huitron Resendiz et al., 2002) . Similar results reported in two studies from the 
Peter Deyn laboratory. APP23 mice, which overexpress human APP carrying the Swedish 






months of age (Van Dam et al., 2003). Cognitive deficits precede amyloid deposition in 
APP23 mice. APP23 mice begin to develop amyloid plaques in the cortex and hippocampus 
by 6 months of age. Subsequently, Vloeberghs et al. (2004) reported in APP23 mice an age-
dependent increase in cage activity during the second half of the active dark phase. This 
resembles sundowning found in AD patients. In 3 month old mice, there are only minor 
differences in cage activity, whereas 6 and 12 month old mice exhibit a bimodal night-time 
activity pattern.  
 
However, Wisor et al. (2005) reported in Tg2576 mice, which overexpress human APP with 
the Swedish double mutation (K670N, M671L), no differences in wheel running activity up 
to 22 months of age. Amyloid deposits are present in Tg2576 mice by 5-7 months of age. 
Cognitive impairments coincide with amyloid deposition in Tg2576 mice. In contrast, 
Gorman and Yellon (2010) reported in Tg2576 mice an age-independent increase in cage 
activity during the active dark phase (5-22 month old). Additionally, Gil-Bea et al. (2007) 
reported an increase in spontaneous activity in Tg2576 mice. Ambree et al. (2006) reported 
similar findings in TgCRND8 mice overexpressing human APP with the Swedish 
(K670N/M671L) and Indiana (V717F) mutations. TgCRND8 mice develop amyloid plagues in 
the cortex and hippocampus by 3 months of age. TgCRND8 mice are hyperactive both pre- 
and post-amyloid plaques (1-4 month old) (Ambree et al., 2006). Collectively, these studies 
show APP mice exhibit an age-independent increase in activity, particularly during the active 
dark phase. 
 
Studies on sleep in APP mice have yielded confusing and contradictory findings. Huitron 
Resendiz et al. (2002) reported 3-5 month old PDAPP mice exhibit a reduction in sleep 
during the inactive light phase but not during the active dark phase. Whereas, 22 month old 
PDAPP mice exhibit a reduction in wakefulness and increase in sleep during the inactive light 
phase and an increase in wakefulness and reduction in sleep during the active dark phase. In 
contrast, Wisor et al. (2005) reported no difference in the amount of overall sleep in Tg2576 
mice up to 17 months of age. Contradictory findings were reported by Zhang et al. (2005). 
The authors report Tg2576 mice exhibit an age-dependent reduction in daily sleep, sleep is 






mice exhibit age-related abnormalities in a sleep electroencephalogram (EEG) (Wisor et al., 
2005; Zhang et al., 2005). Inconsistencies in findings in APP mouse models could be 
attributed to differences in the level of APP expression, different APP constructs, sex 
differences, or differences in the method used to measure activity (either wheel running or 
cage activity).  
 
Similarly, mice expressing disease linked-variants of APP and PS1 also exhibit abnormalities 
in sleep and daily activity rhythms in LD conditions. APP/PS1 knock-in mice (uses 
endogenous promoters to prevent supraphysiological levels of APP/PS1) exhibit a two hour 
phase delay in wakefulness (Duncan et al., 2012), reminiscent of the phase delays in activity 
and body temperature rhythms found in AD patients (Satlin et al., 1995; Harper et al., 2001; 
Volicer et al., 2001). APP/PS1 knock-in mice also show a reduction in endogenous mPer 
mRNA oscillations (but no change in VIP or AVP expression). Roh et al. (2012) reported in 
APPswe/PS1δE9 mice, which express APP with the Swedish mutation and exon 9 deleted PS1 
mutation an age-related fragmentation of the sleep-wake cycle. Cognitive deficits and 
amyloid deposits appear in APPswe/PS1δE9 mice at about 6-9 months of age. In 3 month old 
mice, the sleep-wake cycle is normal, whereas in 6 and 9 month old mice, there is a 
progressive increase in wakefulness and decease in sleep during the inactive light phase. 
Additionally, Bano Otalora et al. (2012) reported an increase in activity specifically during 
the second half of the inactive light phase in APPswe/PS1δE9 mice. However, APPswe/PS1δE9 
mice display normal daily body temperature rhythms (Bano Otalora et al., 2012). Taken 
together, these studies show APP/PS1 mice exhibit an increase in activity and decrease in 
sleep during the inactive light phase, reminiscent of human AD.  
 
Only minor abnormalities in activity rhythms in constant darkness have been reported in 
APP and APP/PS1 mice. Wisor et al. (2005) reported 5-22 month old Tg2576 mice display a 
longer period (~0.25 h) in wheel running activity. However, Gorman and Yellon (2010) 
reported Tg2576 mice up to 22 months of age display a normal period. Similarly, Bano 
Otalora. (2012) reported APPswe/PS1δE9 mice exhibit a normal period. Inconsistences in the 
findings could be attributed to differences in methodology (wheel running/cage activity or 






3xTg-AD mice, which overexpress disease linked variants of APP (Swedish), PS1 (M146V) and 
tau (P301), show increased activity during inactive light phase and reduced percentage of 
overall activity during the active dark phase both pre- and post-amyloid plaques. The 
alterations in activity rhythms coincide with loss of AVP- and VIP- containing cells in the SCN 
(Sterniczuk et al., 2010). This suggests that damage to the central clock may cause the 
circadian dysfunction; a notion, which is supported by post mortem studies on brain tissue 
from AD patients (Swaab et al., 1985; Zhou et al., 1995; Swaab et al., 1998). As with AD 
patients and APP/PS1 mice, 3xTg-AD mice exhibit an increase in activity during the typically 
inactive phase. Additionally, Knight et al. (2013) reported oscillations in daily body 
temperature rhythms are phase advanced in 3xTg-AD mice. Sterniczuk et al. (2010) reported 
3xTg-AD mice display a shorter period (~0.25 h) in free-running conditions both pre- and 
post-amyloid plaques. 
 
Drosophila models, in which Aβ42 or aggregate-prone Aβ42arc (E226 mutation) are 
expressed directly in the nervous system, have been developed as a complement to β-
amyloidosis mice models. Pan-neuronal expression (using Elav-Gal4) of Aβ42 or Aβ42 arc 
causes progressive age-dependent behavioural arrhythmia in LD and DD conditions. 
However, despite the behavioural arrhythmia, the central clock remains intact as indicated 
by normal endogenous per mRNA and PER protein oscillations and normal morphology of 
central clock neurons (Chen et al., 2014; Long et al., 2014). Thus, these studies suggest that 
circadian dysfunction is not caused by damage to the central clock, but by blocking its 
communication with output neurons.  
 
Tabuchi et al. (2015) reported ubiquitous Aβ42 expression during adulthood (using 
daughterlessGS) reduces night-time sleep, but daytime sleep is unaffected. Whereas, 
ubiquitous Aβ42arc expression during adulthood reduces daytime sleep and reduces and 
fragments night-time sleep. Reduced and fragmented sleep at night is characteristic of AD 
and FTD (Harper et al., 2001; for review see Musiek et al. 2015). The authors also showed 
altering sleep affects Aβ deposition. Reducing sleep increases the Aβ burden, whereas 
increasing sleep reduces the Aβ burden. Additionally, sleep deprivation via Aβ42 expression 






Gerstner et al. (2017) demonstrated pan-neuronal Aβ42 expression during adulthood (using 
elavGS) reduces and fragments daytime sleep, but night-time sleep is unaffected. There is 
also a reduction in night-time activity, but daytime activity is unaffected. Inconsistencies in 
the findings could be attributed to differences in the expression system (ubiquitous or 
limited to the nervous system), duration of expression, or sex differences. The authors also 
showed pan-neuronal Aβ42 expression (using Elav-Gal4) reduces and fragments both 
daytime and night-time sleep and increases night-time activity (but daytime activity 
unaffected). The sleep and activity abnormalities are already present in 2-3 day old flies, 
whereas learning and memory abnormalities first appear in 6-7 day old flies. Therefore, the 
circadian and sleep disruption precedes the onset of the cognitive deficits, consistent with 
findings in AD mice models. Additionally, Dissel et al. (2017) showed ubiquitous APP and 
BACE (secretase that proteolytically cleaves APPL to produce Aβ peptides) expression during 
adulthood (using daughterlessGS) reduces and fragments night-time sleep (but daytime 
sleep is unaffected). Collectively, these studies demonstrate that Aβ42 expression (either 
ubiquitous or limited to the nervous system) affects activity and sleep in LD conditions.  
 
1.13.2   Tauopathy  
 
In contrast to the large number of studies on circadian and sleep disturbances in mouse and 
Drosophila models of β-amyloidosis, very few studies have investigated whether circadian 
dysfunction exists in animal models of tauopathy. Circadian abnormalities have been 
reported in daily activity and body temperature rhythms in 3xTg-AD mice (which 
overexpress APPswe, PS1M146V, and tauP301L). However, it is not possible to assess the specific 
contribution of tau to the circadian dysfunction, because β-amyloidosis is also present 
(Sterniczuk et al., 2010; Knight et al., 2013). The behavioural characterisation of early 
transgenic tau mice was hindered by brainstem and spinal cord pathology, resulting in 
motor deficits. But more recently, the use of region specific promoters (i.e. CaMKII) mostly 
overcame this problem and allowed in-depth assessment of behaviour. However, to date 
daily activity rhythms in LD and DD conditions have been characterised in only two mouse 







Tg4510 mice which overexpress FTD-linked mutant P301L tau (0n4r isoform), under the 
control of the forebrain specific CaMKII promoter, exhibit an increase in activity during the 
inactive light phase (but activity during the active dark phase is unaffected) at an age when 
NFTs and cognitive deficits are present (Stevanovic et al., 2107). Similar to AD patients and 
3xTg-AD mice, Tg4510 mice exhibit an increase in the percentage of total daily activity, 
occurring during the inactive phase. In free running conditions, Tg4510 mice display a long 
period (~1 h) in wheel running activity. No change in overall daily activity in Tg4510 mice in 
DD conditions. Behavioural abnormalities in Tg4510 mice coincide with the appearance of 
hyperphosphorylated pathological tau in the SCN (and hippocampus) and disruption of 
cyclic expression of PER (but not BMAL1) in the hypothalamus and hippocampus. Thus, tau 
expression impacts the clock at a molecular level (Stevanovic et al., 2017). In contrast, 
knock-in PLB2 mice, which express FTD-linked mutant P301L and R406W tau (2n4r isoform) 
under the control of the CaMKII promoter, exhibit a reduction in activity during both the 
inactive light phase and active dark phase. However, they exhibit increased wakefulness and 
reduced sleep during the inactive light phase. Thus, they are more awake during the inactive 
light phase despite reduced activity. Additionally, PLB2 mice exhibit abnormalities in a sleep 
EEG (Koss et al., 2016).  
 
To date no studies have described in detail circadian behavioural abnormalities in a 
Drosophila model of tauopathy. Recently, Dissel et al. (2017) showed in Drosophila 
ubiquitous expression of tau during adulthood (using daughterlessGS) causes a reduction in 
daytime sleep (but night-time sleep is unaffected), opposite to what has been reported in 














1.14   Aims of thesis 
 
Chapter 2  
 Investigate whether different 4r tau isoforms and proteins have differential ability to 
cause neuronal dysfunction and neuronal death. 
 Study whether tau-mediated neuronal dysfunction is separable from neuronal death.  
 Test whether adult-onset tau expression causes functional and structural 
degeneration. 
 Analyse whether tau phosphorylation plays a causative role in tau-mediated 
neuronal dysfunction.  
 Test whether coexppression of Aβ42 with tau synergistically enhances tau-mediated 
neuronal dysfunction.  
 
Chapter 3  
 Develop a fly model of tauopathy that recapitulates the circadian rhythm disruption 
in AD i.e. increased daytime sleep, reduced night-time sleep and reduced amplitude 
circadian rhythms with phase shifts.  
 Investigate whether the circadian rhythm disturbances are due to dysfunction or 
degeneration in the central pacemaker or in neurons downstream of the central 
pacemaker.  
 Test whether adult-onset tau expression is capable of causing circadian dysfunction. 
 Examine whether tau abnormalities in glial cells plays a role in AD-linked circadian 
dysfunction.  
 
Chapter 4  
 Measure the limit of the spatial resolution of Drosophila motion vision through 










Chapter 2:   Neuronal dysfunction is separable from neuronal death in a 
Drosophila model of tauopathy 
 
2.1   Introduction 
 
Tauopathies are a group of neurodegenerative diseases including Alzheimer’s disease (AD), 
Frontotemporal dementia (FTD) and Parkinson’s disease (PD). Depending upon its 
phosphorylation status, tau binds to and stabilises microtubules. In tauopathies, tau is 
hyperphosphorylated and aggregates into neurofibrillary tangles (NFTs). Mutations in tau 
lead to familial FTD; indicating, tau abnormalities give rise to neurodegeneration (Kouri et 
al., 2014; Coppola et al., 2012). Hyperphosphorylated tau has reduced binding affinity for 
microtubules, which leads to the breakdown of the microtubule network. Recent evidence 
shows tau also regulates neuronal activity and synaptic plasticity (Wang and Mandelkow, 
2016; Guo et al., 2017).  
 
Tauopathies are clinically characterised by cognitive decline. The presence of NFTs does not 
correlate well with cognitive decline found in individuals with AD. Instead, analysis of AD 
brains has revealed synapse loss correlates far better with cognitive decline. Memory 
deficits in AD patients coincide with a reduction in the density of presynaptic glutamatergic 
boutons. However, neuron death fails to account for the substantial synapse loss, thus 
synapses must be lost prior to death (reviewed in Arendt, 2009). Furthermore, levels of 
various synaptic proteins are dramatically reduced in brains from AD patients (Masliah et al., 
2001; Marksteiner et al., 2002). Similarly, analysis of PD brains has shown dopaminergic 
terminal dysfunction precedes nigral cell death (Kordower et al., 2013). Therefore, the early 
clinical symptoms in tauopathies, such as AD and PD, precede NFT formation and overt 
neuronal death. Currently, much effort is being directed at identifying affected individuals 
earlier, which would allow therapeutic intervention before irreparable neuronal damage. 
 
Therefore, animal models of tau-mediated neuronal dysfunction are required. Mice models, 
overexpressing human tau, show depletion of synaptic proteins, memory deficits, loss of 






formation and cell death (Schindowski et al., 2006; Kimura et al. 2007). Switching of tau 
expression, in mice overexpressing human tau, rescues the cognitive deficits although 
aggregates continue to form (Santacruz et al., 2005). Thus, overaccumulation of soluble tau 
is capable of causing neuronal dysfunction in the absence of neurodegeneration and NFT 
formation. However, the mechanisms of tau-mediated neuronal dysfunction remain poorly 
understood. Hoover et al. (2010) showed in Tg4510 mice, which overexpress human P301L 
tau under the control of the forebrain specific CaMKII promotor, tau mislocalises and 
overaccumulates in the somatodendritic compartment. Dendritic tau interferes with NMDA 
receptor trafficking and anchoring to the postsynaptic membrane, resulting in impairments 
in long-term potentiation (LTP) in the hippocampus (CA1-CA3 synapses). Whereas, other 
studies have shown tau induces neuronal dysfunction by reducing the probability of 
neurotransmitter release from the presynaptic terminal (Yoshiyama et al., 2007; Polydoro et 
al., 2009; Tai et al., 2012). 
 
Drosophila are a valuable tool for studying neurodegenerative disease (for review see Lu 
and Vogel, 2009). Overexpression of human wild-type (WT) or FTD-linked mutant 
(R406W/V337M/P301L) tau in the developing Drosophila brain is associated with 
neurotoxicity (Wittmann et al., 2001). Similarly, overexpression of tau in the developing 
Drosophila eye is also associated with neurotoxicity, which manifests as a rough eye 
phenotype (REP) in adult flies (Jackson et al., 2002). In other Drosophila models, tau 
expression is associated with behavioural abnormalities in the absence of neuronal death 
(Mudher et al., 2004; Chee et al., 2005, Ubhi et al., 2007; Talmat-Amar et al., 2011). Mudher 
et al. (2004) showed overexpression of human tau in larval motor neurons disrupts 
neuromuscular junction (NMJ) morphology and axonal transport, which causes severe 
defects in locomotor function. Additionally, Chee et al. (2005) showed overexpression of 
human or Drosophila tau in larval motor neurons causes a reduction in synaptic boutons and 
perturbs synaptic transmission. Several studies have shown overexpression of human or 
Drosophila tau in adult mushroom body (MB) neurons impairs associative learning and 
memory (Mershin et al., 2004; Kosmidis et al., 2010; Papanikolopoulou et al., 2010). No 






models of tauopathy faithfully recapitulate the neuronal dysfunction, observed in the early 
stages of AD. 
 
Spatiotemporally regulated alternative splicing of the MAPT gene creates six tau isoforms in 
the human brain. These contain three or four carboxyl (C)-terminal inserts and zero to two 
amino (N)-terminal inserts. The C-terminal inserts comprise the microtubule binding domain 
of tau. In humans, 3r and 4r tau isoforms are normally expressed in the brain at a ratio of 
1:1 (Goedert et al., 1989). FTD-causing mutations increase the ratio of 4r to 3r tau isoforms 
in the brain. The function of the N-terminal inserts is not well known. Differential splicing 
results in 2n tau being relatively sparse compared to the 0n and 1n tau isoforms. 0n, 1n and 
2n tau isoforms are expressed at an approximate ratio of 27:54:9 in the human brain 
(Goedert and Jakes, 1990). Mutant and wild-type tau are associated with different diseases 
with distinct pathology, symptomology and molecular aetiology (reviewed in Guo et al., 
2017). In vitro, different tau proteins exhibit different phosphorylation susceptibilities 
(Goedert and Jakes, 1990; Goedert et al., 1992; Buee et al., 2000), microtubule binding 
capabilities (Kanaan et al., 2011; Matsumoto et al., 2015), subcellular distribution (Liu and 
Gotz, 2013; Paholikova et al., 2015) and interaction partners (Liu et al., 2016). 
 
It is not known whether different tau isoforms precipitate equivalent results when studied 
in insolation. Several studies have investigated the toxic effects of different tau proteins in 
the developing Drosophila visual system (Jackson et al., 2002; Grammenoudi et al., 2008; 
Chatterjee et al., 2009) and MB neuroblasts (Kosmidis et al., 2010; Papanikoloulou et al., 
2010). These studies have shown that specific tau isoforms have differential effects in 
different neuronal populations. Other studies have investigated the ability of different tau 
proteins to cause associative learning and memory deficits when expressed in adult MB 
neurons (Mershin et al. 2004; Kosmidis et al., 2010; Papanikolopoulou et al., 2010), and 
axonal transport defects when expressed in larval motor neurons (Mudher et al., 2004; Chee 
et al., 2005; Ubhi et al., 2007; Talmat-Amar et al., 2011). These studies show isoform-
specific effects in tau-mediated neuronal dysfunction in different neuronal types and at 
different life stages. However, to date no study has compared the ability of different 4r tau 







In this study, we develop a model overexpressing human tau in the Drosophila retina. In our 
model, tau is expressed at a low enough level, as to not produce a REP. Therefore, this 
provides a powerful system to examine age-dependent changes in function and structure. 
We further restrict tau expression to adulthood; this allows us to compare the effects of tau 
in adult neurons versus developing neurons. In this study, we investigate whether different 
human 4r tau proteins have a differential ability to cause functional and structural 
degeneration in the fly eye. We further investigate whether tau-mediated neuronal 
dysfunction is separable from neuronal death.  
 
In this study, we demonstrate isoform-specific differences in tau-mediated neuronal 
dysfunction and neuronal death. We show human 0n4r tau causes age-related progressive 
functional degeneration without structural degeneration. On the other hand, human 2n4r 
tau causes progressive functional degeneration, which precedes structural degeneration, 
when expressed in the developing Drosophila eye. In contrast, mutant (R406W) and wild-
type tau (0n4r isoform) precipitate similar effects in our model. 2n4r tau expression in the 
adult Drosophila retina causes progressive neuronal dysfunction without neuronal death. 
Thus, adult tau-mediated toxicity requires a neurodevelopmental component. Collectively, 
these results demonstrate that tau-mediated neuronal dysfunction is independent from 
neuronal death. We further show phosphodeficient S2A tau fails to cause dysfunction; this 
suggests tau phosphorylation plays a role in tau-mediated neuronal dysfunction. Therefore, 
S2A inhibitors may be a valid therapeutic strategy. Finally, we show human Aβ42 expression 
does not produce neuronal dysfunction, but coexpression of Aβ42 with 2n4r tauWT potently 
exacerbates tau-mediated neuronal dysfunction. These results suggest tau abnormalities 












2.2   Materials and Methods 
 
2.2.1   Fly strains 
 
All flies were reared on standard food (containing 0.8 % agar, 1.0 % soy flour, 8.0 % medium 
cornmeal, 8.0 % malt extract, 1.8 % yeast, 4.0 % molasses, 2.5 % 10% Nipagin in absolute 
ethanol and 0.4 % propionic acid) in a 12 h/12 h light/dark (LD) cycle at 25 °C, except for 
animals carrying tub-Gal80ts which were reared at 18 °C. To obtain flies expressing human 
tau or Aβ in the Drosophila eye we used longGMR-Gal4 (pan-retina) or Rh1-Gal4 (R1-R6 
photoreceptors) to drive expression of UAS-tau or UAS-Aβ. Whereas, to obtain flies 
expressing tau pan-neuronally we used Elav-Gal4 to drive expression of UAS-tau. The UAS-
0n4r tauWT transgene expresses the full-length (383 amino acids) 0n4r isoform of human 
wild-type tau. The UAS-0n4r tauR406W transgene expresses the full-length 0n4r isoform of 
human R406W tau (Wittmann et al., 2001). The UAS-2n4r tauWT1 and UAS-2n4r tauWT2 
transgenes express the full-length (441 amino acids) 2n4r isoform of human wild-type tau. 
The UAS-2n4r tauS2A1 and UAS-2n4r tauS2A2 transgenes express the full-length 2n4r isoform 
of human wild-type with mutations at the two PAR1 phosphorylation sites (S262A and 
S356A). The UAS-2n4r tauS11A transgene expresses the full-length 2n4r isoform of human 
wild-type with mutations at 11 GSK/sgg phosphorylation sites (S46A, T50A, S119A, T202A, 
T212A, S214A, T231A, S235A, S396A and S404A) (Chatterjee et al., 2009). The UAS-Aβ42 
transgene expresses the 42 amino acid fragment of human APP (Iijima et al., 2004). 
 
Tau expression in the adult retina was achieved by using the TARGET system: temperature 
sensitive tub-Gal80ts combined with longGMR-Gal4. At 18 °C (permissive temperature), 
Gal80ts is active and represses the transcriptional activity of Gal4. After adult flies are shifted 
to 30 °C (restrictive temperature), Gal80ts becomes inactive and no longer represses Gal4 
activity (McGuire et al., 2003, McGuire et al., 2004). All transgenic lines were backcrossed 
against Canton-S for five generations to reduce the variation from genetic background. 
ninaE (Rh1)-eGFP was used to visualise the photoreceptor rhabdomeres in live flies (Pichaud 
and Desplan, 2001). The various UAS-tau lines used were previously generated by P-element 






expression levels and activity of transgenes. A summary of stocks used, including full 
genotype, source and references, can be found in Table 2.1. 
 
Stock  Full genotype  Source References  
Canton-S +; +; + In house   
UAS-0n4r tauWT w[*]; +; P{UAS-Hsap\MAPT.WT} 
 
Mel Feany (Harvard 
Medical School, US) 
Wittmann et al., 2001  
UAS-0n4r tauR406W  w[*]; +; P{UAS-Hsap\MAPT.R406W} 
 
Mel Feany (Harvard 
Medical School, US) 
Wittmann et al., 2001 
UAS-2n4r tauWT1 w[1118]; P{w[+mC]=UAS-Tau.wt}1.13; + Bloomington stock 
centre (#51362) 
Chatterjee et al., 
2009 
UAS-2n4r tauWT2 w[1118]; +; P{w[+mC]=UAS-Tau.wt}7B Bloomington stock 
centre (#51363) 
Chatterjee et al., 
2009 
UAS-2n4r tauS2A1 y[1] w[1118]; P{w[+mC]=UAS-TauS2A}1.13; + Bloomington stock 
centre (#51364) 
Chatterjee et al., 
2009 
UAS-2n4r tauS2A2 w[1118]; P{w[+mC]=UAS-TauS2A}1.62; + Bloomington stock 
centre (#51365) 
Chatterjee et al., 
2009 
UAS-2n4r tauS11A w[1118]; P{w[+mC]=UAS-TauS11A}1.2; + Bloomington stock 
centre (#51366) 
Chatterjee et al., 
2009 
UAS-Aβ42 w[*]; P{w[+mC]=UAS-Abeta1-42.G}3 Bloomington stock 
centre (#32037) 
Iijima et al., 2004  
tub-Gal80ts w[*]; +; P{w[+mC]=tubP-GAL80[ts]}2/TM2 Bloomington stock 
centre (#7017) 
McGuire et al., 2003; 
McGuire et al., 2004  
Elav-Gal4 P{w[+mW.hs]=GawB}elav[c155]; +; + Bloomington stock 
centre (#458) 
Luo et al., 1994 
Rh1-Gal4  w[*]; P{ry[+t7.2]=rh1-Gal4}2/Cyo; + Bloomington stock 
centre (#68385) 
Mollereau et al., 2000 
lGMR-Gal4 w[*]; P}w[+mC]=longGMR-Gal4}2; + Bloomington stock 
centre (#8605) 
Freeman et al., 1996; 
Wernet et al., 2003 
ninaE(Rh1)-eGFP w[*]; P{w[+mC]=ninaE-EGFP.p}2; MKRS/TM2  Bloomington stock 
centre (#7460) 
Pichard and Desplan, 
2001  
ElavGS-Gal4 y[1] w[*]; +; P[w[+mC]=elav-Switch.O}GSG301 Bloomington stock 
centre (#43642) 
Osterwalder et al., 
2001 





Kaneko and Hall, 
2000 
Pdf-Gal4 w[*]; P{w[+mC]=Pdf-Gal4.P2.4}2; + R. Stanewsky 
(University of 
Munster, Germany) 
Renn et al., 1999 
Pdf-Gal80  w[*]; P{Pdf-GAL80.S}96A; + 
 
C. Forster (University 
of Wurzburg, 
Germany) 
Stoleru et al., 2004 




Munster, Germany)  
Awasaki et al., 2008 
 
Table 2.1: Stocks used in Chapters 2 and 3.  
 
2.2.2   Corneal neutralisation  
 
Flies were anesthetized using CO2 and placed in a 35 mm petri dish, half-filled with 1 % 
molten agarose (~55 °C). The agarose was allowed to solidify and covered with ice-cold 
water (4 °C). The petri dish was kept on ice until imaging (Pichaud and Desplan, 2001). Eyes 
photoreceptor rhabdomeres were imaged using an upright confocal fluorescent microscope 
(Olympus Fluoview FV1000), equipped with a 40x water immersion long-distance objective. 






recommended for the objective. Images were analysed using ImageJ and Adobe Photoshop. 
Photoreceptor rhabdomeres were visually quantified.  
 
2.2.3   ERGs 
 
Flies were immobilised with low melting point wax inside a copper cone. ERGs were 
recorded using ~10 MΩ glass microelectrodes filled with Ringer (containing in nM: 120NaCl, 
5KCl, 10TES, 1.5CaCl2, 4MgCl2 and 30 sucrose) inserted in the distal retina. A similar 
reference electrode was inserted into the ocellus. All flies tested were female. All flies were 
dark-adapted for two minutes prior to recording. We used a high-power white LED driven by 
an OptoLED power supply as a light source, mounted on a cardan arm system. The stimulus 
was composed of a one second light pulse preceded by 0.2 seconds of darkness and 
followed by one second of darkness. The 2.2 second stimulus was repeated ~20 times. The 
mean ± SEM of all ERG responses for each genotype/age is shown. Two of the three main 
components of an ERG were quantified; the ON transient and photoreceptor-dependent 
depolarization (Heisenberg, 1971). For each genotype and age, the mean and SEM were 
calculated. For each genotype and age, at least eight flies were tested. Biosyst run in Matlab 
was used for stimulus generation and data acquisition. Origin and GraphPad Prism were 
used for data analysis and graphing.  
 
2.2.4   Flight simulator system 
 
In all experiments, 1- to 3-day-old female flies were used. Flies were reared in bottles at a 
low population density to prevent overcrowding and maximise size. Under cold-anaesthesia 
(lasting <three minutes), a triangle-shaped copper-wire hook (diameter ~0.5 mm) was glued 
(Loctite UV glue) to both a fly’s head and thorax. Flies were prepared in the late afternoon 
(four-six pm). They were then left overnight to recover individually in small moist chambers 
with sugar. To study Drosophila’s optomotor behaviour we used a bespoke flight simulator 
system (Wardill et al., 2012). Drosophila were connected to a small metal clamp by their 
small triangular hooks. The small metal clamp was then connected to the torque meter 






circular arena. Homogenous illumination of the arena was provided by a ring–shaped light 
tube (Philips, 350-900 nm). The arena forms a continuous (360°) scene of alternative black 
and white vertical stripes around the fly. The arena is rotatable by the use of a stepping 
motor. We used an eight second stimulus which consisted of two seconds of 
counterclockwise rotation and two seconds of clockwise rotation separated by two seconds 
when the arena was still – preceded and concluded by one second when the arena was still. 
The eight second stimulus was repeated ~20 times. When presented with scene rotations, 
flies attempt to follow them producing yaw torque responses (optomotor response). At 
least 10 flies per genotype were tested. All experiments were performed in a dark room at 
23 °C.  
 
2.2.5   Statistical analysis  
 
Statistical analysis was performed in Graph Pad Prism 7. Data distribution was normal 
(Kolmogorov-Smirnov normality test). All graphs show individual datapoints with mean ± 
SEM. Data were analysed by a two-tailed Student’s t-test if there were two groups, 1-way 
ANOVA if there were more than two groups with a single factor (genotype) and 2-way 
ANOVA if there were more than two groups with two factors (genotype and age) followed 
by post-hoc tests. Multiple comparisons after ANOVA were performed by a Tukey HSD test. 
P levels are indicated as ns p>0.05, *p<0.05, **p<0.001 or ***p<0.0001. In all graphs, 
asterisks (in black) show differences between the experimental genotypes and the control 
genotype of the same age. Asterisks (in black) above horizontal lines show differences 
between experimental genotypes of the same age. Numbers symbols (in red) show 
differences between 5-, 10- or 30-day old flies and 1-day old flies of the same genotype. 
Graphs were created in Graph Pad Prism 7. Sample sizes are reported in figures. Sample 
sizes were not predetermined by any statistical test. However, sample sizes are similar to 
those used in previous publications (Gonzalez-Bellido et al., 2009; Chouhan et al., 2016; 









2.3   Results  
 
2.3.1   0n4r tau expression in the retina causes neuronal dysfunction 
  
The transgenic models we used in this study used the binary Gal4/UAS system, in which 
cDNA encoding different human tau isoforms is placed downstream of UAS sequences. 
Using a Gal4 driver it is possible to drive UAS-tau expression in a tissue specific manner. The 
shortGMR-Gal4 (sGMR-Gal4) driver is strongly expressed in all retinal cell types during 
development (Freeman, 1996). However, expression of Gal4 in the developing eye under 
the control of the sGMR promotor causes developmental defects; sGMR-Gal4 expression 
causes a REP in newborn adult flies when reared at ≥23 °C (Kramer and Staveley, 2003). We 
therefore selected the longGMR-Gal4 (lGMR-Gal4) driver, which has the same expression 
pattern as the more commonly used sGMR-Gal4 but lower expression levels (Freeman, 
1996; Wernet et al., 2003). To examine the toxic effects of different tau proteins in the eye 
we used both functional and structural assays. We used electroretinograms (ERGs) and 
visual behaviour in the flight system, to examine function (Heisenberg, 1971; Wang and 
Montell, 2007), and we used the corneal neutralisation technique, quantified by counting 
the number of photoreceptor rhabdomeres, to examine structure (Pichaud and Desplan, 
2001).  
 
UAS-tau transgenic lines, which express full-length human wild-type or R406W tau (0n4r 
isoform), were crossed to the lGMR-Gal4 driver (Wittmann et al, 2001). Both wild-type and 
R406W tau (0n4r isoform) cause adult-onset progressive neurodegeneration and premature 
death, when expressed in the developing Drosophila brain (using Elav-Gal4), and a REP, 
when expressed in the developing Drosophila eye (using sGMR-Gal4). Previous studies have 
reported R406W tau is more toxic than wild-type tau when expressed in either the 
developing Drosophila brain or visual system (Wittmann et al., 2001; Jackson et al., 2002; 
Nishimura et al., 2004; Khurana et al., 2006). 
 
The external appearance of lGMR>0n4r tauWT and lGMR>0n4r tauR406W eyes was normal 






pulses with an electrode inserted into the distal retina. lGMR-Gal4 control flies exhibited a 
strong rapid sustained photoreceptor-dependent depolarization (~10 mV) in response to a 
light stimulus, as well as second order neurons response in the optic lobe, detectable as ON 
and OFF peaks (transients) before and after photoreceptor-dependent depolarization 
(indicated in Figure 2.1A).  
 
We found normal depolarization in young lGMR>0n4r tauWT flies. There were no significant 
differences in depolarization in 1- and 5-day old lGMR>0n4r tauWT flies compared with age-
matched Gal4 control flies, indicating normal photoreceptor function in lGMR>0n4r tauWT 
flies early in life. However, in aged animals, the situation had changed dramatically. 
lGMR>0n4r tauWT flies showed an age-related progressive reduction in depolarization. 
Quantification of the depolarization revealed that it was moderately reduced (~20 %) in 10-
day old lGMR>0n4r tauWT flies and severely reduced (~60 %) in 30-day old lGMR>0n4r tauWT 
flies, compared with age-matched controls. lGMR>0n4r tauWT flies showed a significant age-
related decline in depolarization. Depolarization in 10- and 30-day old lGMR>0n4r tauWT flies 
was significantly smaller than in 1-day old lGMR>0n4r tauWT flies. In contrast, depolarization 
was stable in Gal4 control flies up to 30-days of age. We found no significant differences in 
depolarization between age groups in control flies (Figure 2.1A,B).  
 
We observed normal ON transients in young lGMR>0n4r tauWT flies. No significant 
differences in ON transients were seen in 1- and 5-day old lGMR>0n4r tauWT flies with 
respect to age-matched controls, indicating normal synaptic transmission in lGMR>0n4r 
tauWT flies up to 5-days of age. With aging, there was a rapid and progressive loss of ON 
transients in lGMR>0n4r tauWT flies. We found a severe reduction in ON transients in 10-day 
old lGMR>0n4r tauWT flies (~1 mV compared to ~3.5 mV in control flies), indicating 
compromised synaptic transmission. 10-day old lGMR>0n4r tauWT flies exhibited a wide 
range of ON transients: two flies displayed responses in the wild-type range, 15 flies 
displayed small transients and 15 flies displayed no transients. We found no 30-day old 
lGMR>0n4r tauWT flies exhibited an ON transient, indicating a total block of synaptic 
transmission. lGMR>0n4r tauWT flies showed a significant reduction in ON transients as a 






tauWT flies compared to 1-day old lGMR>0n4r tauWT flies. Whereas, no significant age-
related differences in ON transients were seen in control flies (Figure 2.1A,C). 
 
Similarily, we also found normal depolarization in lGMR>0n4r tauR406W flies up to 5-days of 
age. With aging, there was a progressive reduction in depolarization in lGMR>0n4r tauR406W 
flies. We found 10-day old lGMR>0n4r tauR406W flies showed a ~40 % reduction in 
depolarization and 30-day old lGMR>0n4r tauR406W flies showed a ~80 % reduction in 
depolarization, relative to age-matched controls. lGMR>0n4r tauR406W flies showed a 
significant age-related reduction in depolarization. Depolarization was significantly smaller 
in 10- and 30-day old lGMR>0n4r tauR406W flies compared to 1-day old lGMR>0n4r tauR406W 
flies (Figure 2.1A,B). We observed normal ON transients in 1-day old lGMR>0n4r tauR406W 
flies. With aging, there was a rapid and progressive loss of ON transients in lGMR>0n4r 
tauR406W flies. A severe reduction in ON transients was seen in 5-day old lGMR>0n4r tauR406W 
flies (~2 mV compared to ~3.5 mV in control flies). 5-day old lGMR>0n4r tauR406W flies 
exhibited a wide range of ON transients: seven flies displayed responses in the wild-type 
range, nine flies displayed small transients and one fly displayed no transient. We found 
nearly a complete lack of ON transients in 10-day old lGMR>0n4r tauR406W flies, 17 out of 20 
flies recorded from had no ON transient. Furthermore, we found a complete abolishment of 
ON transients in 30-day old lGMR>0n4r tauR406W flies. lGMR>0n4r tauR406W flies showed a 
significant age-related decrease in ON transients. ON transients in 5-, 10- and 30-day old 
lGMR>0n4r tauR406W flies were significantly smaller than in 1-day old lGMR>0n4r tauR406W 




















Figure 2.1: 0n4r tau expression in the retina causes neuronal dysfunction. (A) Measuring retinal function 
using ERGs in control and tau-expressing flies at various ages. ERG recordings in response to a one second light 
pulse are shown from 1-, 5-, 10- and 30-day-old lGMR-Gal4, lGMR>0n4r tauWT and lGMR>0n4r tauR406W eyes. 
Normal depolarization (arrow) and ON transient (arrowhead) indicated, which reflect the phototransduction 
cascade and synaptic transmission, respectively. Normal depolarization in 1- and 5-day old 0n4r tau-expressing 
flies. Age-related progressive reduction in depolarization in 0n4r tau-expressing flies. Moderate reduction in 
depolarization in 10-day old 0n4r tau-expressing flies and severe reduction in depolarization in 30-day old 0n4r 
tau-expressing flies. Normal ON transients in 1-day old 0n4r tau-expressing flies. Age-related rapid and 
progressive loss of ON transients in 0n4r tau-expressing flies. Tiny ON transients in 10-day old 0n4r tau-
expressing flies and no ON transients in 30-day old 0n4r tau-expressing flies. ERGs are stable in control flies up 
to 30-days of age. Each trace represents the mean response from >8 flies from the mean of ~15 responses per 
fly. (B) Quantification of ERG depolarization. 2-way ANOVA showed a significant effect of genotype (p<0.0001) 
and age (p<0.0001) on depolarization, with a significant interaction between factors (p<0.0001). (C) 
Quantification of ERG ON transients. 2-way ANOVA showed a significant effect of genotype (p<0.0001) and age 
(p<0.0001) on ON transients, with a significant interaction between factors (p<0.0001). Graphs show individual 
datapoints with mean ± SEM. n = 8-24 flies per genotype/age. ns p>0.05,**p<0.001, ***p<0.0001. Data were 
normally distributed. Asterisks (in black) show comparisons with the control genotype of the same age, 
asterisks (in black) above horizontal lines show comparisons between experimental genotypes of the same age 
and number symbols (in red) show comparisons with 1-day old flies of the same genotype by post-hoc Tukey 
HSD tests.  
 
Thus, we found a similar but more severe phenotype in lGMR>0n4r tauR406W flies compared 
to lGMR>0n4r tauWT flies. There was a more dramatic age-related reduction in 
depolarization in lGMR>0n4r tauR406W flies compared to lGMR>0n4r tauWT flies. 
Depolarization in 1- and 5-day old lGMR>0n4r tauR406W flies did not differ significantly from 
age-matched lGMR>0n4r tauWT flies. On the other hand, depolarization in 10- and 30-day 
old lGMR>0n4r tauR406W flies was significantly smaller than in age-matched lGMR>0n4r 
tauWT flies. Additionally, there was an accelerated loss of ON transients in lGMR>0n4r 
tauR406W flies compared with lGMR>0n4r tauWT flies. We found ON transients were 
significantly smaller in 5-day old lGMR>0n4r tauR406W flies compared to age-matched 
controls. Whereas, ON transients in 5-day old lGMR>0n4r tauWT flies did not significantly 
differ from age-matched controls. We found a significant reduction in ON transients 
between the 1- and 5- day old age groups in lGMR>0n4r tauR406W flies, but not in lGMR>0n4r 
tauWT flies. These transgenic UAS-0n4r tau lines were generated by P-element mediated 






Therefore, positional effects on transgene activity and expression may account for the 
stronger phenotype in lGMR>0n4r tauR406W flies compared to lGMR>0n4r tauWT flies. 
 
We also tested lGMR>0n4r tauR406W flies’ sight behaviourally. In concordance with the ERG 
data, young (1- to 3-day old) tethered flying lGMR>0n4r tauR406W flies in the flight simulator 
system successfully followed scene rotations, generating reflex-like turns (optomotor 
responses) to the left or the right (Figure 2.5A). When we quantified the optomotor 
responses (min-to-max) for lGMR>0n4rtauR406W flies, they did not differ significantly from 
Gal4 control flies (Figure 2.5B). It is not possible to reproducibly test visual behaviour in 
older (≥10 day old) flies in the flight simulator system, because although they can be 
motivated to fly by airflow they fail to do so for long enough to collect sufficient data. Taken 
together, these results demonstrate intact retinal function in both lGMR>0n4r tauWT and 
lGMR>0n4r tauR406W flies at a young age, as indicated by the normal ERG responses and 
visual behaviour in the flight simulator system in <5-day old 0n4r tau-expressing flies. 
However, retinal function is severely compromised in aged flies, as indicated by the 
progressive reduction in ERG depolarization, which coincides with the rapid and progressive 
loss of ERG ON transients, in >5-day old 0n4r tau-expressing flies.  
 
2.3.2   No neuronal death in 0n4r tau-expressing retina 
 
Next, we investigated whether neuronal dysfunction in 0n4r tau-expressing eyes coincides 
with neuronal death. To achieve this we assessed the survival of photoreceptor 
rhabdomeres in living adult flies at various ages. Rhabdomeres are the expanded apical 
domain of photoreceptors, which consist of many (~30,000) microvilli, which contain the 
light sensing apparatus (Harris et al., 1976). For this, we used the quantitative cornea 
neutralisation technique, in which one visualises the photoreceptor rhabdomeres directly 
though the cornea of a living water covered anesthetised fly with an immersion objective 
(Franceschini and Kirschfeld, 1971). The six outer photoreceptors (R1-R6) are detected 








First, to ensure the presence of eGFP in the photoreceptors did not have an adverse effect 
on function we recorded ERGs from lGMR-Gal4; Rh1-eGFP flies. Depolarization and ON 
transients in lGMR-Gal4; Rh1-eGFP flies did not differ significantly from lGMR-Gal4 flies 
(Supplementary Figure 1). Typically in Drosophila eyes, ommatidia are regularly spaced and 
within each ommatidium rhabdomeres are arranged in a precise asymmetric trapezoidal 
pattern. In the eyes of lGMR>0n4r tauWT and lGMR>0n4r tauR406W flies the spatial 
organisation of rhabdomeres appeared normal. Furthermore, rhabdomere morphology 
(both size and shape) seemed to be similar in 0n4r-tau expressing and control flies (Figure 
2.2A). Thus, lGMR>0n4r tau expression does not have a toxic effect on photoreceptor 
development.  
 
We found no evidence of structural degeneration in either lGMR>0n4r tauWT or lGMR>0n4r 
tauR406W flies up to 30-days of age. All photoreceptor rhabdomeres were present in the eyes 
of lGMR>0n4r tauWT and lGMR>0n4r tauR406W flies up to 30-days of age. The number of 
rhabdomeres per ommatidium in lGMR>0n4r tauWT and lGMR>0n4r tauR460W flies did not 
significantly differ from age-matched controls in all age groups. We found no significant age-
related differences in the number of rhabdomeres per ommatidium within each genotype 
(Figure 2.2A,B). We also quantified the percentage of ommatidia with a complete set of 
rhabdomeres. The percentage of ommatidia with a full complement of rhabdomeres was 97 
% in control flies, 95 % in lGMR>0n4r tauWT flies and 94 % in lGMR>0n4r tauR460W flies at 1-
day of age. Similarily, in 30-day old flies, the percentage of ommatidia with a complete set 
of rhabdomeres was 92 % in lGMR>0n4r tauWT flies, 93 % in lGMR>0n4r tauR406W flies and 95 
% in control flies (Table 2.2). Collectively, these results show that 0n4r tau-expressing eyes 
lose their responsiveness to light without loss of their photoreceptor rhabdomeres. This 
evidence supports the notion that tau-mediated neuronal dysfunction is separable from 



















Figure 2.2: No neuronal death in 0n4r tau-expressing retina. Water immersion microscopy images of Rh1-
eGFP fluorescence in the eyes of 1-, 10- and 30-day-old lGMR-Gal4, lGMR>0n4r tauWT and lGMR>0n4r tauR406W 
flies. Outer (R1-R6) photoreceptor rhabdomeres are arranged in an asymmetric trapezoidal pattern. Normal 
number and arrangement of rhabdomeres in the eyes of lGMR>0n4r tauWT and lGMR>0n4r R406W flies. No 
apparent age-related differences in the number of rhabdomeres per ommatidium. All photoreceptor 
rhabdomeres are visible in the eyes of control, lGMR>0n4r tauWT and lGMR>0n4r tauR406W flies up to 30-days of 
age. (B) Quantification of the number of photoreceptor rhabdomeres per ommatidium. 2-way ANOVA showed 
no significant effect of genotype (p=0.2954) and age (p=0.1063) on the number of photoreceptor rhabdomeres 
per ommatidium, with no significant interaction between factors (p=0.9346). Graphs show individual 
datapoints with mean ± SEM. n = 6 flies per genotype/age from ~20 ommatidia per fly. ns p>0.05. Data were 
normally distributed. Asterisks (in black) show comparisons with the control genotype of the same age, 
asterisks (in black) above horizontal lines show comparisons between experimental genotypes of the same age 
and number symbols (in red) show comparisons with 1-day old flies of the same genotype by post-hoc Tukey 
HSD tests.  
 
2.3.3   2n4r tau expression in the retina causes temporally separable neuronal dysfunction 
and death  
 
Previous studies have compared the toxicity of 3r and 4r tau isoforms in different neuronal 
types (Grammenoudi et al., 2008; Kosmidis et al., 2010; Papanikoloulou et al., 2010), but to 
date no study has described in detail the consequences of expressing different 4r tau 
isoforms in the same neuronal population. Therefore, next we sought to investigate 
whether lGMR>2n4r tau expression precipitates equivalent results with lGMR>0n4r tau 
expression. These isoforms differ in the number of N-terminal inserts they carry in their N-
terminal domain; 0n4r tau carries no N-terminal inserts, whereas 2n4r tau carries two N-
terminal inserts. The role of the N-terminal inserts is not well understood. In vitro, different 
4r tau isoforms exhibit different phosphorylation susceptibility (Goedert and Jakes, 1990; 
Goedert et al., 1992; Buee et al., 2000), microtubule binding affinity (Kanaan et al., 2011; 
Matsumoto et al., 2015), subcellular distribution (Liu and Gotz, 2013; Paholikova et al., 
2015) and interaction partners (Liu et al., 2016). 
 
We monitored age-related changes in function and structure in flies expressing the full-






independent UAS-2n4r tauWT transgenic lines, which were previously generated by P-
element mediated transgenesis (Chatterjee et al., 2009). We found a small increase in 
depolarization in 1-day old lGMR>2n4r tauWT1 flies compared with age-matched Gal4 
control flies. With aging, there was a progressive reduction in depolarization in lGMR>2n4r 
tauWT1 flies consistent with progressive photoreceptor dysfunction. Quantification of the 
depolarization revealed a ~10 % increase in 1-day old lGMR>2n4rtauWT1 flies, a ~40 % 
decrease in 10-day old lGMR>2n4rtauWT1 and a ~70 % decrease in 30-day old lGMR>2n4r 
tauWT1 flies, compared to age-matched controls (Figure 2.3A,B). The lGMR>2n4r tauWT1 flies 
showed a dramatic decline in depolarization as a consequence of aging. Depolarization was 
significantly smaller in 5-, 10- and 30-day old lGMR-2n4r tauWT1 flies, compared to 1-day old 
lGMR>2n4r tauWT1 flies. Alongside the increase in depolarization, 1-day old lGMR>2n4r 
tauWT1 flies exhibited severe synaptic transmission defects, as indicated by the minute ON 
transients (~0.2 mV compared to ~3.4 mV in controls flies): seven flies displayed no ON 
transient and eight flies displayed tiny ON transients. No aged (5-, 10- and 30-day old) 
lGMR>2n4r tauWT1 flies displayed ON transients, indicating a total block of synaptic 
transmission. We found no significant differences between age groups in lGMR>2n4r tauWT1 
flies, as a result of the minute ON transients in 1-day old lGMR>2n4r tauWT1 flies (Figure 
2.3A,C).  
 
Similarly, we found a small increase in depolarization in 1- and 5-day old lGMR>2n4r tauWT2 
flies compared with age-matched controls. A weak reduction in depolarization became 
apparent after 10 days and progressively worsened by 30 days in lGMR>2n4r tauWT2 flies. 
Quantification of the depolarization revealed a ~10 % increase in 1-day old 
lGMR>2n4rtauWT2 flies, a ~15 % increase in 5-day old lGMR>2n4r tauWT2 flies, a ~10 % 
decrease in 10-day old lGMR>2n4rtauWT2 and a ~60 % decrease in 30-day old 
lGMR>2n4rtauWT2 flies, compared to age-matched control flies. lGMR>2n4r tauWT2 flies 
showed a significant age-related reduction in depolarization. No significant differences in 
depolarization were seen in lGMR>2n4r tauWT2 flies between the 5- and 1-day old age 
groups. On the other hand, depolarization was significantly smaller in 10- and 30-day old 
lGMR>2n4r tauWT2 flies, compared to 1-day old lGMR>2n4r tauWT2 flies (Figure 2.3A,B). We 






~3.4 mV in controls), only four out of 18 flies tested displayed no ON transient. No ON 
transients were found in aged (>5-day old) lGMR>2n4r tauWT2 flies. lGMR>2n4r tauWT2 flies 
showed a small, but significant, age-related reduction in ON transients. ON transients were 
significantly smaller in 5-, 10- and 30-day old lGMR>2n4r tauWT2 flies, compared to 1-day old 
lGMR>2n4r tauWT2 flies (Figure 2.3A,C). Thus, in 2n4r tau-expressing retina, the loss of ERG 
ON transients precedes the reduction in ERG depolarization, suggesting synaptic 
transmission is more sensitive to lGMR>2n4r tauWT expression than cell body function.  
 
Thus, we found lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 expression produced a similar 
reduction in depolarization as a function of age. No significant differences in depolarization 
were seen between lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 flies at 10- and 30-days of 
age. However, the decline in depolarization began at an earlier age in lGMR>2n4r tauWT1 
flies compared to lGMR>2n4 tauWT2 flies. Between the 1- and 5-day old age groups, we 
found a significant reduction in depolarization in lGMR>2n4r tauWT1 flies, but not in 
lGMR>2n4r tauWT2 flies. In 1-day old flies, there was a more dramatic reduction in ON 
transients in lGMR>2n4r tauWT1 flies, than in lGMR>2n4r tauWT2 flies, compared to age-
matched controls. A highly significant increase in ON transients was seen in 1-day old 
lGMR>2n4r tauWT2 flies compared to age-matched lGMR>2n4r tauWT1 flies. However, it is 
possible the differences in phenotype strength between lGMR>2n4r tauWT1 and lGMR>2n4r 
tauWT2 flies could be related to the positional effects of different transgenes.  
 
Next, we examined visual behaviour in young (1- to 3-day old) lGMR>2n4r tauWT1 and 
lGMR>2n4r tauWT2 flies in the flight simulator system. In the flight simulator system, 
tethered flying lGMR> 2n4r tauWT1 flies failed to follow the scene rotations. Flight behaviour 
appeared to be random and not coupled to the optomotor stimuli. Optomotor responses in 
lGMR> 2n4r tauWT1 flies were substantially smaller than in Gal4 control flies. In contrast, 
lGMR>2n4r tauWT2 flies seemed to follow the scene rotations to some extent. However, 
they also displayed much smaller optomotor responses than in control flies. Optomotor 
responses in lGMR>2n4r tauWT2 flies were larger than in lGMR> 2n4r tauWT1 flies, albeit 






young flies (<5-days old) larger ON transients in lGMR>2n4r tauWT2 flies than in lGMR>2n4r 








Figure 2.3: 2n4r tau expression in the retina causes neuronal dysfunction. (A) ERG recordings in response to a 
one second light pulse are shown for 1-, 5-, 10- and 30-day-old lGMR-Gal4, lGMR-Gal4>2n4r tauWT1 and lGMR-
Gal4>2n4r tauWT2 eyes. Moderate increase in depolarization in 1-day old 2n4r tau-expressing flies. Lack of ON 
transients in 1-day old lGMR-Gal4>2n4r tauWT1 flies. Small ON transients in 1-day old lGMR-Gal4>2n4r tauWT2 
flies. Moderate increase in depolarization in 5-day old lGMR-Gal4>2n4r tauWT2 flies. Lack of ON transients in 5-
day old lGMR>2n4r tauWT2 flies. Age-related progressive reduction in depolarization in 2n4r tau-expressing 
flies. Moderate reduction in depolarization in 10-day old 2n4r tau-expressing flies and severe reduction in 
depolarization in 30-day old 2n4r tau-expressing flies. Each trace represents the mean response from >10 flies 
from the mean of ~15 responses per fly. (B) Quantification of ERG depolarization. 2-way ANOVA showed a 
significant effect of genotype (p<0.0001) and age (p<0.0001) on depolarization, with a significant interaction 
between factors (p<0.0001). (C) Quantification of ERG ON transients. 2-way ANOVA showed a significant effect 
of genotype (p<0.0001) and age (p<0.0001) on ON transients, with a significant interaction between factors 
(p<0.0001). Graphs show individual datapoints with mean ± SEM. n = 10-23 flies per genotype/age. ns p>0.05, 
*p<0.05, **p<0.001, ***p<0.0001. Data were normally distributed. Asterisks (in black) show comparisons with 
the control genotype of the same age, asterisks (in black) above horizontal lines show comparisons between 
experimental genotypes of the same age and number symbols (in red) show comparisons with 1-day old flies 
of the same genotype by post-hoc Tukey HSD tests.  
 
 
In order to assess if functional degeneration was associated with structural degeneration, 
we assessed photoreceptor rhabdomere structure in the eyes of 2n4r tau-expressing flies 
using the quantitative corneal neutralisation technique. In the eyes of 1-day old lGMR>2n4r 
tauWT1 and lGMR>2n4r tauWT2 flies the ommatidia appeared to contain a complete set of 
rhabdomeres (Figure 2.4A). No significant differences in the number of rhabdomeres per 
ommatidium were seen between 1-day old 2n4r tau-expressing and control flies (Figure 
2.4B). However, we found mild disorganisation in the trapezoidal pattern of rhabdomeres in 
the eyes of 1-day old 2n4r tau-expressing flies. Additionally, some of the rhabdomeres were 
abnormal in shape, they appeared rectangular or oblong rather than circular. Also, some of 
the rhabdomeres were abnormal in size, some appeared to be smaller than in controls, 
whereas others appeared to be larger than in controls. Additionally, a few of the 
rhabdomeres appeared split. Finally, a small number of ommatidia had supernumerary 
outer photoreceptors (Figure 2.4A). Thus, 2n4r tauWT expression during development had a 







As the lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 flies aged, there was a progressive loss of 
photoreceptor rhabdomeres. In lGMR>2n4r tauWT1 flies a small reduction in the number of 
rhabdomeres per ommatidium was seen in 10-day old flies, and a large reduction in the 
number of rhabdomeres per ommatidium was seen in 30-day old flies, compared to age-
matched controls. Similarily, a large reduction in the number of rhabdomeres per 
ommatidium was seen in 30-day old lGMR>2n4r tauWT2 flies compared to age-matched 
controls. The number of rhabdomeres per ommatidium in 10-day old lGMR>2n4r tauWT2 
flies did not significantly differ from age-matched controls. By 30-days of age, ommatidia in 
the eyes of 2n4r-tau expressing flies contained on average half the normal number of 
rhabdomeres. Unlike in controls flies, there was a highly significant age-related reduction in 
the number of rhabdomeres per ommatidium in lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 
flies. In lGMR>2n4r tauWT1 flies, the number of rhabdomeres per ommatidium was 
significantly smaller in 10- and 30-day old flies compared to 1-day old flies. Likewise, in 
lGMR>2n4r tauWT2 flies the number of rhabdomeres per ommatidium was significantly 
smaller in 30-day old flies compared to 1-day old flies (Figure 2.4B). We also quantified the 
percentage of ommatidia that contained a full complement of rhabdomeres. In 1-day old 
flies, the percentage of ommatidia with a complete set of rhabdomeres was 84 % in 
lGMR>lGMR>2n4r tauWT1 flies, 93 % in lGMR>2n4r tauWT2 flies and 97 % in control flies. On 
the other hand, in 10-day old flies, the fraction of ommatidia which had a complete set of 
rhabdomeres was only 25 % in lGMR>2n4r tauWT1 flies and 84 % in lGMR>2n4r tauWT2 flies, 
compared to 96 % in control flies. By 30-day of age, <1 % of ommatidia had a full 
complement of rhabdomeres in lGMR>2n4r tauWT1 and lGMR>2n4r WT2 flies, compared to 
95 % in control flies (Table 2.2). 
 
lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 expression produced a similar phenotype in 30-
day old flies. In 30-day old flies no significant differences in the number of rhabdomeres per 
ommatidium were seen between lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 flies. However, 
there was an accelerated loss of photoreceptor rhabdomeres in lGMR>2n4r tauWT1 flies 
compared to lGMR>2n4r tauWT2 flies. In 10-day flies, there were significantly fewer 
rhabdomeres per ommatidium in lGMR>2n4r tauWT1 flies, but not in lGMR>2n4r tauWT2 






groups, there was a significant loss of rhabdomeres in lGMR>2n4r tauWT1 flies, but not in 
lGMR>2n4r tauWT2 flies. We found synaptic transmission defects without detectable 
photoreceptor rhabdomere loss in 1-day old 2n4r tau-expressing flies (Figure 2.3A,C and 
Figure 2.4A,B). Collectively, these results show lGMR>2n4r tau expression, unlike 
lGMR>0n4r tau expression, is sufficient to cause age-related progressive structural 
degeneration. However, it is unclear whether it is bona fide degeneration, because it is not 
possible to determine whether adult structural degeneration is contributed to by tau-
dependent toxicity during development. These findings show that 2n4r tau expression in our 



















Figure 2.4: Neuronal death in 2n4r tau-expressing retina. Water immersion microscopy images of Rh1-eGFP 
fluorescence in the eyes of 1-, 10- and 30-day-old lGMR-Gal4, lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 flies. 
Outer (R1-R6) photoreceptor rhabdomeres are arranged in an asymmetric trapezoidal pattern. A normal 
number of rhabdomeres is seen in the eyes of 1-day 2n4r tau-expressing flies. However, in 2n4r-tau expressing 
flies we see mild disruption in the pattern of their rhabdomere spatial organisation. Additionally, some of the 
rhabdomeres are slightly deformed in lGMR>2n4r tauWT flies. With aging, we find a progressive loss of 
photoreceptors rhabdomeres in 2n4r tauWT-expressing flies. A dramatic loss of rhabdomeres is seen in 30-day 
old lGMR>2n4r tauWT flies. (B) Quantification of the number of photoreceptor rhabdomeres per ommatidium. 
2-way ANOVA shows a significant effect of genotype (p<0.0001) and age (p<0.0001) on the number of 
rhabdomeres per ommatidium, with a significant interaction between factors (p<0.0001). Graphs show 
individual datapoints with mean ± SEM. n = 6-13 flies per genotype/age from ~20 ommatidia per fly. ns p>0.05, 
*p<0.05, **p<0.001, ***p<0.0001. Data were normally distributed. Asterisks (in black) show comparisons with 
the control genotype of the same age, asterisks (in black) above horizontal lines show comparisons between 
experimental genotypes of the same age and number symbols (in red) show comparisons with 1-day old flies 














Figure 2.5: Visual behaviour in a flight-simulator system of tau-expressing flies. (A) Optomotor responses 
(yaw torque) of tethered flying lGMR-Gal4, lGMR>0n4r tauR406W, lGMR>2n4r tauWT1 and lGMR>2n4r tauWT2 
flies to counterclockwise and clockwise (arrows) scene rotations recorded in a Drosophila flight simulator 
system. lGMR-Gal4 and lGMR>0n4r tauR406W flies robustly follow the scene rotations. lGMR>2n4r tauWT1 flies 
fail to follow the scene rotations. lGMR>2n4r tauWT2 flies partially follow the scene rotations. (B) 
Quantification of the maximum torque response. One-way ANOVA shows a significant effect of genotype 
(p<0.0001) on the maximum torque response. Graphs show individual datapoints with mean ± SEM. n = 8-15 
flies per genotype. ns p>0.05, *p<0.05, **p<0.001, ***p<0.0001. Data were normally distributed. Asterisks 
show comparisons with the control genotype and asterisks above horizontal lines show comparisons between 
experimental genotypes by post-hoc Tukey HSD tests.  
 
Elav>2n4r tauWT1 expression caused a reduced and rough eye (Figure 2.6A). A rough eye has 
been indirectly associated with photoreceptor viability (Feany et al., 1996; Wittmann et al., 
2001; Jackson et al., 2002; Chatterjee et al., 2009). However, ERG recordings from these 
eyes in 30-day old flies revealed normal depolarization and ON transients, indicating adult 






together, these results demonstrate that tau-dependent toxicity during development is 





2.3.4   Adult-onset 2n4r tauWT expression causes neuronal dysfunction but not neuronal 
death 
 
The problem with the lGMR-Gal4 driver is it induces expression of tau from early 
developmental stages (Freeman et al., 1996). We have shown that 2n4r tauWT expression 
during development has both functional and structural effects in the eyes of newborn adult 
flies (Figure 2.3 and Figure 2.4). Therefore, it is not possible to determine whether 2n4r 
tauWT-evoked neuronal dysfunction and neuronal death in adult fly eyes, is related to 
development defects. Previous studies on whether adult-onset tau expression in the 
Drosophila eye, is sufficient to cause neuronal death have yielded a confusing and 
contradictory picture (Chouhan et al., 2016; Gorsky et al., 2016; Malmanche et al., 2017). 
Figure 2.6: Elav>2n4r tauWT expression is toxic 
during development but does not compromise 
adult photoreceptor function. (A) Eye pictures of 
Elav-Gal4 and Elav>2n4r tauWT1 flies. (B) ERG 
recordings in response to a one second light 
pulse are shown for 30-day old Elav-Gal4 and 
Elav>2n4r tauWT1 flies. Normal depolarization and 
ON transients in Elav>2n4r tauWT1 flies. (C) No 
differences in depolarization are found in 
Elav>2n4r tauWT1 flies relative to controls. (D) No 
differences in ON transients are found in 
Elav>2n4r tauWT1 flies relative to controls. Graphs 
show individual datapoints with mean ± SEM. n = 
10-12 flies per genotype. Data were normally 







Therefore, it remains unclear whether 4r tau-mediated toxicity in adult flies requires a 
neurodevelopmental component. Surprisingly, whether tau expression in the adult 
Drosophila retina precipitates neuronal dysfunction has as of yet not been investigated. To 
answer these questions we developed a model expressing tau throughout the adult fly 
retina using the TARGET system (McGuire et al., 2003), to circumvent any developmental 
defects due to tau expression during development and therefore analyse the toxic effects 
exclusively related to tau expression during adulthood.  
  
lGMR; tub-Gal80ts>2n4r tauWT1 and lGMR; tub-Gal80ts control flies raised at 18 °C had 
comparable ERGs. We found no significant differences in depolarization and ON transients 
between lGMR; tub-Gal80ts>2n4r tauWT1 and control flies raised at 18 °C (Figure 2.7A,B,C). 
Thus, retinal function was preserved in lGMR; tub-Gal80ts>2n4r tauWT1 flies raised at 18 °C. 
So, there was no leaky 2n4r tauWT expression during development. However, it was a 
different story after shifting the flies to 30 °C. They exhibited an age-related progressive 
reduction in depolarization, indicating progressive photoreceptor dysfunction. 
 
Quantification of the depolarization revealed a moderate reduction (~25 %) after 7 days at 
30 °C and a severe reduction (~80 %) after 14 days at 30 °C in lGMR; tub-Gal80ts>2n4r 
tauWT1 flies, compared with age-matched controls (Figure 2.7A,B). Moreover, shifting the 
flies to 30 °C also caused a progressive and rapid loss of the ON transients. We found tiny 
ON transients in lGMR; tub-Gal80ts>2n4r tauWT1 flies after 7 days at 30 °C (~0.7 mV 
compared to ~3.4 mV in control flies), indicating severely compromised synaptic 
transmission. Furthermore, we found a lack of ON transients in any lGMR; tub-Gal80ts>2n4r 
tauWT1 flies after 14 days at 30 °C, indicating a total block of synaptic transmission (Figure 
2.7A,C). lGMR; tub-Gal80>2n4r tauWT1 flies showed a dramatic age-related decline in 
depolarization and ON transients. In lGMR; tub-Gal80>2n4r tauWT1 flies we found 
depolarization and ON transients were significantly smaller in 7- and 14-day old flies kept at 
30 °C, compared to age-matched control flies kept at 18 °C. In contrast, both depolarization 
and ON transients were well maintained in control flies after being shifted to 30 °C (Figure 







During the course of this work, Chouhan et al (2016) published a study demonstrating that 
Rh1-Gal4 driven 0n4r tauWT expression causes an age-related progressive loss of the ERG 
response. Rh1-Gal4 is expressed in the outer R1-R6 photoreceptors in the late pupa after 
development has finished (Kumar and Ready, 1995), so tau expression is restricted to 
adulthood. Thus, this is in agreement with our findings using the TARGET system that adult-
onset tau expression compromises retinal function. However, when we tried to replicate 
these findings we were unable to do so. Instead, we found that ERG responses in Rh1>2n4r 
tauWT1 eyes were indistinguishable from age-matched controls in flies up until 30-days of 
age (Figure 2.8). 
 
We next investigated whether adult-onset 2n4r tauWT expression leads to structural 
degeneration by quantifying the number of photoreceptor rhabdomeres, using the corneal 
neutralisation technique. Ommatidia in 1-day old lGMR; tub-Gal80ts>2n4r tauWT1 flies raised 
at 18 °C had a full complement of rhabdomeres (Figure 2.9). In 1-day old lGMR; tub-
Gal80ts>2n4r tauWT1 flies raised at 18 °C 97 % of ommatidia contained a full complement of 
rhabdomeres, similar to 99 % in control flies of the same age (Table 2.2). The spatial 
organisation and roundness of rhabdomeres was normal in 1-day old lGMR; tub-
Gal80ts>2n4r tauWT1 flies raised at 18 °C (Figure 2.9A). After shifting the lGMR; tub-
Gal80ts>2n4r tauWT1 flies to 30 °C for up to 14 days, we observed no loss of photoreceptor 
rhabdomeres. We found no significant differences in the number of rhabdomeres per 
ommatidium in 7- and 14-day old lGMR; tub-Gal80ts>2n4r tauWT1 flies kept at 30 °C, 
compared to age-matched control flies kept at 18 °C. Furthermore, we found no significant 
age-related differences in the number of rhabdomeres per ommatidium within each 
genotype (Figure 2.9B). In 14-day old flies kept at 30 °C, the fraction of ommatidia with a 
complete set of rhabdomeres was 94 % in lGMR; tub-Gal80ts>2n4r tauWT1 flies and 97 % in 





















Figure 2.8: Rh1>2n4r tauWT expression fails to 
induce neuronal dysfunction. (A) ERG recordings 
in response to a one second light pulse are shown 
for 30-day old Rh1-Gal4 and Rh1>2n4r tauWT1 flies. 
Normal depolarization and ON transients in 
Rh1>2n4r tauWT1 flies. (B) No differences in 
depolarization are found in Rh1>2n4r tauWT1 flies 
relative to controls. (C) No differences in ON 
transients are found in Rh1>2n4r tauWT1 flies 
relative to controls. Graphs show individual 
datapoints with mean ± SEM. n = 12 flies per 
genotype. Data were normally distributed. ns 
p>0.05; two-tailed Student’s t-test. 
 
 
Figure 2.7: Adult-onset 2n4r tauWT expression in the retina induces neuronal dysfunction. (A) ERG recordings 
in response to a one second light pulse are shown for lGMR-Gal4; tub-Gal80ts and lGMR; tub-Gal80ts>2n4r 
tauWT1 flies. Flies were raised at 18 °C and after eclosion shifted to 30 °C for up to 14 days to induce 2n4r 
tauWT1 expression in the eye. 1-day old lGMR; tub-Gal80ts>2n4r tauWT1 flies raised at 18 °C exhibit normal 
depolarization and ON transients. On the other hand, after shifting lGMR; tub-Gal80ts>2n4r tauWT1 flies to 30 
°C, there is a progressive reduction in depolarization and rapid and progressive loss of ON transients. 
Moderate reduction in depolarization after 7 days at 30 °C and a severe reduction in depolarization after 14 
days at 30°C in lGMR; tub-Gal80ts>2n4r tauWT1 flies. Tiny ON transients after 7 days at 30 °C and no ON 
transients after 14 days at 30 °C in lGMR; tub-Gal80ts>2n4r tauWT1 flies. Whereas, ERGs are well maintained in 
control flies after shifting to 30 °C. (B) Quantification of ERG depolarization. 2-way ANOVA showed a significant 
effect of genotype (p<0.0001) and age (p<0.0001) on depolarization, with a significant interaction between 
factors (p<0.0001). (C) Quantification of ERG ON transients. 2-way ANOVA showed a significant effect of 
genotype (p<0.0001) and age (p<0.0001) on ON transients, with a significant interaction between factors 
(p<0.0001). Graphs show individual datapoints with mean ± SEM. n = 8-27 flies per genotype/age. ns p>0.05, 
***p<0.0001. Data were normally distributed. Asterisks (in black) show comparisons with the control genotype 
of the same age and number symbols (in red) show comparisons with 1-day old flies of the same genotype by 












Taken together, these results show that adult-onset lGMR>2n4r tauWT expression causes 
progressive neuronal dysfunction, independent of overt neuronal death. Thereby, providing 
further evidence that tau-evoked functional degeneration is separable from structural 
degeneration. Additionally, these results suggest that 4r tau-dependent toxicity in adult flies 
requires a neurodevelopmental component.  
Figure 2.9: Adult-onset 2n4r tauWT expression in 
the retina does not cause structural degeneration. 
Water immersion microscopy images of Rh1-eGFP 
fluorescence in the eyes of lGMR-Gal4; tub-Gal80ts 
and lGMR; tub-Gal80ts>2n4r tauWT1 flies. Flies were 
raised at 18 °C and after eclosion shifted to 30 °C for 
up to 14 days to induce 2n4r tauWT expression in the 
eye. Outer (R1-R6) photoreceptor rhabdomeres are 
arranged in an asymmetric trapezoidal pattern. 
Normal number and arrangement of rhabdomeres 
in the eyes of lGMR; tub-Gal80ts>2n4r tauWT1 flies. 
No loss of photoreceptor rhabdomeres is seen in 
lGMR; tub-Gal80ts>2n4r tauWT1 flies after 14 days at 
30 °C. (B) Quantification of the number of 
photoreceptor rhabdomeres per ommatidium. 2-
way ANOVA showed no significant effect of 
genotype (p=0.1441) and age (p=0.4816) on the 
number of rhabdomeres per ommatidium, with no 
significant interaction between factors (p>0.9999). 
Graphs show individual datapoints with mean ± 
SEM. n = 6 flies per genotype/age from ~20 
ommatidia per fly. ns p>0.05. Data were normally 
distributed. Asterisks (in black) show comparisons 
with the control genotype of the same age and 
number symbols (in red) show comparisons with 1-
day old flies of the same genotype by post-hoc 








2.3.5   Varying the phosphorylation status of tau affects tau-mediated neuronal 
dysfunction and toxicity 
 
One of the earliest abnormalities detected in tauopathies, such as AD, is an increase in tau 
phosphorylation. Tau is phosphorylated by several kinases. One of the best studied is the 
microtubule-affinity regulating kinase (MARK)/PAR1 kinase. The PAR1 kinase has been 
previously shown to regulate microtubule dynamics via tau phosphorylation (Wang et al., 
2007). Tau phosphorylation at the PAR1 kinase sites (Ser262/Ser356) is required for the REP 
(Nishimura 2004; Chatterjee et al., 2009). Therefore, we sought to investigate whether PAR1 
function is also associated with tau-mediated neuronal dysfunction in our model. To this 
end, we used the UAS-2n4r tauS2A transgene, in which the two PAR1 phosphorylation sites 
(Ser262/SerS356) have been mutated to phosphoresistant alanine. We tested two well 
characterised UAS-2n4r tauS2A transgenic lines, which were previously generated by P-
element mediated transgenesis (Chatterjee et al., 2009). The depolarization of lGMR>2n4r 
tauS2A-expressing flies was normal. At both ages analysed, no significant differences in 
depolarization were seen in lGMR>2n4r tauS2A1 and lGMR>2n4r tauS2A2 flies with respect to 
age-matched controls. No significant age-related differences in depolarization were seen 
within each genotype (Figure 2.10A,B). The ON transients were slightly smaller in 1-day old 
lGMR>2n4r tauS2A1 flies (~2 mV compared to ~3.4 mV in controls), but normal in 30-day old 
lGMR>2n4r tauS2A1 flies, compared to age-matched controls. Regardless of age, normal ON 
transients were found in lGMR>2n4r tauS2A2 flies relative to age-matched control flies. In 
lGMR>2n4r tauS2A1 flies a small, but significant, age-related increase in ON transients was 
seen. No significant age-related differences in ON transients were found in lGMR>2n4r 
tauS2A flies. Thus, lGMR>2n4r tauS2A expression failed to produce an age-related decline in 
ON transients (Figure 2.10A,C). These results show that lGMR>2n4r tauS2A expression is 
insufficient to cause neuronal dysfunction and suggest tau phosphorylation by the PAR-1 
kinase plays an essential role in tau-mediated neuronal dysfunction. An alternative 
explanation is a conformational change in 2n4r tauS2A as a result of the S262A and S356A 
mutations, modifies its toxicity independently of PAR1 function. Another possible 
explanation for the different levels of toxicity mediated by the UAS-2n4r tauWT and UAS-












Figure 2.10: Varying tau phosphorylation status affects tau-mediated functional and structural 
degeneration. (A) ERG recordings from 1- and 30-day old lGMR-Gal4, lGMR>2n4r tauS2A1 and lGMR>2n4r 
tauS2A2 flies. Normal depolarization in 1- and 30-day old 2n4r tauS2A-expressing flies. No age-related reduction 
in depolarization in 2n4r tauS2A-expressing flies. Normal ON transients in 2n4r tauS2A-expressing flies, except for 
a small reduction in 1-day old lGMR>2n4r tauS2A1 flies. (B) Quantification of ERG depolarization. 2-way ANOVA 
showed no significant effect of genotype (p=0.7178) and age (p=0.6102) on depolarization, with no significant 
interaction between factors (p=0.9478). (C) Quantification of ERG ON transients. 2-way ANOVA showed a 
significant effect of genotype (p=0.0098) and age (p=0.0012) on ON transients, with a significant interaction 
between factors (p=0.0098). n = 12-31 flies per genotype/age. (D) ERG recordings from 1- and 30-day old 
lGMR-Gal4 and lGMR>2n4r tauS11A flies. Severe reduction in depolarization in lGMR>2n4r tauS11A flies at both 
ages analysed. Dramatic age-related decline in depolarization in lGMR>2n4r tauS11A flies. Lack of ON transients 
in lGMR>2n4r tauS11A flies at both ages analysed. (E) Quantification of ERG depolarization. 2-way ANOVA 
showed a significant effect of genotype (p<0.0001) and age (p<0.0001) on depolarization, with a significant 
interaction between factors (p<0.0001). Graphs show individual datapoints with mean ± SEM. n = 12-24 flies 
per genotype/age. ns p>0.05, *p<0.05, **p<0.001, ***p<0.0001. (B,C,E) Data were normally distributed. 
Asterisks (in black) show comparisons with the control genotype of the same age, asterisks (in black) above 
horizontal lines show comparisons between experimental genotypes of the same age and number symbols (in 
red) show comparisons with 1-day old flies of the same genotype by post-hoc Tukey HSD tests. (F) Water 
immersion microscopy images of Rh1-eGFP florescence in the eyes of 1-day old lGMR-Gal4 and lGMR>2n4r 
tauS11A flies. Very few discernible photoreceptor rhabdomeres in lGMR>2n4r tauS11A flies. 
 
We next investigated whether the 2n4r tauS11A construct (in which 11 glycogen synthase 
kinase (GSK)/ shaggy (sgg) (serine/threonine) phosphorylation sites have been mutated to 
phosphoresistant alanine) with increased microtubule binding affinity precipitates a more 
severe phenotype than 2n4r tauWT in the fly eye. Previous studies have demonstrated that 
tauS11A is more toxic than wild-type tau when overexpressed in the developing Drosophila 
visual system (Chatterjee et al., 2009). At both ages analysed, depolarization in lGMR>2n4r 
tauS11A flies was substantially reduced compared to both age-matched lGMR>2n4r tauWT1 
and control flies. Quantification of depolarization revealed a ~70 % reduction in 1-day old 
lGMR>2n4r tauS11A flies and a ~90 % reduction in 30-day old lGMR>2n4r tauS11A flies, 
compared with control flies of the same age. Also, quantification of depolarization revealed 
a ~70 % reduction in 1-day old lGMR>2n4r tauS11A flies and a ~60 % reduction in 30-day old 
lGMR>2n4r tauS11A flies, compared with age-matched lGMR>2n4r tauWT1 flies. Thus, there 






lGMR>2n4r tauWT1 flies (Figure 2.10D,E). We found a lack of ON transients in any 
lGMR>2n4r tauS11A flies, indicating a total block of synaptic transmission (Figure 2.10D). We 
observed severe structural defects in 1-day old lGMR>2n4r tauS11A flies as evidenced by a 
complete loss of photoreceptor rhabdomeres in the vast majority of ommatidia (Figure 
2.10F). It is likely the functional and structural defects in 1-day old lGMR>2n4r tauS11A flies 
are due to developmental toxic mechanisms. These results support the idea that the 
microtubule binding properties of tau directly affect its toxicity. 
 
2.3.6   Aβ42 exacerbates tau-mediated neuronal dysfunction 
 
Some tauopathies like AD, are characterised by additional filamentous lesions. The 
pathological hallmarks of AD are the aggregation of hyperphosphorylated tau protein into 
intraneuronal NFTs, and the aggregation of amyloid beta (Aβ) peptides into extracellular 
neuritic plagues. We therefore sought to investigate whether Aβ expression enhances tau-
evoked neuronal dysfunction. But first we investigated whether Aβ expression alone is 
sufficient to cause functional degeneration. Many studies have shown Aβ expression in the 
Drosophila brain results in amyloid deposition, premature death, cognitive deficits and age-
dependent neurodegeneration, recapitulating several key features of AD (Iijima et al., 2004; 
Finelli et al., 2004; Crowther et al., 2005; Iijima et al., 2008; Jahn et al., 2011).  
 
We expressed the previously published and well characterised UAS-Aβ42 line (Iijima et al., 
2004) using the lGMR-Gal4 driver. ERG recordings from lGMR>Aβ42 animals did not show 
any evidence of neuronal dysfunction. At both ages analysed, no significant differences in 
depolarization were seen in lGMR>Aβ42 flies compared with age-matched UAS control flies. 
Between the 1- and 30-day old age groups, no significant differences in depolarization were 
found within genotypes (Figure 2.11A,B). The ON transients were a little smaller in 1- and 
30-day old lGMR>Aβ42 flies compared with age-matched controls. We found no age-related 
differences in ON transients in lGMR>Aβ42 flies (Figure 2.11A,C). Thus, in flies up to 30-days 
of age, lGMR>Aβ42 expression fails to inhibit synaptic transmission. Collectively, these 
results show that unlike lGMR>4r tau expression, lGMR>Aβ42 expression is insufficient to 






 Finally, we analysed whether coexpression of Aβ42 with 2n4r tauWT1 exacerbates tau-
mediated neuronal dysfunction. We coexpressed a single copy of UAS-2n4r tauWT 1 and 
UAS-Aβ42 using a single copy of the lGMR-Gal4 driver. At both ages analysed, we found a 
highly significant reduction in depolarization in lGMR>2n4r tauWT1; Aβ42 flies compared 
with age-matched control flies. Regardless of age, a significant reduction in depolarization 
was seen in lGMR>2n4r tauWT1; Aβ42 flies with respect to age-matched lGMR>2n4r tauWT1 
flies. A more substantial age-related reduction in depolarization was seen in lGMR>2n4r 
tauWT1; Aβ42 flies compared to lGMR>2n4r tauWT1 flies. Quantification of the depolarization 
revealed a ~15 % reduction in 1-day old lGMR>2n4r tauWT1; Aβ42 flies and a ~90 % 
reduction in 30-day old lGMR>2n4r tauWT1; Aβ42 flies, compared with age-matched control 
flies (Figure 2.11D,E). We found minute ON transients in 1-day old lGMR>2n4r tauWT1; Aβ42 
flies (only four out of 15 flies tested had an ON transient. No ON transients were found in 
30-day old lGMR>2n4r tauWT1; Aβ42 flies, indicating a total block of synaptic transmission 
(Figure 2.11F). These results demonstrate that coexpression of Aβ42 with 2n4r tauWT1 
aggravates tau-mediated functional degeneration in our model. Different tau expression 
levels as a result of UAS copy number imbalance may account for the stronger phenotype in 













Figure 2.11: Aβ42 expression potently exacerbates tau-mediated neuronal dysfunction. (A) ERG recordings in 
response to a one second light pulse of 1- and 30-day old UAS-Aβ42 and lGMR>Aβ42 flies. Normal 
depolarization in Aβ42-expressing flies. Moderate reduction in ON transients in Aβ-expressing flies. No age-
related differences in depolarization and ON transients in lGMR>Aβ42 flies. (B) Quantification of ERG 
depolarization. 2-way ANOVA showed no significant effect of genotype (p=0.2228) and age (p=0.9609) on 
depolarization, with no significant interaction between factors (p=0.8090). (C) Quantification of ERG ON 
transients. 2-way ANOVA showed a significant effect of genotype (p<0.0001) but not age (p=0.0596) on ON 
transients, with no significant interaction between factors (p=0.7944). n = 10-23 flies per genotype/age. (D) 
ERG recordings in response to a one second light pulse of 1- and 30-day old lGMR>2n4r tauWT1 and lGMR>2n4r 
tauWT1; Aβ42 flies. Lack of ON transients in lGMR>2n4r tauWT1; Aβ42 flies. At both ages analysed, reduction in 
depolarization in lGMR>2n4r tauWT1; Aβ42 flies compared with age-matched control and lGMR>2n4r tauWT1 
flies. Substantial age-related reduction in depolarization in both lGMR>2n4r tauWT1 and lGMR>2n4r tauWT1; 
Aβ42 flies. (E) Quantification of ERG depolarization. 2-way ANOVA showed a significant effect of genotype 
(p<0.0001) and age (p<0.0001) on depolarization, with a significant interaction between factors (p<0.0001). (F) 
Quantification of ERG ON transients. 2-way ANOVA showed a significant effect of genotype (p<0.0001) but not 
age (p=0.0826) on ON transients, with no significant interaction between factors (p=0.9535). n = 9-18 flies per 
genotype/age. Graphs show individual datapoints with mean ± SEM. ns p>0.05, *p<0.05, **p<0.001, 
***p<0.0001. Data were normally distributed. Asterisks (in black) show comparisons with the control genotype 
of the same age, asterisks (in black) above horizontal lines show comparisons between experimental 
genotypes of the same age and number symbols (in red) show comparisons with 1-day old flies of the same 






Genotype Age n ERG ON transient 
(mV ± SEM) 
ERG depolarization 
(mV ± SEM) 





ommatidia with a 




lGMR-Gal4  1 12 3.4 ± 0.25 9.5 ± 0.23 6 6.0 ± 0.01 97  
lGMR-Gal4  5 10 3.4 ± 0.25 9.4 ± 0.20     
lGMR-Gal4 10 13 3.4 ± 0.21  9.2 ± 0.24 6 6.0 ± 0.01 96  
lGMR-Gal4 30 17 3.3 ± 0.17 9.4 ± 0.25 6 6.0 ± 0.01 95  
lGMR>0n4r tauWT 1 10 3.4 ± 0.23 9.2 ± 0.26 6 6.0 ± 0.01 95  
lGMR>0n4r tauWT  5 8 3.8 ± 0.34 9.0 ± 0.41     
lGMR>0n4r tauWT  10 32 1.1 ± 0.25 7.1 ± 0.23 6 6.0 ± 0.01 95  
lGMR>0n4r tauWT  30 19 0 ± 0 4.1 ± 0.17 6 5.9 ± 0.01 92  
lGMR>0n4r tauR406W 1 21 3.3 ± 0.15 10.1 ± 0.22 6 5.9 ± 0.02 94  
lGMR>0n4r tauR406W 5 17 2.3 ± 0.26 9.6 ± 0.24     
lGMR>0n4r tauR406W 10 20 0.1 ± 0.07 5.6 ± 0.21 6 5.9 ± 0.04 93  
lGMR>0n4r tauR406W  30 14 0 ± 0 2.2 ± 0.10 6 5.9 ± 0.03 92  
lGMR>2n4r tauWT1 1 15 0.2 ± 0.07 10.8 ± 0.14 8 5.9 ± 0.01 84  
lGMR>2n4r tauWT1  5 17 0 ± 0  9.4 ± 0.19     
lGMR>2n4r tauWT1  10 14 0 ± 0 5.7 ± 0.26 6 4.7 ± 0.09 25  
lGMR>2n4r tauWT1 30 18 0 ± 0 2.5 ± 0.15 11 2.9 ± 0.18 <1  
lGMR>2n4r tauWT2  1 18 1.3 ± 0.19 10.4 ± 0.20 13 6.0 ± 0.04 93  
lGMR>2n4r tauWT2  5 22 0 ± 0 10.9 ± 0.22     
lGMR>2n4r tauWT2  10 16 0 ± 0 8.1 ± 0.18 6 5.8 ± 0.06 81  
lGMR>2n4r tauWT2  30 12 0 ± 0 3.8 ± 0.19 6 2.9 ± 0.11 <1  
Elav-Gal4 30 12 3.4 ± 0.19 8.4 ± 0.36     
Elav>2n4r tauWT1  30 10 3.3 ± 0.13 8.8 ± 0.41     
lGMR-Gal4; tub-Gal80ts (18 °C) 1 8 3.4 ± 0.14  8.4 ± 0.20 6 6.0 ± 0.01 99  






lGMR-Gal4; tub-Gal80ts (30 °C) 14 8 3.4 ± 0.27 8.5 ± 0.09 6 6.0 ± 0.02 97  
lGMR; tub-Gal80ts>2n4r tauWT1 
(18 °C) 
1 8 3.1 ± 0.22 8.3 ± 0.41 6 6.0 ± 0.02 97  
lGMR; tub-Gal80ts>2n4r tauWT1 
(30 °C) 
7 27 0.7 ± 0.20 6.5 ± 0.23  6 6.0 ± 0.02 96  
lGMR; tub-Gal80ts>2n4r tauWT1 
(30 °C) 
14 11 0 ± 0 1.6 ± 0.16 6 5.9 ± 0.02 94  
Rh1-Gal4 30 12 4.2 ± 0.13 9.3 ± 0.23      
Rh1>2n4r tauWT1 30 12  4.1 ± 0.17 9.2 ± 0.35     
lGMR>2n4r tauS2A1 1 28 2 ± 0.13 9.4 ± 0.19     
lGMR>2n4r tauS2A1  30 18 3.1 ± 0.13 9.3 ± 0.26     
lGMR>2n4r tauS2A2  1 18 2.9 ± 0.24 9.7 ± 0.28     
lGMR>2n4r tauS2A2  30 31 3.5 ± 0.18 9.5 ± 0.15     
lGMR>2n4r tauS11A  1 24 0 ± 0 3.1 ± 0.10     
lGMR>2n4r tauS11A  30 13 0 ± 0 1.0 ± 0.07     
UAS-Aβ42 1 16 2.8 ± 0.15 8.3 ± 0.49     
UAS-Aβ42 30 10 3.1 ± 0.24 8.4 ± 0.40     
lGMR>Aβ42  1 23 2.0 ± 0.11 8.0 ± 0.26     
lGMR>Aβ42  30 18 2.2 ± 0.13 7.9 ± 0.26     
lGMR>2n4r tauWT1; Aβ42 1 15 0.2 ± 0.10 8.1 ± 0.31     
lGMR>2n4r tauWT1; Aβ42  30 9 0 ± 0 1.1 ± 0.12     
 
Table 2.2: Quantification of ERG ON transients and ERG depolarization by genotype and age. Quantification of the number of photoreceptor rhabdomeres per ommatidium 
and the percentage of ommatidia with a full complement of photoreceptor rhabdomeres by genotype and age. n = number of flies tested per genotype/age. Colour 







2.4   Discussion  
 
In this study we expressed different isoforms of human tau in the Drosophila retina and 
performed a systematic assessment of the resulting functional and structural changes. First, 
we show that 0n4r tau expression causes adult-onset progressive functional degeneration 
without structural degeneration. Whereas, 2n4r tau expression causes progressive 
functional degeneration, which precedes progressive structural degeneration. Thus, we 
show 4r tau isoform-specific differences. Next, we show adult-onset 2n4r tau expression 
causes functional degeneration in the absence of structural degeneration. Our results show 
that one of the earliest manifestations of human tau expression in the Drosophila eye is 
neuronal dysfunction without neuronal death. Thus, tau-mediated neuronal dysfunction is 
separate from neuronal death. These results suggest that tau-mediated neuronal 
dysfunction may underlie early symptoms in tauopathies, such as AD. Further understanding 
of the contribution of tau-evoked neuronal dysfunction, in the early stages of the disease 
process, may provide novel therapeutic options to slow down or even halt disease 
progression. Next, we show that tau phosphorylation via the PAR1 kinase plays a role in tau-
mediated neuronal dysfunction in our model. Finally, we show that coexpression of Aβ42 
with 2n4r tauWT1 exacerbates tau-evoked neuronal dysfunction.  
 
2.4.1   Neuronal dysfunction in tau-expressing eyes  
 
We expressed several different isoforms of human tau in the Drosophila eye and monitored 
age-related changes in function using retinal ERGs. We selected a Gal4 driver that expressed 
tau at low enough levels so as not to produce a rough eye, which allowed us to study age-
dependent changes. This is the first study to compare the ability of different 4r tau isoforms 
to produce neuronal dysfunction. We demonstrate that the overaccumulation of either 0n4r 
or 2n4r tau in the fly eye causes neuronal and synaptic dysfunction. However, they produce 
distinct pathological phenotypes. lGMR>0n4r tau expression causes adult-onset progressive 
neuronal dysfunction. We found intact retinal function in young flies (<5-day old) as 
indicated by the normal ERG responses (Figure 2.1) and visual behaviour in the flight 






day old) as indicated by the progressive reduction in ERG depolarization, which coincides 
with the rapid and progressive loss of ERG ON transients (Figure 2.1). These results clearly 
show that human tau is capable of causing adult-onset neuronal dysfunction. lGMR>2n4r 
tau expression also causes progressive neuronal dysfunction, however, it is not adult-onset. 
A clear phenotype was observed in the eyes of young (<5-day old) lGMR>2n4r tauWT flies. 
We found severe defects in synaptic transmission in young flies (<5-day old) as shown both 
electrophysiologically (lack of ERG ON transients) (Figure 2.3) and behaviourally (abnormal 
optomotor responses in the flight simulator system) (Figure 2.5). We found that in 
lGMR>2n4r tauWT flies a progressive reduction in ERG depolarization occurs as a function of 
age (Figure 2.3). The synaptic transmission defects in newly eclosed adult flies are likely 
related to tau-dependent toxicity during development. These results show that 2n4r tau is 
more toxic during development than 0n4r tau in the fly eye. And, synaptic transmission is 
more sensitive to lGMR>2n4r tau expression than lGMR>0n4r tau expression in newborn 
adult flies. lGMR>2n4r tauWT expression has a more marked effect on synaptic transmission 
than the phototransduction cascade in young flies. Zhou et al. (2017) showed in Drosophila 
larval NMJs, mutant 0n4r tau binds to synaptic vesicles via its N-terminal domain thereby 
crosslinking them and restricting their mobilisation via presynaptic actin polymerization, 
which reduces their release rate and interferes with synaptic transmission. A possible 
explanation for the more dramatic effect of 2n4r tau on synaptic transmission compared to 
0n4r tau, is 2n4r tau binds synaptic vesicles more strongly due to the presence of the two N-
terminal inserts and therefore has a more of an effect on presynaptic functions. The authors 
did not compare the abilities of different 4r tau proteins to bind synaptic vesicles and 
interfere with synaptic transmission. Wild-type and R406W tau are associated with different 
tauopathies, which have distinct pathology, symptomology and molecular aetiology 
(Williams, 2006; Kovacs, 2015), however, they both cause a similar pathological phenotype 
in our model. We found a stronger phenotype in lGMR>0n4r tauR406W flies compared to 
lGMR>0n4r tauWT flies, as indicated by the accelerated and more dramatic reduction in ERG 
depolarization and the accelerated loss of ERG ON transients (Figure 2.1). 
 
The ability of tau to cause neuronal dysfunction has been investigated in the Drosophila 






characterised by axonal transport and locomotor function defects (Mudher et al., 2004; 
Chee et al., 2005; Ubhi et al., 2007; Talmat-Amar et al., 2011). There is further evidence 
from other experimental animals that tau is capable of causing neuronal dysfunction. Firstly, 
injection of human tau blocks synaptic transmission in squid axons (Moreno et al., 2011). 
Secondly, tau expression in Aplysia motor neurons disrupts axonal transport and synaptic 
transmission (Erez et al., 2014). Finally, many murine studies have indicated expression of 
human wild-type or mutant tau leads to synaptic and neuronal dysfunction (Polydoro et al., 
2009; Hoover et al., 2010; Crimins et al., 2012). However, this is the first study to show 4r 
tau isoform-specific differences in mediating neuronal dysfunction. A major goal is to 
delineate the mechanisms by which tau causes neuronal dysfunction in tauopathies. Our 
model provides such an opportunity because it allows the combination of sophisticated 
genetic manipulation with rapid and reproducible measures of age-dependent changes in 
function and structure; something, which is not possible in other animal models of 
tauopathy. Additionally, our model is suitable for medium to high-throughput screening of 
potential therapeutic agents. 
 
All the UAS-tau transgenic lines used in this study were created by P-element mediated 
transgenesis, in which cDNA inserts at random into the Drosophila genome. We attempted 
to standardise expression by using the same driver line and crossing all transgenic lines into 
a common background. Despite this, it is still possible that positional effects on levels of 
transgene activity and expression contribute to the different pathological phenotypes, as 
tau-induced neurotoxicity has been shown to be highly dose-dependent. For example, the 
tau H1 haplotype which drives slightly higher expression of tau is associated with increased 
risk for AD, PSD and PD (Houlden et al., 2001; Kwok et al., 2004; Refenes et al., 2009; Allen 
et al. 2014). The use of site specific integration of tau transgenes (using the c31 system) 
would eliminate position effects, and therefore allow for better control of the level of 
transgene expression and permit direct comparisons of the neurotoxicity mediated by 
different tau proteins (Groth et al., 2004). However, because we obtained similar results 
from two independently derived UAS-0n4r tau and UAS-2n4r tau transgenic lines, it makes it 
more likely the distinct pathological phenotypes produced by different 4r tau isoforms are 






However, the milder phenotype in lGMR>2n4r tauWT2 flies compared to lGMR>2n4r tauWT1 
flies is most likely related to differences in transgene expression levels (Figure 2.3 and Figure 
2.5). We are unable to determine whether the stronger phenotype in lGMR>0n4r tauR406W 
flies compared to lGMR>0n4r tauWT flies, is due to R406W tau being more toxic than wild-
type tau or differences in transgene expression levels (Figure 2.1). Previous studies have 
reported 0n4r tauR406W is more than toxic than 0n4r tauWT when ectopically expressed in the 
developing Drosophila brain or visual system (Wittmann et al., 2001; Jackson et al., 2002; 
Khurana et al., 2006). However, all of these studies used the same UAS-0n4rWT and UAS-
0n4r tauR406W lines used in this study and as such did not control for position effects. It has 
been a long held belief that the aggregates exert toxicity leading to neurodegeneration. 
However, it is becoming clear that the aggregates are in fact relatively inert and instead 
soluble tau monomers and oligomers are the toxic species. Therefore, higher tau expression 
levels might not necessarily coincide with increased neurotoxicity, as they might promote 
aggregate formation and thereby reduce the amount of toxic soluble tau species. However, 
tau aggregates have not been observed in Drosophila models of tauopathy (reviewed in 
Cowan et al., 2011 and Gistelinck et al., 2012). 
 
2.4.2   Neuronal death in tau-expressing eyes  
 
Tau expression throughout development (using either sGMR-gal4 or Elav-Gal4) produces a 
REP (Wittmann et al., 2001; Jackson et al., 2002; Grammenoudi et al., 2008). The Drosophila 
eye emerges during late larval and pupal stages from a monolayer epithelium, called the 
eye-antennal imaginal disc (Moses, 1991; Ellis et al., 1993). Therefore, a rough eye in 
newborn adult flies is probably as a result of tau-dependent toxicity per se rather than 
degeneration. Bona fide degeneration would be when normal ommatidia in newborn adult 
flies subsequently die. We next investigated whether we would find bona fide degeneration 
in our model. To this end, we quantified the number of photoreceptor rhabdomeres at 
different time points in vivo, using the corneal neutralisation technique (Franceschini and 
Kirschfeld, 1971; Mollereau et al., 2000; Pichard and Desplan, 2001; Gambis et al., 2011). 
We found no structural degeneration in the eyes of 0n4r tau-expressing flies up to 30-days 






and arrangement of rhabdomeres. With aging, there was no loss of photoreceptor 
rhabdomeres in the eyes of 0n4r tau-expressing flies (Figure 2.2). It is possible 
ultrastructural defects are present in the photoreceptors of 1-day old 0n4r tau-expressing 
flies, however this was beyond the scope of this investigation. In contrast, we found age-
related progressive structural degeneration in 2n4r tau-expressing flies. Ommatidia in the 
eyes of newborn 2n4r-tau expressing flies contained a full complement of rhabdomeres, but 
there were minor abnormalities in the spatial organisation of rhabdomeres and rhabdomere 
roundness. A progressive loss of photoreceptor rhabdomeres occurs in the eyes of 2n4r tau-
expressing flies as a consequence of aging. In 30-day old 2n4r-tau expressing flies, 
ommatidia contained on average half their normal number of rhabdomeres. Furthermore, 
less than 1 % of ommatidia had a complete set of rhabdomeres in 30-day old 2n4r-tau 
expressing flies. Whereas, 95 % of ommatidia contained a complete set of rhabdomeres in 
30-day old control flies (Figure 2.4 and Table 2.2). These results suggest defects in 
photoreceptor development due to 2n4r tau-dependent toxicity. Therefore, it is not 
possible to determine whether the subsequent age-related structural degeneration is due to 
the delayed contribution of developmental toxic mechanisms.  
 
Our results show isoform-specific effects in tau-mediated neuronal dysfunction and 
neuronal death. Many in vitro studies have shown that different 4r tau isoforms display 
different phosphorylation susceptibilities (Goedert and Jakes, 1990; Goedert et al., 1992; 
Buee et al., 2000), microtubule binding abilities (Kanaan et al., 2011; Matsumoto et al., 
2015), subcellular distribution (Liu and Gotz, 2013; Paholikova et al., 2015) and interaction 
partners (Liu et al., 2016). These differences most likely contribute to our observed isoform-
specific effects. Our results suggest that different 4r tau isoforms should not be used 
interchangeably when modelling tauopathies in animal models. These data show that 
human 4r tau overaccumulation in the Drosophila eye fails to cause bona fide structural 
degeneration, but not functional degeneration. Thus, our results strongly suggest that tau-
mediated neuronal dysfunction is independent from neuronal death. This opens up the 
possibility that, at least partially, non-overlapping mechanisms mediate tau-evoked 
functional and structural degeneration. Tau-induced neuronal dysfunction before 






previous studies in Drosophila have also reported tau-mediated neuronal dysfunction in the 
absence of neuronal death. For example, tau expression in adult MB neurons impairs 
associative learning without overt neuronal loss (Mershin et al., 2004; Kosmidis et al., 2010; 
Papanikolopoulou et al., 2010). Similarly, tau expression in larval motor neurons disrupts 
NMJ morphology, axonal transport and synaptic transmission without apparent cell death 
(Mudher et al., 2004; Chee et al., 2005; Ubhi et al., 2007; Talmat-Amar et al., 2011). 
Collectively, these results show in Drosophila, irrespective of neuronal type or life stage, 
human tau is able to cause functional degeneration separable from structural degeneration.  
 
Elav driven tau expression caused a rough eye phenotype (Figure 2.6A). The REP correlates 
well with loss of retinal cells (Feany et al., 1996; Wittmann et al., 2001; Jackson et al., 2002; 
Chatterjee et al., 2009). Elav>2nr tauWT1 photoreceptors retained functionality, as measured 
using retinal ERGs, despite the REP (Figure 2.6). Thus, despite tau-dependent toxicity during 
development, function is preserved in adult photoreceptors. It is unclear why Elav>2n4r 
tauWT expression, unlike lGMR>2n4r tauWT expression, fails to cause neuronal dysfunction; 
but this could, for example, be due to different expression levels at specific stages of 
development. These results provide further evidence that tau-induced neuronal dysfunction 
is separate from neuronal death.  
 
2.4.3   Adult-onset tau expression causes functional degeneration without structural 
degeneration 
 
Most Drosophila models of tauopathy have used Gal4 drivers that express during 
development (for example, Elav and sGMR). Therefore, we were interested to know 
whether human 2n4r tauWT tau expression throughout the adult retina is sufficient to cause 
neuronal dysfunction and death. We found dramatic effects on retinal function that were 
specifically attributable to adult-onset 2n4r tauWT expression, as shown using retinal ERGs 
(Figure 2.7). However, adult-onset 2n4r tauWT expression failed to recapitulate the loss of 
ERG ON transients and increased ERG depolarization found in 1-day old lGMR>2n4r tauWT 
flies (Figure 2.3). This suggests that tau-dependent toxicity during development contributes 






During the course of this work, a study was published that expressed human 0n4r tauWT 
exclusively in adult outer R1-R6 photoreceptors (using Rh1-Gal4) and monitored age-
dependent changes in function using retinal ERGs. The authors showed that Rh1>0n4r tauWT 
expression causes age-related progressive neuronal dysfunction (Chouhan et al., 2016). 
However, we were unable to replicate these results. We found normal ERG responses in 
Rh1>2n4r tauWT flies up to 30-days of age (Figure 2.8). Our experimental conditions were 
the same as Chouhan et al. (2016): we both recorded ERGs from flies with a single copy of 
the Gal4 driver and UAS transgene which were raised at 25 °C. Both studies used different 
tau isoforms; we used 2n4r, whereas Chouhan et al (2016) used 0n4r. However, it is unlikely 
the different results can be attributed to this, as we have shown that both lGMR>0n4r tau 
and lGMR>2n4r tau expression produce similar pathological phenotypes. Because Rh1-Gal4 
is a very weak driver (compared to lGMR-Gal4) and the effects of tau are highly dose 
dependent, it is possible that tau expression levels were insufficient to cause neuronal 
dysfunction. However, this does not explain Chouhan et al. (2016) findings. The other major 
difference between Rh1 and lGMR is that whereas Rh1 is expressed only in the outer R1-R6 
photoreceptors, lGMR is expressed in all retinal cell types (including glia). The 
overaccumulation of human tau in glial cells causes apoptotic cell death in both glia and 
neurons and premature death (Colodner and Feany, 2010). However, whether glial 
expression of tau causes neuronal dysfunction is not known. Although, it is possible that tau 
expression in glia contributes to tau-mediated neuronal dysfunction in lGMR>4r tau flies. 
 
We found 2n4r tauWT expression throughout the adult retina does not cause neuronal 
death. We found lGMR; tub-Gal80ts>2n4r tauWT1 flies retained a normal number of 
rhabdomeres per ommatidia after up to 14-days at 30 °C (Figure 2.9). Similarily, Malmanche 
et al. (2017) showed no loss of photoreceptor rhabdomeres upon eye-specific late pupal- or 
adult-onset induction of 4r tau expression, using sGMR-Gal4; tub-Gal80ts or Rh1-Gal4, 
respectively. Likewise, Chouhan et al. (2016) reported no loss of photoreceptor 
rhabdomeres in Rh1>0n4r tauWT flies up to 30-days old. However, conflicting results were 
reported by Gorsky et al. (2016). The authors showed pan-neuronal adult-onset 2n4r tauWT 
expression, using the elav GeneSwitch driver, causes mild but progressive photoreceptor 






levels. These results suggest a note of caution when interpreting results from models, which 
use different expression systems. Our results show 4r tau expression during development is 
required for adult-onset progressive retinal structural degeneration. 
 
A few studies have shown that human tau expression in adult MB neurons precipitates 
associative learning and memory deficits in absence of neurodegeneration (Mershin et al., 
2004; Papanikolopoulou et al., 2010). However, MB neuron confined neurodegeneration 
detected in a few animals over 45-days old (Mershin et al., 2004). Therefore, it is possible 
that in our model, if we age our flies for longer, photoreceptor rhabdomere loss might 
become detectable. These studies in combination with ours demonstrate that adult-onset 
tau expression, irrespective of the neuronal population, is capable of causing neuronal 
dysfunction in the absence of neuronal death. Similarly, Kimura et al. (2007) showed mice 
overexpressing human tau exhibit age-related place learning and memory impairments 
without neuronal loss. 
 
2.4.4   Varying the phosphorylation status of tau influences tau-mediated neuronal 
dysfunction and toxicity 
 
The next question is to understand what regulates tau-mediated neuronal dysfunction. We 
show a possible role for the PAR1 kinase in tau-induced neuronal dysfunction. Expression of 
a 2n4r tauS2A construct, which cannot be phosphorylated at the two PAR1 phosphorylation 
sites (S262 and S356), in the Drosophila eye fails to cause neuronal dysfunction, as shown 
using retinal ERGs (Figure 2.10). Similar findings reported by Papanikolopoulou et al. (2010), 
who showed expression of 2n4r tauS2A in adult MB neurons does not impair associative 
learning and memory. Results from mice models of tauopathy also suggest that tau 
hyperphosphorylation is required for tau-mediated neuronal dysfunction (Kimura et al., 
2007). Another possible explanation for the lack of phenotype in lGMR>2n4r tauS2A flies 
compared to lGMR>2n4r tauWT flies are differences in transgene expression levels. However, 
because we obtained consistent results from two independently derived UAS-2n4r tauS2A 






 Mechanistically how hyperphosphorylated tau disrupts neuronal function is not well 
understood. It has been proposed that hyperphosphorylated tau directly or indirectly 
disrupts axonal transport and synaptic transmission. For example, overexpressing tau in 
Drosophila larval motor neurons disrupts axonal transport, leading to vesicle aggregation in 
the axon and a reduction in mitochondria in the presynaptic terminal (Mudher et al., 2004; 
Chee et al., 2005). Similarly, expression of human tau in Aplysia glutamatergic sensory-
motor neuron synapses leads to reduced releasable presynaptic vesicles pools, as a result of 
impaired axoplasmic transport (Erez et al., 2014). Additionally, human tau injected directly 
into the presynaptic axon terminal of the squid giant synapse blocks synaptic transmission 
and causes synaptic vesicles to aggregate in the active zone (Moreno et al., 2011). The next 
step is to study the ultrastructure of the photoreceptor terminals to see if any of these 
pathological features exist in our model.  
 
Other studies have shown PAR1 phosphorylation is required for tau-dependent toxicity in 
the developing eye (Nishimura et al., 2004; Chatterjee et al., 2009) and MB neuroblasts 
(Kosmidis et al., 2010). Taken together, these studies suggest PAR1 phosphorylation is a 
common mechanism underlying tau-mediated neuronal dysfunction and toxicity. Our model 
provides the opportunity to examine the role of other tau kinases; for example, GSK3β, cdk5 
and PKA, which have been previously implicated in tauopathies (Avila, 2008; Guo et al., 
2017), in tau-mediated functional and structural degeneration. We found that lGMR>2n4r 
tauS11A expression (with a higher microtubule binding affinity than 2n4r tauWT) precipitated a 
stronger phenotype than lGMR>2n4r tauWT expression. The degenerative phenotype in 
lGMR>2n4r tauS11A flies is likely related to tau-dependent toxicity during development, as it 
is already established upon adult emergence (Figure 2.10D,E,F). Similarily, 0n4r tauAP (with a 
higher microtubule-binding affinity than 0n4r tauWT) has a more dramatic effect on axonal 
transport in the Drosophila larval NMJ than 0n4r tauWT (Talmat-Amar et al., 2011). These 










2.4.5   Aβ42 enhances tau-mediated neuronal dysfunction  
 
Next, we investigated whether human Aβ expression produces neuronal dysfunction under 
similar experimental conditions. We found lGMR>Aβ42 expression had little effect on the 
ERG response (Figure 2.11A,B,C). Similar findings reported by Chouhan et al. (2016), who 
showed that Rh1>Aβ42 expression also has little effect on the ERG response. However, this 
is in contrast to previous studies, which have shown Aβ expression induces significant 
neuronal dysfunction. For example, Zhao et al. (2010) showed Aβ42 expression in the 
Drosophila giant fibre system causes age-related synaptic transmission defects and 
depletion of mitochondria from the presynaptic terminal (Huang et al., 2013). In addition, 
patch clamp analysis revealed a depression of Drosophila cholinergic synapses upon Aβ42 
expression (Fang et al., 2012). It is unknown why Aβ42 expression in the Drosophila eye fails 
to recapitulate the neuronal dysfunction observed in the Drosophila giant fibre system and 
cholinergic synapses upon Aβ42 expression. However, these results suggest that specific 
neuronal populations are differentially susceptible to Aβ42-evoked neuronal dysfunction. It 
is possible that increasing the level of Aβ expression, by introducing additional copies of the 
Gal4 driver or UAS transgene, or aging the flies for longer might produce a phenotype.  
 
We found that coexpression of Aβ42 with human 2n4r tauWT potently exacerbates tau-
mediated neuronal dysfunction in the Drosophila eye (Figure 2.11D,E,F). Expression levels of 
tau are likely to differ in lGMR>2n4r tauWT1 and lGMR>2n4r tauWT1; Aβ42 flies due to UAS-
copy number imbalance. These differences in the level of UAS-2n4r tauWT expression may 
contribute to the different phenotype strengths in lGMR>2n4r tauWT1 and lGMR>2n4r 
tauWT1; Aβ42 flies. These findings suggest that tau is an important downstream mediator of 
Aβ-mediated neuronal dysfunction. In support of this, Folwell et al. (2010) showed 
coexpression of human tauWT and Aβ42 enhances tau-mediated neuronal dysfunction in 
Drosophila larval motor neurons. Similar findings have been reported in AD mice models. 
For example, reduction of endogenous tau in an AD mice model mitigates both Aβ-
dependent excitotoxicity and cognitive deficits (Roberson et al., 2011). Thus, in both mouse 






dysfunction. The next step is to investigate the mechanisms by which human Aβ and tau 
interact to cause neuronal dysfunction.  
 
Much of the research in tauopathies, such as AD, has focused on aggregate formation and 
neurodegeneration. However, recent evidence has shown clinical symptoms appear in the 
absence of aggregate formation and prior to neuronal death (reviewed in Guo et al., 2017), 
indicating a period of cellular dysfunction may precede cell death in the early stages of 
tauopathies. There are a range of tauopathies with different clinical profiles, which are 
characterised by abnormalities in specific tau proteins, suggesting potential-isoform specific 
differences. Currently, little is known about the ability of different tau proteins to 
precipitate neuronal dysfunction in the same neuronal population. We show in a Drosophila 
eye model, 0n4r tau causes age-related progressive neuronal dysfunction (Figure 2.1 and 
Figure 2.5) in the absence of neuronal death (Figure 2.2). Whereas 2n4r tau causes 
progressive neuronal dysfunction (Figure 2.3 and Figure 2.5), which precedes neuronal 
death (Figure 2.4). Thus, our Drosophila model recapitulates the tau-mediated functional 
degeneration without structural degeneration found in the early stages of human 
tauopathies. We further show 2n4r tau expression in the adult Drosophila retina is capable 
of causing neuronal dysfunction (Figure 2.7), but not cell death (Figure 2.9). Thus, adult tau-
induced structural degeneration, but not functional degeneration, requires a 
neurodevelopmental component. Collectively, these results demonstrate tau-mediated 
neuronal dysfunction is uncoupled from neuronal death. We also suggest tau 
phosphorylation by the PAR1 kinase is involved in tau-mediated neuronal dysfunction, 
because mutant tau that cannot be phosphorylated at the PAR1 phosphorylation sites fails 
to cause neuronal dysfunction in our model (Figure 2.10). Finally, we demonstrate that Aβ42 
expression alone is insufficient to cause dysfunction, but coexpression of Aβ42 with 2n4r 
tauWT potently exacerbates tau-mediated neuronal dysfunction (Figure 2.11). These results 












Supplementary Figure 2.1: Presence of Rh1-eGFP does not interfere with retinal function. (A) No differences 
in ERG depolarization are found in lGMR-Gal4; Rh1-eGFP flies relative to lGMR-Gal4 flies. (B) No differences in 
ERG ON transients are found in lGMR-Gal4; Rh1-eGFP flies relative to lGMR-Gal4 flies. Graphs show individual 
datapoints with mean ± SEM. n =6-17 flies per genotype/age. ns p>0.05; two-tailed Student’s t-test. Asterisks 
(in black) show comparisons between different genotypes of the same age and number symbols (in red) show 





















Chapter 3:   Characterisation of sleep-wake and circadian rhythm 
disturbances in Drosophila models of tauopathy 
 
3.1   Introduction 
 
Alzheimer’s disease (AD) is the most common form of dementia among the elderly. It is 
estimated to affect 46 million people worldwide (see the UsAgainstAlzheimer’s website) and 
increases in prevalence with age. Therefore, because of the aging human population it is 
becoming more common. By 2050, it is expected to affect over 130 million people 
worldwide. Currently, there is no effective treatment to prevent, cure or inhibit AD 
(Coughlin and Irwin, 2017). AD is histologically characterised by the dual pathologies of β-
amyloidosis, the formation of extracellular amyloid plagues due to the accumulation of Aβ 
peptides, and tauopathy, the formation of intraneuronal neurofibrillary tangles (NFTs) due 
to the accumulation of hyperphosphorylated tau protein (Braak et al., 1994; Braak and 
Braak, 1994). 
 
As well as the memory deficits that typify AD, the vast majority of AD patients also exhibit 
disturbances in their sleep-wake cycle and circadian rhythms. In early AD, the sleep 
disturbances are characterised by increased daytime naps and reduced and fragmented 
night-time sleep (Satlin et al., 1995; Volicer et al., 2001; Bliwise, 2004; Bliwise et al., 2011). 
Furthermore, a large number of AD patients display sundowning, which is a significant 
increase in behavioural symptoms in the hours before bedtime (Volicer et al., 2001). 
Additionally, a large proportion of individuals with AD also show reduced amplitude daily 
rhythms of activity and body temperature with marked phase shifts (Satlin et al., 1995; 
Harper et al., 2001; Volicer et al., 2001; Tranah et al., 2011). These sleep and circadian 
disturbances are a massive burden for AD patients and their caregivers (Gallagher-
Thompson, 1992; Gaugler et al., 2006).  
 
At a cellular level, circadian rhythms are based upon autoregulatory interlocking 






transcription factors BMAL1 and CLOCK, heterodimerise and activate transcription of a large 
number of genes, including Period (Per) and Cryptochrome (Cry). PERIOD (PER) and 
CRYPTOCHROME (CRY) after a time delay inhibit BMAL1 and CLOCK activity, resulting in ~24 
hour oscillations in gene expression (Mohawk et al., 2012; Hardin and Panda, 2013). In 
mammals, the vast majority of cells in the body exhibit circadian oscillations, however the 
~20,000 neurons in the suprachiasmatic nucleus (SCN) of the hypothalamus are the master 
pacemakers. SCN neurons are divided into a dorsal shell (arginine vasopressin (AVP)-
positive) and ventral core (vasoactive intestinal polypeptide (VIP)-positive). Circadian 
oscillators in the SCN receive direct photic inputs (from the retinohypothalamic tract) and 
entrain to light-dark (LD) cycles. The SCN then synchronises through a variety of electrical, 
endocrine and metabolic signalling pathways all the other circadian oscillators operating 
throughout the brain and body, so that they all oscillate in phase with each other and the 
environment (Reppert and Weaver, 2002; Welsh et al., 2010; Herzog et al., 2017). Free-
running circadian rhythms persist in the absence of external cues (i.e. constant darkness) 
because the circadian oscillators in the SCN are self-sustaining.  
 
Studies of circadian locomotor activity, using animal models of β-amyloidosis, have yielded a 
complex and confusing picture. For example, in LD conditions, mice overexpressing mutant 
human APP (amyloid β precursor protein; which is proteolytically cleaved to produce Aβ 
peptides) display normal activity rhythms (Wisor et al., 2005; Ambree et al., 2006; Gorman 
and Yellon, 2010). Whereas, mice overexpressing mutant APP and PS1 (presenilin 1; 
secretase that proteolytically cleaves APP to produce Aβ peptides) show a two hour phase 
delay in wakefulness (Duncan et al., 2012). Surprisingly, these APP and APP/PS1 mice have 
relatively normal activity rhythms in constant darkness (Wisor et al., 2005; Gorman and 
Yellon, 2010; Bano Otalora et al., 2012). However, two studies have shown that Drosophila 
models of β-amyloidosis exhibit age-related progressive behavioural arrhythmia in both LD 
and DD conditions (Chen et al., 2014; Long et al., 2014). 
 
In comparison to Aβ pathology, very few studies have assessed the contribution of tau 
pathology to sleep-wake cycle and circadian rhythm disturbances in AD. Sterniczuk et al. 






and tau, exhibit increased activity during the day (inactive phase) in LD conditions, but only 
minor deficits in activity rhythms in DD conditions. Additionally, aged 3xTg-AD mice exhibit 
core body temperature rhythm disturbances (Knight et al., 2013). Although, because Aβ 
pathology is also present, it is not possible to identify how tau specifically contributes to the 
observed circadian behaviour abnormalities. More recently, it has been shown that Tg4510 
mice, which overexpress P301L tau in the forebrain (under the control of the forebrain-
specific CaMKII promoter), exhibit increased activity during the day (inactive phase) in LD 
conditions and mild abnormalities in free-running behaviour (Stevanovic et al., 2017). 
However, PLB2Tau mice, which express P301L and R406W tau in the forebrain (under the 
control of the CaMKII promotor), show normal activity rhythms but abnormalities in sleep 
electroencephalograms (EEGs) (Koss et al., 2016). For these reasons, the role of tau in AD-
linked sleep-wake cycle and circadian rhythm disturbances remains elusive. In Drosophila, 
disruption of the circadian Doubletime (Dbt) kinase causes cleavage of endogenous tau, 
which leads to circadian behavioural deficits and a shortened lifespan. In addition, 
disruption of Dbt also leads to enhanced neurodegeneration, produced by overexpression of 
human tau in the Drosophila visual system (Means et al., 2015). These results establish a link 
between the circadian clock and tau pathology. 
 
Studies on post-mortem brains of human AD patients show a dramatic loss of AVP- and VIP-
expressing neurons in the SCN (Swaab et al., 1985; Wu and Swaab, 2007), suggesting that 
damage to the SCN might cause circadian behavioural deficits. In support of this, 3xTg-AD 
mice exhibit substantial reductions in AVP- and VIP-containing neurons and APP/PS1 mice 
have disrupted endogenous Per2 mRNA oscillations in the SCN (Sterniczuk et al., 2010; 
Duncan et al., 2012). Additionally, Tg4510 mice have disrupted PER2 protein oscillations in 
the hypothalamus and hippocampus (Stevanovic et al., 2017). In Drosophila, boosting the 
cleavage of APPL (the Drosophila homolog of APP) by overexpressing β-secretase disrupts 
activity rhythms and PER expression in the central clock neurons (Blake et al., 2015). 
However, results from Drosophila overexpressing human Aβ suggest that defects in the 
output pathways, rather than disrupted oscillations in the central clock, are the cause of the 






show age-induced progressive behavioural arrhythmia in free-running conditions, despite 
normal oscillations in their master pacemaker neurons (Chen et al., 2014; Long et al., 2014).  
 
The remarkable conservation of circadian mechanisms between humans and Drosophila 
justifies the use of Drosophila as a model organism (Bell-Pedersen et al., 2005). Circadian 
locomotor activity in Drosophila is driven by ~150 neurons in the fly brain that express a 
molecular clock. The ~150 neurons can be divided into several groups: small ventrolateral 
neurons (sLNvs), large ventrolateral neurons (lLNvs), dorsolateral neurons (LNds), lateral 
posterior neurons (LPNs), and three groups of dorsal neurons (DN1s, DN2s and DN3s), based 
on their anatomical position (Peschel and Helfrich-Forster, 2011). The neuropeptide 
pigment dispersing factor (PDF) is released from all the ventrolateral neurons, except the 5th 
sLNv (~16 neurons). PDF paracrinely synchronises the oscillations of the clock neurons so 
that they oscillate in phase with one another (Renn et al., 1999; Hyun et al., 2005; Stoleru et 
al., 2005; Cusumano et al., 2009). The sLNvs are the master pacemakers in Drosophila, 
because in free-running conditions they control the speed of behavioural and molecular 
rhythms in a PDF-dependent manner (Stoleru et al., 2005; Yao and Shafter, 2014). Clock 
neurons make synaptic contacts with specific non-clock neurons in the pars intercerebralis 
(PI) and lateral horn (LH), which show circadian production of the neuropeptides diuretic 
hormone 44 (DH44) and leucokinin (LK), respectively. Correct signalling at these synapses is 
needed for normal free-running circadian behaviour (Cavanaugh et al., 2014; Cavey et al., 
2016).  
 
Numerous Drosophila models of tauopathy have been produced by overexpressing human 
wild-type (WT) tau or FTD-linked mutant (R406W/V337M) tau in the developing fly brain 
(Wittmann et al., 2001). These fly models of tauopathy replicate many of the key features of 
human AD, including progressive age-related neurodegeneration (Wittmann et al., 2001; 
Nishimura et al., 2004), a reduced lifespan (Wittmann et al., 2001) and associative learning 
and memory deficits (Mershin et al., 2004). To date, no studies have described in detail the 







First, we show pan-neuronal tau expression (either wild-type or R406W) in the fly brain 
results in elevated night-time activity and daytime and night-time sleep loss in LD 
conditions, and progressive behavioural arrhythmia in DD conditions. Next, we show tau 
expression exclusively in PDF neurons causes elevated night-time activity, daytime sleep 
gains and night-time sleep loss in LD conditions, but is insufficient to induce progressive 
behavioural arrhythmia in DD conditions. In contrast, tau expression in all clock neurons 
causes progressive behavioural arrhythmia in DD. We found no detectable loss of PDF 
neurons in either Pdf>tau or tim>tau flies. These results suggest that the tau-evoked 
elevated night-time activity, daytime sleep gains and night-time sleep loss in LD conditions 
are as a result of dysfunction in the central pacemaker neurons. These results also indicate 
that the non-PDF clock neurons are the primary target for mediating tau-linked progressive 
behavioural arrhythmia in DD. In support of these ideas, suppression of tau expression in 
PDF neurons is sufficient to rescue the elevated night-time activity and night-time sleep loss 
in LD conditions, but not progressive behavioural arrhythmia in DD conditions in tau-
expressing flies. Tau expression in the PDF neurons also prolongs the free-running period 
and makes the flies hyperactive in DD. Collectively, these experiments show that distinct 
groups of neurons mediate different tau-evoked circadian behavioural abnormalities. 
Recent evidence has shown in tauopathies dysfunction in the circadian system contributes 
to the disease process (Musiek et al., 2015; Hood and Amir, 2017). Thus, treating the 
circadian misalignment and sleep disruption early in the disease process might not just 
improve patient wellbeing but also clinical outcome. The development of a fly model that 
faithfully recapitulates AD-linked sleep-wake cycle and circadian rhythm disturbances 
provides a platform to screen for potential therapeutic agents. Given the projected increase 
in prevalence in AD and other tauopathies, effective treatment options are urgently needed.  
 
3.2   Materials and Methods 
  
3.2.1   Fly strains 
  
All flies were raised on standard food (containing 0.8 % agar, 1.0 % soy flour, 8.0 % medium 






ethanol and 0.4 % propionic acid). Flies were raised under a 12 h light: 12 h dark (LD) cycle 
at 25 °C, except for flies carrying tub-Gal80ts which were raised at 18 °C. Mated male flies of 
5- or 25-days of age were used in all experiments. The following lines were used in the 
study: Canton-S, ElavC155-Gal4, ElavGS-Gal4, tim-Gal4, Pdf-Gal4, Pdf-Gal80, repo-Gal80, tub-
Gal80ts, UAS-2n4r tauWT, UAS-0n4r tauR406W, UAS-0n4r tauWT and UAS-2n4r tauS11A, for 
details see Table 2.1. To reduce the variation from genetic background all lines were 
backcrossed against Canton-S for five generations. All lines have been previously described 
(for references see Table 2.1). The various UAS-tau lines used were previously generated by 
P-element mediated transgenesis. The pan-neuronal expression of tau is driven by Elav-
Gal4. The pan-clock expression of tau is driven by tim-Gal4. Expression of tau exclusively in 
PDF clock neurons is driven by Pdf-Gal4. The tim-Gal4, repo-Gal80 line which labels all 
timeless clock neurons was generated by combining two transgenes: tim-Gal4 and repo-
Gal80. The Elav-Gal4, Pdf-Gal80 line which labels all neurons apart from the PDF clock 
neurons was generated by combining transgenes: Elav-Gal4 and Pdf-Gal80.  
 
Adult-onset pan-neuronal tau expression was achieved by using the Elav GeneSwitch 
(ElavGS)-UAS system (Osterwalder et al., 2001). Adult-onset pan-neuronal tau expression by 
ElavGS was induced by treatment with 500 µM mifepristone (RU486) added to standard 
food. Tau expression in the adult clock neurons was achieved by using the TARGET system: 
temperature sensitive tub-Gal80ts combined with tim-Gal4. At 18 °C (permissive 
temperature), Gal80ts is active and represses Gal4 activity. After shifting adult flies to 30 °C, 
Gal80ts becomes inactive and no longer represses Gal4 activity (McGuire et al., 2003). The 
same Elav-Gal4, tim-Gal4 and Pdf-Gal4 driver lines were used in all experiments. 
 
3.2.2   Lifespan experiments  
 
Elav-Gal4 females were crossed to males carrying either UAS-2n4r tauWT or UAS-0n4r 
tauR406W. UAS-tau flies served as controls. Crosses were set up in bottles. Adult males were 
collected 0-48 h after eclosion and transferred under short CO2 anaesthesia to vials 
containing standard food. All flies were kept in continuous LD cycles (12 h: 12 h) at 25 °C and 






without anaesthesia to new vials containing fresh food three times a week. Deaths were 
scored every day, except for weekends. 20 vials per genotype were used. Log-rank analysis 
of survivorship curves was performed using Graph Pad Prism 7. 
 
3.2.3   Locomotor behaviour assay  
 
Adult males were collected within a few hours of eclosion and no more than 20 were aged 
on standard food and were tipped on to new food every two-three days. Flies were housed 
individually in 65 mm x 5 mm glass tubes containing 5 % sucrose with 2 % agarose at one 
end of the tube (approximately 1/3 of the tube). Cotton wool was used to plug the open end 
of the tube. Locomotor activity was collected with a Drosophila activity monitor (DAM2) 
system (TriKinetics, Waltham, US) in one minute bins. The glass tubes containing the flies 
are placed in a DAM2 where an infrared beam bisects each tube. When the fly is active it 
breaks this beam and activity is recorded (Chiu et al., 2010; Pfeiffenberger et al., 2010). 
Monitors were placed in an incubator at 25 °C and 50-70 % humidity (Panasonic Mir155). 
Flies were entrained in continuous LD cycles (12 h: 12 h) for three-four full days, after which 
the lights were switched off and activity was monitored in constant darkness (DD) for seven-
nine full days. Average daily activity histograms were produced from activity data from 
three consecutive days of LD or seven-nine consecutive days of DD. Daytime and night-time 
activity is the total number of beam counts during the light and dark phase of LD, averaged 
across three consecutive days. A fly was characterised as being asleep when it was inactive 
for at least five minutes (Hendricks et al., 2000; Shaw et al., 2000). Sleep analysis was 
conducted using a custom-written Excel macro (Donlea et al., 2014). Average daily sleep 
profiles were produced from activity data from three consecutive days of LD. Daytime and 
night-time sleep is the total amount of sleep during the light and dark phase of LD, averaged 
across three consecutive days. GraphPad prism was used for plotting.  
 
Circadian rhythm strength (power, PN) was assessed by Lomb-Scargle periodogram analysis 
of the DD data using an Image J plugin, Actogram J (Schmid et al., 2011). Flies were 
characterised as rhythmic or arrhythmic based upon the presence or absence of any peak 






al., 1999). Average power and period length were only calculated from flies with rhythmic 
activity profiles. In flies with complex rhythms (more than a single peak above the 0.05 
significance line), the largest peak was used for analysis. Activity in DD is the average 
number of activity counts/24 h averaged across seven-nine days. For temperature shift 
experiments, power and period length were calculated from the initial 6 days in DD at 20 °C 
and the subsequent six days at 30 °C (flies were first entrained to LD cycles for three days). 
Graph Pad Prism 7 was used for plotting.  
 
3.2.4   Immunohistochemistry  
 
To visualise the clock neurons, we used tim-Gal4 and Pdf-Gal4 to drive expression of a UAS-
mCD8::GFP transgene. Fly brains were dissected in phosphate buffered saline (PBS). After 
dissection, brains were fixed in freshly prepared 4 % paraformaldehyde in PBS for 30 
minutes. Brains were rinsed three times in PBS with 0.5 % Triton X100 (PBS-T 0.5 %) and 
mounted on microscope slides in Vectashield mounting media (Vector Laboratories, 
Burlingame, US). Slides were stored at 4 °C and imaged within a week. Images were taken 
with an Olympus FV1000 confocal microscope, using Fluoview acquisition software. Images 
were analysed using ImageJ and Adobe Photoshop.  
 
3.2.5   Statistical analysis  
 
Graph Pad Prism 7 was used for statistical analysis. Sample sizes are reported in figures. Box 
plots show median with interquartile range and the 10 % and 90 % percentiles as whiskers. 
Data from flies which died before the end of the experiment was excluded from analysis. All 
data were tested for normal or lognormal distribution by a Kolmogorov-Smirnov test. 
Activity (LD and DD) and power datasets were lognormally distributed. Log-transformed 
activity and power datasets were analysed by a two-tailed Student’s t-test if there were two 
groups, 1-way ANOVA if there were more than two groups with a single factor (genotype) 
and 2-way ANOVA if there were more than two groups with two factors (genotype and age) 
followed by post-hoc tests. Multiple comparisons after ANOVA were performed by a Tukey 






therefore we chose to use non-parametric tests rather than parametric tests (i.e. t-test and 
ANOVA), which assume normal distribution. Sleep and period datasets were analysed by a 
Mann-Whitney U-test if there were two groups and Kruskal-Wallis ANOVA if there were 
more than two groups with a single factor (genotype) followed by post-hoc tests. Sleep and 
period datasets with more than two groups with two factors (genotype and age) were 
analysed in two ways. First, Kruskal-Wallis ANOVA followed by post-hoc tests were used to 
check for differences between different genotypes of the same age (either 5- or 25-days 
old). Multiple comparisons after ANOVA were performed by a Dunn’s test. Second, a Mann-
Whitney U-test was used to check for differences between different ages (5- and 25-day old) 
of the same genotype. No statistical tests were done to predetermine sample size. However, 
sample size are consistent with previous publications in the field (Chen et al., 2014; Long et 
al., 2014; Julienne et al., 2017). P levels are indicated as ns p>0.05, * p<0.05, ** p<0.001 or 
*** p<0.0001.  
 
3.3   Results 
 
3.3.1   Pan-neuronal human wild-type tau (2n4r isoform) expression affects activity and 
sleep in LD conditions  
 
First, we expressed human full-length wild-type tau (2n4r isoform) (Jackson et al., 2002) in 
all neurons using the Gal4/UAS system (driven by the pan-neuronal Elav-Gal4 driver) and 
investigated whether the flies showed normal circadian behaviour by monitoring their 
locomotor activity in LD and DD conditions. Several studies have shown human wild-type 
tau overexpression in the developing Drosophila brain or visual system results in 
neurodegeneration, which resembles several key features of tauopathies, including age-
dependency, cell-type specificity, and accumulation and mislocalisation of abnormally 
phosphorylated tau (Jackson et al., 2002; Mershin et al., 2004; Nishimura et al., 2004; Chen 
et al., 2007; Kosmidis et al., 2010). 
 
In LD conditions, Drosophila normally exhibit a morning activity peak (centred around the 






transition). Flies anticipate the light transitions by gradually increasing their activity in 
advance of them. The timing of the activity peaks is controlled by the clock. Independent of 
the clock, flies also exhibit startle responses, which are transient bursts of activity in 
response to the light transitions. Drosophila show a midday siesta between the two activity 
peaks and a period of consolidated sleep at night (reviewed in Dubowy and Sehgal, 2017). 
Both Gal4 control and Elav>2n4r tauWT flies showed a normal bimodal activity profile (Figure 
3.1A, left column and middle column). However, Elav>2n4r tauWT flies seemed to show 
elevated basal activity. Elav>2n4r tauWT flies appeared to show normal morning and evening 
anticipation, but largely abolished morning and evening startle responses (Figure 3.1A). We 
found that levels of daytime activity were unaffected, whereas levels of night-time activity 
were substantially increased, in both 5- and 25-day old Elav>2n4r tauWT flies compared to 
age-matched controls. Between the 5- and 25-day old age groups, we found no significant 
differences in levels of daytime and night-time activity in either Elav>2n4r tauWT or control 
flies (Figure 3.1B,C).  
 
Next, we investigated whether the elevated night-time activity in Elav>2n4r tauWT flies 
coincides with sleep loss. We found a small loss of daytime sleep in Elav>2n4r tauWT flies 
compared to age-matched controls. The daytime sleep loss just failed to reach significance 
in 5-day old Elav>2n4r tauWT flies. No significant age-related differences in daytime sleep 
were seen in Elav>2n4r tauWT flies. On the other hand, we found a significant age-related 
increase in daytime sleep in Gal4 control flies. As a result, the daytime sleep loss reached 
significance in 25-day old Elav>2n4r tauWT flies (Figure 3.2A,C). Regardless of age, we found 
a large loss of night-time sleep in both 5- and 25-day old Elav>2n4r tauWT flies, compared to 
age-matched controls. Elav>2n4r tauWT flies showed a significant age-related reduction in 
night-time sleep (Figure 3.2A,D). These results demonstrate that pan-neuronal human wild-
type tau (2n4r isoform) expression promotes night-time activity and suppresses daytime 







Figure 3.1: Locomotor activity of tau-expressing flies in LD conditions. (A) Average daily activity histograms 
for three days of LD conditions are shown for 5- and 25-day old Gal4 control (left column), Elav>2n4r tauWT 
(middle column) and Elav>0n4r tauR406W (right column) flies. All genotypes exhibit normal bimodal activity 
rhythms. Elevated baseline activity in tau-expressing flies. Vertical bars represent activity counts displayed in 
30-min bins (mean ± SEM). Lights-on (white bars). Lights-off (grey bars). (B-C) Quantification of daytime and 
night-time activity. Elav>2n4r tauWT expression has no effect on daytime activity, but increases night-time 
activity, relative to controls. Elav>0n4r tauR406W expression decreases daytime activity (in 25-day old, but not in 
5-day old flies), but increases night-time activity, relative to controls. Graphs show median with second and 
third quartiles and 10th and 90th percentiles. n= 62-159 flies per genotype/age from 4-8 independent 
experiments. ns p>0.05; *p<0.05; ***p<0.0001. Data were lognormally distributed. Multiple comparisons 
between different genotypes of the same age (asterisks in black) and different ages of the same genotype 







Figure 3.2: Pan-neuronal tau expression reduces sleep. (A) Average daily sleep profile for three days of LD 
conditions are shown for 5- and 25-day old Elav>2n4r tauWT and control flies. (B) Average daily sleep profile for 
three days of LD conditions are shown for 5- and 25-day old Elav>0n4r tauR406W and control flies. All genotypes 
display a bimodal profile, with peaks at midday and midnight and troughs at dawn and dusk. The horizontal 
bars show when the lights were on (white) or off (black). Graphs show mean ± SEM. (C-D) Quantification of 
daytime and night-time sleep. Elav>2n4r tauWT expression reduces daytime sleep (difference does not quite 
reach the level of significance in 5-day old flies) and night-time sleep relative to controls. Elav>0n4r tauR406W 
expression reduces daytime sleep (difference does not reach significance in 5-day old flies) and night-time 
sleep relative to controls. Graphs show median with second and third quartiles and 10th and 90th percentiles. n 
= 62-159 flies per genotype/age from 4-8 independent experiments. ns p>0.05; *p<0.05; **p<0.001; 
***p<0.0001. Data were neither normally nor lognormally distributed. Multiple comparisons between 
different genotypes of the same age (asterisks in black) by Kruskal-Wallis ANOVA and post-hoc Dunn’s tests. 







3.3.2   Pan-neuronal human wild-type tau (2n4r isoform) expression affects free-running 
circadian rhythms  
 
In DD conditions, Gal4 control flies maintained a rhythm of daytime activity and night-time 
activity, with a period of nearly 24 hours. Similarly, Elav>2n4r tauWT flies were more active 
during the day than at night. However, in Elav>2n4r tauWT flies relative night-time activity 
appeared to be elevated, so the distinction between daytime activity and night-time 
inactivity was less clear. Average daily activity histograms and representative double-plotted 
actograms for Gal4 control and Elav>2n4r tauWT flies can be seen in Figure 3.3 (left column 
and middle column). To quantify rhythm strength (power), we used Lomb-Scargle 
periodogram analysis (Van Dongen et al., 1999). The power of Elav>2n4r tauWT flies was 
substantially reduced compared with age-matched controls at both ages analysed (Figure 
3.3B). By 25-days of age, only 85 % of Elav>2n4r tauWT flies remained rhythmic, compared to 
100 % of control flies (Table 3.1). A representative actogram for a rhythmic and arrhythmic 
25-day old Elav>2n4r tauWT fly is shown in Figure 3.3 (middle column, bottom row). Between 
the 5- and 25-day old age groups, all genotypes exhibited a significant reduction in overall 
rhythmicity (Figure 3.3B).  
 
Pan-neuronal tau expression had no effect on the period length of rhythms (Figure 3.3C). It 
is possible the dysrhythmia in Elav>2n4r tauWT flies could be due to reduced activity levels. 
In support of this, Ali et al. (2011) showed pan-neuronal tauWT expression resulted in 
locomotor activity deficits. However, we found pan-neuronal 2n4r tauWT expression resulted 
in age-induced hyperactivity in DD. We found normal activity levels in 5-day old Elav>2n4r 
tauWT flies, but increased levels of activity in 25-day old Elav>2n4r tauWT flies, compared to 
age-matched controls. A small, but significant, age-related decline in activity levels was seen 
in control flies. Whereas, we found in Elav>2n4r tauWT flies activity levels were well 
maintained with aging (Figure 3.3D). Thus, the reduced rhythmicity in Elav>2n4r tauWT flies 
was not an artifact of reduced activity levels. These results show that the overaccumulation 
of human wild-type tau (2n4r isoform) in all neurons causes progressive behavioural 






3.3.3   Pan-neuronal human R406W tau (0n4r isoform) expression affects circadian 
locomotor behaviour in LD and DD conditions  
 
Different tau proteins are associated with different diseases with distinct pathology, 
molecular aetiology and symptomology (reviewed in Guo et al., 2017). Therefore, it remains 
unclear whether different tau proteins would precipitate equivalent results when studied in 
insolation. To explore this we monitored the locomotor activity (in LD and DD conditions) of 
flies pan-neuronally expressing human wild-type or R406W tau (0n4r isoform). Both human 
0n4r tauWT and 0n4r tauR406W have been previously shown to cause premature death, adult-
onset progressive neurodegeneration and associative memory deficits when expressed 
ectopically in the Drosophila brain (Wittmann et al. 2001; Kosmidis et al., 2010; Sealey et al., 
2017). We found Elav>2n4r tauWT expression reduced lifespan by 16 % and Elav>0n4r 
tauR406W expression reduced lifespan by 20 % (Supplementary Figure 3.1). Previous studies 
have shown that Elav>tau expression results in a more dramatic lifespan reduction 
(Wittmann et al., 2001; Gorsky et al., 2016). This discrepancy could be due to differences in 
the genetic background or experimental protocol, we used male flies kept on standard food 
at a low population density (≤20 flies per vial), tipped three times a week on to fresh food. 
As the median lifespan of Elav>2n4r tauWT flies was 57 days and Elav>0n4r tauR406W flies was 
63 days and we used flies up 35-days old in our experiments, pan-neuronal tau expression 
does not shorten lifespan sufficiently to influence our observations of circadian behaviour 
(Supplementary Figure 3.1). As such, a similar number of Elav>2n4r tauWT, Elav>0n4r 
tauR406W and control flies survived to the end of the ten day experiment (Table 3.1).  
 
Pan-neuronal 0n4r tauR406W expression had little effect on the shape of the bimodal activity 
profile in LD conditions. However, basal activity appeared to be elevated in Elav>0n4r 
tauR406W flies. The timing of morning and evening anticipation seemed to be normal in 
Elav>0n4r tauR406W flies. However, morning and evening startle responses were largely 
abolished in Elav>0n4r tauR406W flies (Figure 3.1A, right column). We found levels of daytime 
activity were unaffected in 5-day old Elav>0n4r tauR406W flies, but slightly reduced in 25-day 
old Elav>0n4r tauR406W, compared to age-matched controls. On the other hand, levels of 






matched controls at both ages analysed. No significant age-related differences in daytime or 








Figure 3.3: Pan-neuronal tau expression causes behavioural arrhythmia. (A) Average daily activity histograms 
and representative double-plotted actograms for seven days of DD conditions are shown for 5- and 25-day old 
Gal4 control (left column), Elav>2n4r tauWT (middle column) and Elav>0n4r tauR406W (right column) flies. Flies 
were entrained in standard LD cycles for three days and then monitored in DD for seven days. Control flies 
exhibit robust rhythms of daytime activity and night-time inactivity, with a period of just under 24 h. Tau-
expressing flies exhibit either weak rhythms with a normal period or are arrhythmic. Vertical bars represent 
activity counts displayed in 30-min bins (mean ± SEM). (B) Pan-neuronal tau expression severely reduces 
power, determined by Lomb-Scarle analysis. See Table 3.1 for the percentage of rhythmic flies. (C) Pan-
neuronal tau expression has no effect on the period length of rhythms. (D) Pan-neuronal 2n4r tauWT expression 
causes age-induced hyperactivity in DD. Pan-neuronal 0n4r tauR460W expression has no effect on activity levels 
in DD. Graphs show median with second and third quartiles and 10th and 90th percentiles. n = 53-115 flies per 
genotype/age from 4-6 independent experiments. ns p>0.05; *p<0.05; **p<0.001; ***p<0.0001. (B,D) Data 
were lognormally distributed. Multiple comparisons between different genotypes of the same age (asterisks in 
black) and different ages of the same genotype (number symbols in red) by 2-way ANOVA and post-hoc Tukey 
HSD tests with log-transformed data. (C) Data were neither normally nor lognormally distributed. Multiple 
comparisons between different genotypes of the same age (asterisks in black) by Kruskal-Wallis ANOVA and 
post-hoc Dunn’s tests. Comparisons between different ages of the same genotype (number symbols in red) by 
Mann-Whitney U-tests.  
 
Elav>0n4r tauR406W expression resulted in a small loss of daytime sleep. Daytime sleep loss 
approached but did not quite achieve significance in 5-day old Elav>0n4r tauR406W flies. 
Between the 5- and 25-day old age groups, no significant differences in daytime sleep were 
seen in Elav>0n4r tauR460W flies. Therefore, as a result of the age-related increase in daytime 
sleep in Gal4 control flies, the daytime sleep loss reached significance in 25-day old 
Elav>0n4r tauR406W flies (Figure 3.2B,C). Elav>2n4r tauWT and Elav>0n4r tauR406W expression 
produced a similar daytime sleep loss phenotype at both ages analysed (Figure 3.2C). We 
found Elav>0n4r tauR406W expression resulted in the loss of a large proportion of night-time 
sleep. The night-time sleep loss phenotype in Elav>0n4r tauR406W flies was not progressive 
(Figure 3.2B,D). Elav>2n4r tauWT and Elav>0n4r tauR406W expression produced similar night-
time activity phenotypes (Figure 3.1C). In 5-day old flies, we found a stronger night-time 
sleep loss phenotype in Elav>0n4r tauR406W flies compared to Elav>2n4r tauWT flies. However, 
we found a similar night-time sleep loss phenotype in 25-day old Elav>2n4r tauWT and 
Elav>0n4r tauR406W flies, as a result of the age-related reduction in night-time sleep in 






expression promotes night-time activity and suppresses daytime and night-time sleep in LD 
conditions.  
 
Compared to Gal4 control flies, Elav>0n4r tauR406W flies appeared to show less distinction 
between daytime activity and night-time inactivity and relative night-time activity seemed 
to be elevated in free-running conditions. Average daily activity histograms and 
representative actograms for Elav>0n4r tauR406W flies can be seen in Figure 3.3 (right 
column). Both 5- and 25-day old Elav>0n4r tauR406W flies showed a substantial reduction in 
power compared with age-matched controls (Figure 3.3B). Additionally, 5 % of 5-day old 
Elav>0n4r tauR406W flies and 15 % of 25-day old Elav>0n4r tauR406W flies were arrhythmic 
(active around the clock), compared to 0 % of control flies (Table 3.1). Elav>0n4r tauR406W 
and control flies showed a similar age-related decline in rhythmicity. In 5-day old flies, 
Elav>0n4r tauR406W expression produced a more severe reduction in overall rhythmicity 
compared to Elav>2n4r tauWT expression. We found a more substantial age-related 
reduction in rhythmicity in Elav>2n4r tauWT flies compared to Elav>0n4r tauR406W flies. As a 
result, in 25-day old flies, Elav>0n4r tauR406W and Elav>2n4r tauWT expression produced a 
similar reduction in rhythm strength (Figure 3.3B). The period length of rhythms was normal 
in Elav>0n4r tauR406W flies (Figure 3.3C). No significant differences in levels of activity in DD 
were seen in Elav>0n4r tauR406W flies compared with age-matched controls at both ages 
analysed. Between the 5- and 25-day old age groups, both Elav>0n4r tauR406W and control 
flies showed a small, but significant, reduction in activity levels (Figure 3.3D). These results 
show that Elav>0n4r tauR406W expression reduces overall rhythmicity, but has no effect on 
the period length of rhythms or activity levels in DD conditions.  
 
3.3.4   Pan-neuronal 0n4r tauWT expression fails to induce behavioural arrhythmia  
 
Surprisingly, we found that Elav>0n4r tauWT expression exhibited robust behaviour, in 
contrast to the behavioural arrhythmia produced by Elav>2n4r tauWT and Elav>0n4r tauR406W 
expression (Supplementary Figure 3.2A,B,C). Regardless of age, power and period length did 
not significantly differ between Elav>0n4r tauWT flies and age-matched controls 






and control flies was activity levels in DD. In free-running conditions, we found a substantial 
increase in levels of activity in Elav>0n4r tauWT flies compared to controls. As the Elav>0n4r 
tauWT flies aged the elevated activity levels were stable (Supplementary Figure 3.2D). Thus, 
Elav>0n4r tauR406W expression reduces overall rhythmicity without affecting activity levels, in 
comparison Elav>0n4r tauWT expression fails to affect general rhythmicity but increases 
activity levels.  
 
3.3.5   Adult-onset pan-neuronal human tau expression does not affect circadian 
locomotor behaviour 
  
To determine whether adult-onset pan-neuronal tau expression can affect rhythmicity, we 
employed the GeneSwitch (GS) inducible transgene expression system (Osterwalder et al., 
2001). To ensure the effectiveness of ElavGS, we induced tetanus toxin (which inactivates 
the synaptic release machinery; Sweeney et al., 1995) using ElavGS. Flies, in which tetanus 
toxin expression was induced by treatment with RU486, died within two days (data not 
shown). 
 
ElavGS>2n4r tauWT flies were fed on RU486- or vehicle-containing standard food from one-
two days post eclosion for ten days. Flies were subsequently loaded into the DAMs and their 
locomotor activity was monitored in both LD and DD conditions. In LD conditions, RU486-
fed flies exhibited bimodal activity rhythms that were essentially identical to those found in 
vehicle-fed flies. (Figure 3.4A). No significant differences in activity and sleep were seen 
between RU486- and vehicle-fed flies (Supplementary Figure 3.3A,B,C). In DD conditions, 
both RU486- and vehicle-fed flies maintained robust rhythms of daytime activity and night-
time inactivity, with a period of just under 24 hours (Figure 3.4B). We found power and 
period length did not significantly differ between RU486- and vehicle-fed flies (Figure 
4.4C,D). Levels of activity in DD in RU486-fed flies were not significantly different from in 
vehicle-fed flies (Figure 3.4E), but were dramatically reduced compared to other genotypes 
(Table 3.1). This cannot be attributed to the effects of ethanol exposure as Wolf et al., 






indicate that adult-onset pan-neuronal 2n4r tauWT expression (via ElavGS) is insufficient to 

















Figure 3.4: Adult-onset pan-neuronal tau expression (via Elav-GS) is insufficient to disrupt normal circadian 
locomotor rhythms. ElavGS>2n4r tauWT (A-E) and ElavGS>2n4r tauS11A (F-J) flies were raised on standard food 
during development and were transferred within two days of eclosion onto RU486- or vehicle-containing 
standard food for ten days. Flies were subsequently loaded into the DAMs and their locomotor activity was 
recorded during 3LD cycles followed by 8DD cycles. (A) Average daily activity histograms for three days of LD 
conditions are shown for RU486- and vehicle-fed ElavGS>2n4r tauWT flies. Activity rhythms are essentially 
identical in RU486- and vehicle-fed flies. (B) Average daily activity histograms and representative double-
plotted actograms for eight days of DD conditions are shown for RU486- and vehicle-fed ElavGS>2n4r tauWT 
flies. Both RU486- and vehicle-fed flies show robust rhythms of daytime activity and night-time inactivity, with 
a period of just under 24 h. (C) Power. (D) Period length. (E) Activity in DD. n = 46-68 flies per group from 3-4 
independent experiments. (F) Average daily activity histograms for three days of LD conditions are shown for 
RU486- and vehicle-fed ElavGS>2n4r tauS11A flies. Activity rhythms are virtually identical in RU486- and vehicle-
fed flies. (G) Average daily activity histograms and representative double-plotted actograms for eight days of 
DD conditions are shown for RU486- and vehicle-fed ElavGS>2n4r tauS11A flies. Both RU486- and vehicle-fed 
flies show robust rhythms of daytime activity and night-time inactivity, with a period of nearly 24 h. (H) Power. 
(I) Period length. (J) Activity in DD. n = 16-29 flies per group from a single experiment. Graphs show median 
with second and third quartiles and 10th and 90th percentiles. ns p>0.05; two-tailed Student’s t-test with log-
transformed data for (C,E,H,J); Man-Whitney U-test for (D,I).  
 
Next, we tested whether adult-onset pan-neuronal expression of the highly toxic 2n4r 
tauS11A construct could induce behavioural arrhythmia under similar conditions. Previous 
studies have shown that 2n4r tauS11A is more toxic than either 0n4r tauWT or 2n4r tauWT 
when expressed in the Drosophila larval neuromuscular junction (NMJ) or adult visual 
system (Chatterjee et al., 2009; Talmat-Amar et al., 2011). Indeed, Elav-driven 2n4r tauS11A 
expression at both 18 °C and 25 °C, resulted in lethality at the pupal stage (data not shown). 
Both RU486- and vehicle-fed ElavGS>2n4r tauS11A flies showed bimodal activity rhythms in 
LD conditions (Figure 3.4F). We found no significant differences in levels of activity and sleep 
between RU486- and vehicle-fed flies (Supplementary Figure 3.3D,E). In DD conditions, 
RU486-fed flies retained significant rhythmic behaviour (Figure 3.4G). No significant 
differences in power, period length and activity in DD were seen between RU486- and 
vehicle-fed flies (Figure 3.4H,I,J). Taken together, these results show adult-onset pan-
neuronal expression of either 2n4r tauWT or highly toxic 2n4r tauS11A (via ElavGS) fails to 
induce circadian behavioural abnormalities. However, the lack of a phenotype is likely due 






longer exposure to RU486, or introducing additional copies of Gal4/UAS might produce a 
phenotype. In comparison, TNT is effective in the nanomolar concentration range (Sweeney 
et al., 1995; Thum et al., 2006).  
 
3.3.6   Human wild-type tau (2n4r isoform) expression in the clock neurons affects activity 
and sleep in LD conditions 
 
Studies on post mortem brains from AD patients have shown substantial cell loss in the SCN, 
suggesting that damage to the master pacemaker might cause circadian behavioural 
abnormalities (Swaab et al., 1985; Wu and Swaab, 2007). Because of this, we wanted to 
explore the effects of restricting tau expression to the clock system. To achieve this, we 
used the Pdf-Gal4 and tim-Gal4 driver lines to express tau either in the PDF-positive clock 
neurons (~16 neurons) or in all clock neurons (~150 neurons), respectively and recorded 
locomotor activity in LD and DD conditions.  
 
In LD conditions, both tim>2n4r tauWT and Pdf>2n4r tauWT flies showed normal bimodal 
activity rhythms with morning and evening peaks. Except for a loss of morning anticipation 
in 25-day old tim>2n4r tauWT flies, morning and evening anticipation appeared to be normal 
in tim>2n4r tauWT and Pdf>2n4r tauWT flies. Morning and evening startle responses seemed 
to be normal in tim>2n4r tauWT and Pdf>2n4r tauWT flies. Baseline activity levels appeared to 
be slightly elevated in tim>2n4r tauWT and Pdf>2n4r tauWT (Figure 3.5A). We found levels of 
daytime activity were unaffected in tim>2n4r tauWT and Pdf>2n4r tauWT flies, whereas levels 
of night-time activity were substantially increased, compared to age-matched controls at 
both ages analysed (Figure 3.5B,C). No significant age-related differences in daytime activity 
were observed in tim>2n4r tauWT, Pdf>2n4r tauWT and control flies (Figure 3.5B). In 5-day 
old flies, tim>2n4r tauWT and Pdf>2n4r tauWT expression produced a similar night-time 
activity phenotype. With aging, levels of night-time activity were well maintained in 
Pdf>2n4r tauWT flies, but not in tim>2n4r tauWT flies. A severe age-related reduction in night-
time activity was seen in tim>2n4r tauWT flies. Therefore, in 25-day old flies the night-time 






flies showed a small, but significant, age-related reduction in night-time activity (Figure 
3.5C). 
 
Regardless of age, tim>2n4r tauWT expression had no effect on daytime sleep (Figure 
3.7A,C). On the other hand, Pdf>2n4r tauWT expression resulted in a small gain in daytime 
sleep in 5-day old flies, but not in 25-day old flies. We found a moderate reduction in 
daytime sleep in Pdf>2n4r tauWT flies as a function of age (Figure 3.7B,C). Whereas, no 
significant age-related differences in daytime sleep were seen in either tim>2n4r tauWT or 
control flies (Figure 3.7A,C). At both ages analysed, tim>2n4r tauWT and Pdf>2n4r tauWT 
expression resulted in the loss of a large proportion of night-time sleep. In 5-day old flies, 
the night-time sleep loss phenotype was stronger in tim>2n4r tauWT flies than in Pdf>2n4r 
tauWT flies. We found levels of night-time sleep were stable in Pdf>2n4r tauWT flies, but not 
in tim>2n4r tauWT flies, with aging. As a result, in 25-day old flies, the night-time sleep loss 
phenotype was similar in tim>2n4r tauWT and Pdf>2n4r tauWT flies. No significant age-related 
differences in night-time sleep were seen in control flies (Figure 3.7A,B,D). These results 
show that 2n4r tauWT expression in the clock system promotes daytime sleep in an age-
dependent manner and promotes night-time activity and suppresses night-time sleep in an 
age-independent manner. 
 
3.3.7   Human wild-type tau (2n4r isoform) expression in all clock neurons is sufficient to 
trigger behavioural arrhythmia in DD conditions 
 
In DD conditions, UAS control flies were active during the day and inactive at night (Figure 
3.8A, left column). Whereas, tim>2n4r tauWT flies failed to show a clear distinction between 
their daytime activity and night-time inactivity because relative night-time activity seemed 
to be elevated (Figure 3.8A, middle column). Both 5-and 25-day old tim>2n4r tauWT flies 
showed a substantial reduction in power compared with -age-matched controls. All 
genotypes exhibited an age-related decline in overall rhythmicity (Figure 3.8B). By 25-days 
of age, the fraction of tim>2n4r tauWT flies that remained rhythmic was only 70 %, compared 
to 100 % of controls (Table 3.1). An example actogram for a rhythmic and arrhythmic 25-day 






tim>2n4r tauWT flies were less rhythmic than Elav>2n4r tauWT flies at the same age – as 
shown by reduced overall rhythmicity and an increased arrhythmic sub-population 
(Supplementary Figure 3.7A and Table 3.1).  
 
Furthermore, tim>2n4r tauWT expression prolonged the free-running period. The average 
period length of 5-day old tim>2n4r tauWT flies was 0.3-0.4 h longer than in control flies. 
Similarly, the average period length of 25-day old tim>2n4r tauWT flies was 1.1 h longer than 
in control flies. Period lengths in tim>2n4r tauWT flies were much more variable than in 
control flies. For example, in 25-day old tim>2n4r tauWT flies period lengths ranged from 
between 19.1-31.5 h, compared to 22.7-24.7 h in the Gal4 control and 22.6-25.1 h in the 
UAS control. Between the 5- and 25-day old age groups, no significant differences in the 
period length of rhythms were seen in either tim>2n4r tauWT or control flies (Figure 3.8C 
and Table 3.1). We found a substantial increase in activity levels in DD in 5-day old tim>2n4r 
tauWT flies with respect to controls. Tim>2n4r tauWT flies showed a dramatic age-related 
decline in levels of activity. In 25-day old tim>2n4r tauWT flies, activity levels were reduced to 
the point where they no longer significantly differed from age-matched controls. On the 
other hand, control flies showed a moderate age-related reduction in activity levels (Figure 
3.8D). These results show that 2n4r tauWT overexpression in all clock neurons causes 
progressive behavioural arrhythmia and hyperactivity, and prolongs the period length of 

















Figure 3.5: Locomotor activity of flies expressing 2n4r tauWT in the clock system in LD conditions. (A) Average 
daily activity histograms for three days of LD conditions are shown for 5- and 25-day old UAS control (left 
column), tim>2n4r tauWT (middle column) and Pdf>2n4r tauWT (right column) flies. All genotypes exhibit 
bimodal activity rhythms. Elevated baseline activity in tim>2n4r tauWT and Pdf>2n4r tauWT flies. Loss of 
morning anticipation in 25-day old tim>2n4r tauWT flies. Vertical bars represent activity counts displayed in 30-
min bins (mean ± SEM). Lights-on (white bars). Lights-off (grey bars). (B-C) Quantification of daytime and night-
time activity. Tim>2n4r tauWT and Pdf>2n4r tauWT expression has no effect on daytime activity, but increases 
night-time activity, relative to controls. Graphs show median with second and third quartiles and 10th and 90th 
percentiles. n = 31-115 flies per genotype from 2-6 independent experiments. ns p>0.05; *p<0.05; **p<0.001; 
***p<0.0001. Data were lognormally distributed. Multiple comparisons between different genotypes of the 
same age (asterisks in black) and different ages of the same genotype (number symbols in red) by 2-way 







Figure 3.6: Locomotor activity of flies expressing 0n4r tauR406W in the clock system in LD conditions. (A) 
Average daily activity histograms for three days of LD conditions are shown for 5- and 25-day old UAS control 
(left column), tim>0n4r tauR406W (middle column) and Pdf>0n4r tauR406W (right column) flies. All genotypes 
exhibit bimodal activity rhythms. Elevated basal activity in tim>0n4r tauR406W and Pdf>0n4r tauR406W flies. 
Vertical bars represent activity counts displayed in 30-min bins (mean ± SEM). Lights-on (white bars). Lights-off 
(grey bars). (B-C) Quantification of daytime and night-time activity. Tim>0n4r tauR460W and Pdf>0n4r tauR460W 
expression decreases daytime activity in 5-day old flies, but increases daytime activity in 25-day old flies, 
relative to controls (albeit differences approached but fell just short of significance in Pdf>0n4r tauR460W flies). 
Tim>0n4r tauR406W and Pdf>0n4r tauR460W expression increases night-time activity relative to controls. Graphs 
show median with second and third quartiles and 10th and 90th percentiles. n = 28-111 flies per genotype 
from 2-6 independent experiments. ns p>0.05; *p<0.05; **p<0.001; ***p<0.0001. Data were lognormally 
distributed. Multiple comparisons between different genotypes of the same age (asterisks in black) and 
different ages of the same genotype (number symbols in red) by 2-way ANOVA and post-hoc Tukey HSD tests 






Surprisingly, Pdf>2n4r tauWT expression flies robust circadian behaviour, which was in 
contrast to the behavioural arrhythmia produced when 2n4r tauWT was expressed pan-
neuronally or pan-clock. Rhythm strength in Pdf>2n4r tauWT flies did not significantly differ 
from age-matched controls at both ages analysed (Figure 3.8A,B). We found a highly 
significant increase in overall rhythmicity in Pdf>2n4r tauWT flies, compared to tim>2n4r 
tauWT and Elav>2n4r tauWT flies at both ages analysed (Figure 3.8B and Supplementary 
Figure 3.7A). It is possible that the lack of arrhythmicity is due to the weaker expression of 
Pdf, as compared to tim and Elav lines. However, this is unlikely as Chen et al. (2014) 
showed using a GFP reporter that expression levels specifically in the PDF neurons are very 
similar for the Elav, Pdf and tim drivers. Furthermore, Pdf>2n4r tauWT expression prolonged 
the free-running period by 0.7-0.8 h in 5-day old flies and 0.7-0.9 h in 25-day old flies 
compared to controls. Period lengths in Pdf>2n4r tauWT flies were less variable than in 
tim>2n4r tauWT flies. The period-lengthening effects were similar in tim>2n4r tauWT and 
Pdf>2n4r tauWT flies (Figure 3.8C). Regardless of age, we found a substantial increase in 
activity levels in DD in Pdf>2n4r tauWT flies compared to controls. The elevated activity levels 
were well maintained in Pdf>2n4r tauWT flies with aging. Thus, tim>2n4r tauWT and Pdf>2n4r 
tauWT expression produced a similar increase in activity levels in young flies, but not in aged 
flies (Figure 3.8D). These data show that 2n4r tauWT expression in PDF-positive clock neurons 
lengthens the free-running period and causes hyperactivity, but is insufficient to trigger 
behavioural arrhythmicity in DD conditions. 
 
3.3.8   0n4r tauR406W and 2n4r tauWT expression in the clock system produce similar effects 
on circadian locomotor behaviour 
 
Next, we tested whether we would obtain similar results if we expressed 0n4r tauR406W in 
the clock system. Both tim>0n4r tauR406W and Pdf>0n4r tauR406W flies displayed bimodal 
activity rhythms with elevated basal activity in LD conditions. Morning and evening 
anticipation and startle responses appeared to be normal in tim>0n4r tauR406W and Pdf>0n4r 
tauR406W flies (Figure 3.6A). We found levels of daytime activity were reduced in 5-day old 
tim>0n4r tauR406W flies, but increased in 25-day old tim>0n4r tauR406W flies, relative to age-






although the differences fell just short of significance. Both tim>0n4r tauR406W and Pdf>0n4r 
tauR406W flies showed an age-related increase in daytime activity (larger in tim>0n4r tauR406W 
flies). Whereas, levels of daytime activity were stable in control flies as they aged (Figure 
3.6B).  
 
Regardless of age, levels of night-time activity were substantially increased in both tim>0n4r 
tauR406W and Pdf>0n4r tauR406W flies with respect to age-matched controls. We found no 
significant age-related differences in night-time activity in tim>0n4r tauR4046W flies. Whereas, 
we found a significant age-related increase in night-time activity in Pdf>0n4r tauR460W flies. 
Control flies showed a small, but significant, age-related decrease in night-time activity. 
Therefore, tim>0n4r tauR406W and Pdf>0n4r tauR406W expression produced a similar increase 
in night-time activity in 5-day old flies. Whereas, in 25-day old flies, Pdf>0n4r tauR460W 
expression produced a stronger night-time activity phenotype than tim>0n4r tauR460W 
expression (Figure 3.6C). 
 
We found a mild gain in daytime sleep in 5-day old tim>0n4r tauR406W flies, but a large loss of 
daytime sleep in 25-day old tim>0n4r tauR406W flies, compared to age-matched controls 
(Figure 3.7E,G). Whereas, Pdf>0n4r tauR406W expression had on effect on daytime sleep at 
both ages analysed (Figure 3.7F,G). Regardless of age, we found strong night-time sleep loss 
in both tim>0n4r tauR406W and Pdf>0n4r tauR460W flies compared to age-matched controls. 
The night-time sleep loss phenotype was progressive in both tim>0n4r tauR406W and 
Pdf>0n4r tauR406W flies. In control flies levels of night-time sleep were stable with aging. 
Tim>0n4r tauR406W and Pdf>0n4r tauR406W expression resulted in similar night-time sleep loss 
phenotypes at both ages analysed (Figure 3.7E,F,H). 
 
Tim>2n4r tauWT and tim>0n4r tauR406W expression had differential effects on daytime 
activity and sleep. Tim>2n4r tauWT expression had no effect on daytime activity and sleep, 
whereas tim>0n4r tauR460W expression produced age-dependent daytime activity and sleep 
phenotypes (Supplementary Figure 3.5A,C). Tim>2n4r tauWT and tim>0n4r tauR406W 
expression resulted in similar night-time activity and sleep phenotypes in 5-day old flies. As 






flies, whereas the night-time sleep phenotypes strengthened in tim>0n4r tauR406W flies. As a 
result, in 25-day old flies, we found milder night-time activity and sleep phenotypes in 
tim>2n4r tauWT flies compared to tim>0n4r tauR406W flies (Supplementary Figure 3.5B,D). 
Regardless of age, no significant differences in daytime activity and sleep were seen 
between Pdf>2n4r tauWT and Pdf>0n4r tauR406W flies (Supplementary Figure 3.6A,C). At both 
ages analysed, Pdf>2n4r tauWT and Pdf>0n4r tauR406W expression predominately produced 
similar elevated night-time activity and night-time sleep loss phenotypes (Supplementary 
Figure 3.6B,D).  
 
These results show that 0n4r tauR406W expression in the clock system affects daytime activity 
and sleep in an age-dependent manner – it suppresses daytime activity and promotes 
daytime sleep in young flies, but promotes daytime activity and suppresses daytime sleep in 
aged flies. Whereas, 0n4r tauR406W expression in the clock neurons affects night-time activity 
and sleep in an age-independent manner – it promotes night-time activity and suppresses 













Figure 3.7: Tau expression in the clock system promotes daytime sleep and suppresses night-time sleep. (A) 
Average daily sleep profile for three days of LD conditions are shown for 5- and 25-day old tim>2n4r tauWT and 
control flies. (B) Average daily sleep profile for three days of LD conditions are shown for 5- and 25-day old 
Pdf>2n4r tauWT and control flies. (C-D) Quantification of daytime and night-time sleep. Tim>2n4r tauWT 
expression has no effect on daytime sleep, but decreases night-time sleep, relative to controls. Pdf>2n4r tauWT 
expression increases daytime sleep (in 5-day old, but not in 25-day old flies), but decreases night-time sleep, 
relative to controls. (D) Average daily sleep profile for three days of LD conditions are shown for 5- and 25-day 
old tim>0n4r tauR406W and control flies. (F) Average daily sleep profile for three days of LD conditions are 
shown for 5- and 25-day old control and Pdf>0n4r tauR406W and control flies. All genotypes display a bimodal 
pattern, with peaks at midday and midnight and troughs at dawn and dusk. (G-H) Quantification of daytime 
and night-time sleep. Tim>0n4r tauR406W expression increases daytime sleep in 5-day old flies, but decreases 
daytime sleep in 25-day old flies, relative to controls. Tim>0n4r tauR406W expression decreases night-time sleep 
relative to controls. Pdf>0n4r tauR406W expression has no effect on daytime sleep, but decreases night-time 
sleep, relative to controls. The horizontal bars show when the lights were on (white) or off (black). (A-D) n = 
31-115 flies per genotype/age from 2-6 independent experiments. (E-H) n = 28-111 flies per genotype/age 
from 2-6 independent experiments. (A,B,E,F) Graphs show mean ± SEM. (C,D,G,H) Graphs show median with 
second and third quartiles and 10th and 90th percentiles. ns p>0.05; *p<0.05; **p<0.001; ***p<0.0001. Data 
were neither normally nor lognormally distributed. Multiple comparisons between different genotypes of the 
same age (asterisks in black) by Kruskal-Wallis ANOVA and post-hoc Dunn’s test. Comparisons between 
different ages of the same genotype (number symbols in red) by Mann-Whitney U-tests.  
 
UAS control flies were active during the day and inactive during the night in DD conditions 
(Fig 3.9A, left column). Tim>0n4r tauR406W flies maintained some observable rhythmicity in 
DD. However, relative night-time activity appeared to be elevated, so the distinction 
between daytime activity and night-time inactivity was less marked (Figure 3.9A, middle 
column). The power of both 5- and 25-day old tim>0n4r tauR406W flies was substantially 
reduced compared with age-matched controls (Figure 3.9B). <5 % of 5- and 25-day old 
tim>0n4r tauR406W flies were arrhythmic (Table 3.1). Between the 5- and 25-day age groups, 
a decline in behavioural rhythmicity was seen in all genotypes (Figure 3.9B). At both ages 
analysed, tim>2n4r tauWT and tim>0n4r tauR406W expression produced a similar reduction in 
overall rhythmicity (Supplementary Figure 3.5E). However, tim>2n4r tauWT flies showed an 
increased arrhythmic sub-population compared to tim>0n4r tauR4606W flies (Table 3.1). 
Elav>0n4r tauR406W and tim>0n4r tauR406W expression resulted in a similar decline in overall 






Additionally, tim>0n4r tauR406W expression prolonged the free-running period. The average 
period length of 5-day old tim>0n4r tauR406W flies was 0.4 h longer than in control flies. 
Furthermore, the average period length of 25-day old tim>0n4r tauR406W was 0.9-1.1 h 
longer than in control flies (Figure 3.9C). There was a significant age-related increase in the 
period length of rhythms in tim>0n4r tauR406W flies, which was evident in the histograms and 
actograms (Figure 3.9A, middle column; rightward shift in the evening activity peak). Periods 
lengths in tim>0n4r tauR406W flies were much more widely variable than in control flies. For 
example, in 25-day old tim>0n4r tauR406W flies period lengths ranged from between 18.6-
30.9 h, compared to 22.7-24.7 h in the Gal4 control and 23.2-24.7 h in the UAS control 
(Figure 3.9C and Table 3.1). We found similar period-lengthening effects in tim>2n4 tauWT 
and tim> 0n4r tauR406W flies (Supplementary Figure 3.5F). Tim>0n4r tauR406W expression 
caused a slight increase in levels of activity in DD in 5-day old flies, and a considerable 
increase in levels of activity in DD in 25-day old flies, compared to age-matched controls. We 
found no significant age-related differences in activity levels in DD in tim>0n4r tauR406W flies. 
Regardless of age, tim>0n4r tauR406W and Pdf>0n4r tauR406W expression produced a similar 
increase in activity levels in constant darkness (Fig 3.9D). In 5-day old flies, tim>0n4r 
tauR406W expression produced a more substantial increase in activity levels in DD with 
respect to tim>2n4r tauWT expression. Whereas, in 25-day old flies we saw the opposite 
(Supplementary Figure 3.5G). These data show similar to pan-clock 2n4r tauWT expression, 
pan-clock 0n4r tauR406W expression produces behavioural arrhythmicity and hyperactivity, 
and lengthens the free-running period in DD conditions. 
 
We found a small reduction in power in 5-day old, but not in 25-day old, Pdf>0n4r tauR046W 
flies compared to age-matched controls (Fig 3.9B). However, the actograms of Pdf>0n4r 
tauR406W flies showed that the vast majority of animals maintained a pattern of daytime 
activity and night-time inactivity similar to control flies. So, despite the reduced power, 
Pdf>0n4r tauR406W flies clearly maintained a high degree of rhythmicity (Fig 3.9A, right 
column). Furthermore, we found no age-related decline in rhythm robustness in Pdf>0n4r 
tauR406W flies and no Pdf>0n4r tauR406W flies were arrhythmic (Figure 3.9B and Table 3.1). At 
both ages analysed, Pdf>0n4r tauR406W flies were more rhythmic than tim>0n4r tauR406W and 






arrhythmic sub-population (Figure 3.9B, Supplementary Figure 3.7B and Table 3.1). Rhythm 
strength was significantly reduced in 5-day old, but not in 25-day old, Pdf>0n4r tauR406W flies 
compared to Pdf>2n4r tauWT flies of the same age (Supplementary Figure 6E).  
 
Pdf>0n4r tauR460W expression prolonged the free-running period by 0.5 h in both 5- and 25-
day old flies, compared with age-matched controls. No significant age-related differences in 
the period length of rhythms was seen in either Pdf>0n4r tauR406W or control flies. We found 
similar period-lengthening effects in tim>0n4r tauR406W and Pdf>0n4r tauR406W flies, despite 
the significant age-related increase in period length in tim>0n4r tauR460W flies. Compared to 
tim>0n4r tauR460W flies, period lengths in Pdf>0n4r tauR460W flies were not as widely variable 
(Figure 3.9C). We found similar period-lengthening effects in Pdf>2n4r tauWT and Pdf>0n4r 
tauR406W flies (Supplementary Figure 3.6F). Regardless of age, we found a dramatic increase 
in activity levels in DD in Pdf>0n4r tauR406W flies compared to age-matched controls. The 
elevated activity levels were well maintained in Pdf>0n4r tauR406W flies with aging. At both 
ages analysed, tim>0n4r tauR406W and Pdf>0n4r tauR460W expression produced a similar 
increase in activity levels (Figure 3.9D). Regardless of age, Pdf>2n4r tauWT and Pdf>0n4r 
tauR406W expression triggered a similar increase in levels of activity (Supplementary Figure 
3.6G). Similar to Pdf>2n4r tauWT expression, Pdf>0n4r tauR406W expression lengthens the 
free-running period and causes hyperactivity, but is insufficient to produce progressive 



















Figure 3.8: 2n4r tauWT expression in the clock system disrupts normal circadian locomotor rhythms. (A) 
Average daily activity histograms and representative double-plotted actograms for nine days of DD conditions 
are shown for 5- and 25-day old UAS control (left column), tim>2n4r tauWT (middle column) and Pdf>2n4r 
tauWT (right column) flies. Flies were entrained in standard LD cycles for three days and then monitored in DD 
for nine days. UAS control flies exhibit robust rhythms of daytime activity and night-time inactivity, with a 
period of just under 24 h. Tim>2n4r tauWT flies exhibit either very weak rhythms with a long-period (>24 h) or 
are arrhythmic. Pdf>2n4r tauWT flies exhibit robust rhythms with a long-period (>24 h). Vertical bars represent 
activity counts displayed in 30-min bins (mean ± SEM). (B) Tim>2n4r tauWT expression severely reduces power 
relative to controls. Pdf>2n4r tauWT expression has no effect on power relative to controls. See Table 3.1 for 
the percentage of rhythmic flies. (C) Tim>2n4r tauWT and Pdf>2n4r tauWT expression prolongs the free-running 
period. (D) Tim>2n4r tauWT and Pdf>2n4r tauWT expression increases activity levels in DD relative to controls. 
Graphs show second and third quartiles and 10th and 90th percentiles. n = 31-115 flies per genotype/age from 
2-6 independent experiments. ns p>0.05; *p<0.05; ***p<0.0001. (B,D) Data were lognormally distributed. 
Multiple comparisons between different genotypes of the same age (asterisks in black) and different ages of 
the same genotype (number symbols in red) by 2-way ANOVA and post-hoc Tukey HSD tests with log-
transformed data. (C) Data were neither normally nor lognormally distributed. Multiple comparisons between 
different genotypes of the same age (asterisks in black) by Kruskal-Wallis ANOVA and post-hoc Dunn’s tests. 



















Figure 3.9: 0n4r tauR406W expression in the clock system disrupts normal circadian locomotor rhythms. (A) 
Average daily activity histograms and representative double-plotted actograms for nine days of DD conditions 
are shown for UAS control (left column), tim>0n4r tauR406W (middle column) and Pdf>0n4r tauR406W (right 
column) flies. Flies were entrained in standard LD cycles for three days and then released in DD for nine days. 
UAS control flies show robust rhythms of daytime activity and night-time inactivity, with a period of nearly 24 
h. tim>0n4r tauR406W flies exhibit either very weak rhythms with a long period (>24 h) or are arrhythmic. 
Pdf>0n4r tauR406W flies exhibit robust rhythms with a long period (>24 h). Vertical bars represent activity 
counts displayed in 30-min bins (mean ± SEM). (B) Severe reduction in power is found in 5 and 25-day old 
tim>0n4r tauR406W flies relative to controls. Moderate reduction in power is found in 5-day old, but in not 25-
day old, Pdf>0n4r tauR406W flies relative to controls. See Table 3.1 for the percentage of rhythmic flies. (C) 
Prolonged free-running period is found in tim>0n4r tauR460W and Pdf>0n4r tauR406W flies relative to controls. (D) 
Increased activity levels in DD are found in tim>0n4r tauR460W and Pdf>0n4rtauR460W flies relative to controls. 
Graphs show second and third quartiles and 10th and 90th percentiles. n = 27-109 flies per genotype/age from 
2-6 independent experiments. ns p>0.05; *p<0.05; **p<0.001; ***p<0.0001. (B,D) Data were lognormally 
distributed. Multiple comparisons between different genotypes of the same age (asterisks in black) and 
different ages of the same genotype (number symbols in red) by 2-way ANOVA and post-hoc Tukey HSD tests 
with log-transformed data. (C) Data were neither normally nor lognormally distributed. Multiple comparisons 
between different genotypes of the same age (asterisks in black) by Kruskal-Wallis ANOVA and post-hoc 
Dunn’s tests. Comparisons between different ages of the same genotype (number symbols in red) by Mann-
Whitney U-tests.  
 
3.3.9   Highly toxic 2n4r tauS11A expression in the clock system induces behavioural 
arrhythmia in DD conditions  
 
Next, we tested whether pan-clock expression of the highly toxic phosphorylation-resistant 
2n4r tauS11A construct is associated with a more severe phenotype than pan-clock 2n4r 
tauWT expression. We found a highly significant reduction in power in tim>2n4r tauS11A flies 
compared to age-matched controls at both ages analysed. At both ages analysed, overall 
rhythmicity did not significantly differ between tim>2n4r tauS11A flies and tim>2n4r tauWT 
flies (Supplementary Figure 3.4A,B). However, an increased arrhythmic sub-population was 
found in tim>2n4r tauS11A flies compared to tim>2n4r tauWT flies. At 5-days of age, 80 % of 
tim>2n4r tauS11A flies were rhythmic, compared to 95 % of tim>2n4r tauWT flies. By 25-days 
of age, only 60 % of tim>2n4r tauS11A flies remained rhythmic, compared to 70 % of 






expression prolonged the free-running period in an age-dependent manner. The period 
length of rhythms was normal in 5-day old tim>2n4r tauS11A flies. Whereas, the average 
period length of 25-day old tim>2n4r tauS11A flies was 1.0 h longer than in age-matched 
controls. Period lengths in 25-day old tim>2n4r tauS11A flies varied greatly, they ranged from 
between 18.6-32.6 h, compared to 22.7-24.7 h in the Gal4 control and 23.2-24.2 h in the 
UAS control. By 25-days of age, the period-lengthening effects were similar in tim>2n4r 
tauS11A and tim>2n4r tauWT flies (Supplementary Figure 3.4C). Tim>2n4r tauS11A expression 
had no significant effect on activity levels in DD irrespective of age (Supplementary Figure 
3.4D)  
 
3.3.10   Tau expression does not cause structural degeneration of the central pacemaker 
neurons 
 
Next, we wished to investigate whether structural damage to the central pacemaker 
coincides with the behavioural abnormalities. We used a mCD8::GFP transgene to directly 
visualise the morphology of the PDF-positive clock neurons (sLNvs and lLNvs), which are the 
master pacemakers. We observed no obvious loss of sLNvs and lLNvs neurons in either 
Pdf>tau or tim>tau flies up to 25-days of age (Figure 3.10B,C). The PDF neurons have dense 
arborisations in the optic lobes (Helfrich-Forster and Homberg, 1993). The density of the 
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Figure 3.10: Tau expression in the 
clock system results in no loss of PDF 
neurons. (A) Graphic showing the 
~150 clock neurons in the Drosophila 
brain subdivided into seven groups. 
Red circles indicate the PDF-positive 
clock neurons (sLNvs and lLNvs), 
which are the master pacemakers. (B) 
Image stacks of sLNvs and lLNvs 
neurons for 5- and 25-day old control, 
Pdf>2n4r tauWT and Pdf>0n4r tauR406W 
flies. sLNvs and lLNvs neurons appear 
morphologically normal in Pdf>2n4r 
tauWT and Pdf>0n4r tauR406W flies 
compared to controls. (C) Image 
stacks of sLNvs and lLNvs neurons for 
5- and 25-day old control and 
tim>2n4r tauWT flies. sLNvs and lLNvs 
neurons appear morphologically 
normal in tim>2n4r tauWT flies 
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3.3.11   Elevated night-time activity and night-time sleep loss in LD in tau-expressing flies 
is dependent upon tau expression in the master pacemaker neurons 
 
We have shown that tau expression in all neurons, and exclusively in PDF neurons, causes a 
similar increase in night-time activity and loss of night-time sleep (Supplementary Figure 
3.8B,D). Therefore, we sought to investigate whether the night-time activity and sleep 
phenotypes in tau-expressing flies are related to the effects of tau expression in the PDF 
neurons. To achieve this, we used the pan-neuronal Elav-Gal4 driver combined with Pdf-
Gal80 to block Gal4 activity exclusively in the PDF neurons (Stoleru et al., 2004). We found 
levels of both daytime and night-time activity in 5-day old Elav, Pdf-Gal80>0n4r tauR406W flies 
did not significantly differ from age-matched controls. Levels of night-time activity were 
significantly lower in Elav, Pdf-Gal80>0n4r tauR460W compared to Elav>0n4r tauR460W flies 
(Figure 3.11B). No significant differences in levels of daytime and night-time sleep were seen 
in 5-day old Elav, Pdf-Gal80>tauR406W flies relative to age-matched controls. Levels of night-
time sleep were significantly higher in Elav, Pdf-Gal80>0n4r tauR460W flies compared to 
Elav>0n4r tauR460W flies (Figure 3.11C). These results show blocking tau expression 
exclusively in the PDF neurons rescues the night-time activity and sleep phenotypes in tau-
expressing flies. These results suggest tau acts in the master pacemaker neurons to cause 
elevated night-time activity and night-time sleep loss in LD conditions.  
 
3.3 12   Behavioural arrhythmia in DD in tau-expressing flies is not dependent upon tau 
expression in the master pacemaker neurons 
 
We have previously shown that tau expression exclusively in the PDF neurons fails to cause 
progressive behavioural arrhythmia (Figure 3.8 and Figure 3.9). Therefore, we were 
interested to know whether tau expression in all neurons apart from the PDF neurons was 
sufficient to produce progressive behavioural arrhythmia in DD conditions. In 5-day old Elav, 
Pdf-Gal80>tauR406W flies, relative night-time activity seemed to be elevated, so there was 
less distinction between daytime activity and night-time inactivity (Figure 3.11D). We found 
that 5-day old Elav, Pdf-Gal80>0n4r tauR406W flies showed a substantial reduction in power 
compared with controls of the same age (Figure 3.11E). The period length of rhythms was 
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significant differences in levels of activity in DD in 5-day old Elav, Pdf-Gal80>0n4r tauR406W 
flies with respect to age-matched controls (Figure 3.11G). In DD conditions, Elav, Pdf-
Gal80>0n4r tauR406W flies were essentially identical to Elav>0n4r tauR406W flies of the same 
age – we found no significant differences in overall rhythmicity, period length and activity 
levels (Figure 3.11E,F,G). These results show that suppression of tau expression exclusively 
in the PDF neurons is insufficient to rescue tau-evoked behavioural arrhythmia in DD 
conditions. These data further highlight the contribution of neurons downstream of the 
master pacemaker in tau-mediated circadian behavioural arrhythmicity.  
 
3.3.13   Tau expression in tim-positive glial cells plays a role in tau-evoked circadian 
behavioural arrhythmia in DD conditions  
 
We have already established that tim>2n4r tauWT flies are less rhythmic than Elav>2n4r 
tauWT flies as shown by reduced overall rhythmicity and an increased arrhythmic sub-
population (Supplementary Figure 7A and Table 3.1). Elav-Gal4 labels all neurons but not 
glia, whereas tim-Gal4 labels PDF neurons, other nearby clock neurons and glia. Therefore, 
we were interested to know whether tau expression in glia contributes to the more severe 
phenotype in tim>2n4r tauWT flies. Colodner and Feany (2010) showed that wild-type tau 
expression in glia causes aggregate formation and cell death of neurons and glia. We used a 
repo-Gal80 transgene to block tau expression in the glial subset of tim-positive cells 
(Awasaki et al., 2008). At both ages analysed, tim, repo-Gal80>2n4r tauWT flies showed a 
substantial reduction in power compared with age-matched controls. We found a similar 
reduction in overall rhythmicity in 5-day old tim, repo-Gal80>2n4r tauWT and tim>2n4r tauWT 
flies. However, tim, repo-Gal80>2n4r tauWT flies exhibited a less dramatic age-related 
decline in rhythmicity compared to tim>2n4r tauWT flies. Therefore, we found a significantly 
smaller reduction in overall rhythmicity in 25-day old tim, repo-Gal80>2n4r tauWT flies 
compared to age-matched tim>2n4r tauWT flies (Figure 3.12A,B). Additionally, in 25-day old 
flies, we found a reduced arrhythmic sub-population in tim, repo-Gal80>2n4r tauWT flies 
compared to tim>2n4r tauWT flies (Table 3.1). These data suggest that 2n4r tauWT expression 
in the glial subset of tim-positive cells may contribute to the progressive behavioural 
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Figure 3.11: Circadian locomotor behaviour in Elav, Pdf-Gal80>0n4r tauR406W flies in LD and DD conditions. 
(A) Average daily activity histograms for three days of LD conditions are shown for 5-day old UAS control and 
Elav, Pdf-Gal80>0n4r tauR406W flies. Both genotypes exhibit bimodal activity rhythms. Vertical bars represent 
activity counts displayed in 30-min bins (mean ± SEM). (B) Quantification of daytime and night-time activity for 
Elav>0n4r tauR460W, Elav, Pdf-Gal80>0n4r tauR406W and control flies. (C) Quantification of daytime and night-
time sleep for Elav>0n4r tauR460W, Elav, Pdf-Gal80>0n4r tauR406W flies and control flies. n = 32-106 flies per 
genotype from 2-6 independent experiments. (D) Average daily activity histograms and representative double-
plotted actograms for nine days of DD conditions are shown for 5-day old UAS control and Elav, Pdf-
Gal80>0n4r tauR406W flies. UAS control flies exhibit robust rhythms of daytime activity and night-time inactivity, 
with a period of nearly 24 h. Elav, Pdf-Gal80>0n4r tauR406W flies exhibit weak rhythms with a normal period. (E) 
Power is severely reduced in Elav>0n4r tauR460W and Elav, Pdf-Gal80>0n4r tauR406W flies relative to controls. (F) 
No differences in period length of rhythms are found in Elav>0n4r tauR460W and Elav, Pdf-Gal80>0n4r tauR406W 
flies relative to controls. (G) No differences in activity levels in DD are found in Elav>0n4r tauR460W and Elav, 
Pdf-Gal80>0n4r tauR406W flies relative to controls. n = 32-96 flies per genotype from 2-6 independent 
experiments. Box plots show median with second and third quartiles and 10th and 90th percentiles. ns p>0.05; 
*p<0.05; **p<0.001; ***p<0.0001. (B,E,G) Data were lognormally distributed. Multiple comparisons between 
different genotypes by 1-way ANOVA and post-hoc Tukey HSD tests with log-transformed data. (C,F) Data were 
neither normally nor lognormally distributed. Multiple comparisons between different genotypes by Kruskal-
Wallis ANOVA and post-hoc Dunn’s tests.  
 
The average circadian period of tim, repo-Gal80>2n4r tauWT flies was 0.4 h longer in 5-day 
old flies and 0.7-0.8 h longer in 25-day old flies than in age-matched controls. The period-
lengthening effects were similar in tim, repo-Gal80>2n4r tauWT and tim>2n4r tauWT flies 
(Figure 3.12C). Regardless of age, activity levels in DD in tim, repo-Gal80>2n4r tauWT flies did 
not significantly differ from controls of the same age (Figure 3.12D). Thus, suppressing 2n4r 
tauWT expression in tim-positive glial cells rescues the hyperactivity evoked by pan-clock 
2n4r tauWT expression. This is surprising because 2n4r tauWT expression exclusively in PDF 
neurons is sufficient to cause hyperactivity (Figure 3.8D). However, it is possible that the 
repo-Gal80 transgene also affects Gal4 activity in clock neurons, which may contribute to 
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Figure 3.12: Circadian locomotor behaviour in tim, repo-Gal80>2n4r tauWT flies in DD conditions. (A) Average 
daily activity histograms and representative double-plotted actograms for nine days of DD are shown for 5- 
and 25-day old UAS control (left column) and tim, repo-Gal80>2n4r tauWT (right column) flies. Flies were 
entrained in standard LD cycles for three days and then monitored in DD for nine days. UAS control flies exhibit 
robust rhythms of daytime activity and night-time inactivity, with a period of just under 24 h. tim, repo-
Gal80>2n4r tauWT flies exhibit weak rhythms with a long period (>24 h). (B) Substantial reduction in power is 
found in tim>2n4r tauWT and tim, repo-Gal80>2n4r tauWT flies relative to controls. See Table 3.1 for the 
percentage of rhythmic flies. (C) Lengthened free-running period is found in tim>2n4r tauWT and tim, repo-
Gal80>2n4r tauWT flies relative to controls. (D) Large increase in activity levels is found in 5-day old tim>2n4r 
tauWT flies relative to controls. No differences in activity levels are found in tim, repo-Gal80>2n4r tauWT flies 
and 25-day old tim>2nr tauWT flies relative to controls. Graphs show second and third quartiles and 10th and 
90th percentiles. n = 32-115 flies per genotype/age from 2-6 independent experiments. ns p>0.05; **p<0.001; 
***p<0.0001. (B,D) Data were lognormally distributed. Multiple comparisons between different genotypes of 
the same age (asterisks in black) and different ages of the same genotype (number symbols in red) by 2-way 
ANOVA and post-hoc Tukey HSD tests with log-transformed data. (C) Data were neither normally nor 
lognormally distributed. Multiple comparisons between different genotypes of the same age (asterisks in 
black) by Kruskal-Wallis ANOVA and post-hoc Dunn’s tests. Comparisons between different ages of the same 
genotype (number symbols in red) by Mann-Whitney U-tests. 
 
3.3.14   Tau expression in adult clock neurons is sufficient to disrupt circadian behaviour in 
DD conditions  
 
Finally, we sought to investigate whether expressing 2n4r tauWT in all clock cells during 
adulthood (using the TARGET system; McGuire et al., 2003) is sufficient to disrupt locomotor 
activity rhythms. Tim, tub-Gal80ts>2n4r tauWT flies were raised and maintained at 20 °C 
(where Gal80ts is active and blocks tau expression). Activity rhythms of 5-day old tim, tub-
Gal80ts>2n4r tauWT flies were first measured in DD for six days at 20 °C (following three days 
in LD) and then at 30 °C (where Gal80ts becomes inactivated and permits tau expression) for 
six days. At 20 °C, tim, tub-Gal80ts>2n4r tauWT flies showed robust behaviour, consistent 
with no tau expression. After shifting the flies to 30 °C, their overall rhythmicity substantially 
reduced and their average circadian period lengthened by 1 h compared with controls. 
Intriguingly, we found shifting control flies to 30 °C signifcantly increased their overall 
rhythmicity and shortened their free-runing period. On the other hand, shifting tim, tub-
Gal80ts>2n4r tauWT flies to 30 °C had no effect on their overall rhythmcity, but signifcantly 
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tauWT expression in adult clock neurons is sufficient to disrupt normal circadian locomotor 
activity rhythms.  
 
 
Figure 3.13: Behavioural arrhythmia can be induced by 2n4r tauWT expression in the adult clock system. (A) 
Representative double-plotted actograms are shown for tim-Gal4, tub-Gal80ts (left) and tim, tub-Gal80ts>2n4r 
tauWT (right) flies. Flies were maintained at 20 °C (permissive temperature) until after eclosion and for three 
days in LD (not shown) and the first six days in DD. The temperature was then increased to 30 °C (restrictive 
temperature) for six days. (B) 2n4r tauWT expression in adult clock neurons reduces rhythmicity. (C) 2n4r tauWT 
expression in adult clock neurons prolongs the average circadian period. Graphs show second and third 
quartiles and 10th and 90th percentiles. n = 40-85 flies per genotype/age from 2 independent experiments. ns 
p>0.05; *p<0.05; ***p<0.0001; two-tailed Student’s t-tests with log-transformed data for (B); Mann-Whitney 
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3.4   Discussion 
 
3.4.1   Pan-neuronal tau expression affects activity and sleep in LD  
 
Circadian rhythm and sleep-wake cycle disturbances are common in AD. However, it is not 
clear whether tau abnormalities are sufficient to cause them. To answer this question, we 
have looked at the effect on circadian behaviour of pan-neuronally expressing human tau in 
the fly brain. We found that regardless of age, pan-neuronal full-length human tau (wild-
type or R406W) expression (using Elav-Gal4) had an effect on circadian locomotor behaviour 
in both LD and DD conditions (Figure 3.1, Figure 3.2 and Figure 3.3). In LD conditions, both 
tau-expressing and control flies showed strong bimodal activity rhythms, with elevated 
basal activity in tau-expressing flies (Figure 3.1A). Pan-neuronal tau expression produced a 
substantial increase in activity levels during the night (the inactive phase) (Figure 3.1B). 
Similar findings reported in Tg4510 mice (express human 0n4r tauP301L under the control of 
the forebrain-specific CaMKII promoter), which show a substantial increase in daytime 
activity (the inactive phase as mice are nocturnal) (Stevanovic et al., 2017). Thus, both 
Drosophila and mouse models of tauopathy recapitulate the elevated activity during the 
inactive phase and shift towards a higher percentage of total activity occurring during the 
inactive phase found in individuals with AD (Satlin et al., 1995; Volicer et al., 2001; Harper et 
al., 2004).  
 
Although detailed analysis of sleep was beyond the scope of this investigation, we showed 
tau-expressing flies slept less – we saw a small daytime sleep loss and a large night-time 
sleep loss (Figure 3.2). The night-time activity and sleep phenotypes in tau-expressing flies 
were neither age-dependent nor progressive (Figure 3.1 and Figure 3.2). Currently, sleep has 
not been examined in 3xTg-AD mice (express human APP, PS1 and tau) or in transgenic tau 
mice. The reduction in sleep in AD patients and in AD animal models may contribute to the 
observed memory deficits, because many studies have shown the important role of sleep in 
memory consolidation (for review see Dickelmann and Born, 2010). Several studies have 
shown sleep loss in Drosophila and mouse models of β-amyloidosis (Zhang et al., 2005; Roh 
et al., 2012; Gerstner et al., 2017). Thus in AD, where both tauopathy and β-amyloidosis are 
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shown that pan-neuronal human Aβ expression in Drosophila causes dramatic daytime and 
night-time sleep loss. Thus, pan-neuronal expression of neither human tau nor Aβ in 
Drosophila recapitulates the increased propensity to sleep during the day reported in AD 
patients (Bonanni et al., 2005; Musiek et al., 2015). 
 
3.4.2   Pan-neuronal tau expression causes behavioural arrhythmia in DD 
 
Pan-neuronal 2n4r tauWT and 0n4r tauR406W expression caused similar progressive 
behavioural arrhythmia, as evidenced by reduced overall rhythmicity and an increased 
arrhythmic subpopulation in DD conditions (Figure 3.3A,B and Table 3.1). In contrast, we 
found that pan-neuronal 0n4r tauWT expression failed to induce behavioural arrhythmicity 
(Supplementary Figure 3.2A,B). This is surprising because 2n4r tauWT, 0n4r tauR406W and 0n4r 
tauWT have all been shown to cause neurodegeneration when expressed ectopically in the 
developing Drosophila brain and visual system (Wittmann et al., 2001; Jackson et al., 2002; 
Grammenoudi et al., 2008; Kosmidis et al., 2010). Because the changes in circadian 
behaviour (in both LD and DD conditions) are already present in young flies (~5-days old), 
they precede the onset of other traditionally established AD phenotypic markers, including 
neurodegeneration. As previous work using the same model has established 
neurodegeneration first appears in 10-day old flies, with a progressive increase in 25- and 
50-day old flies (Wittmann et al., 2001). In DD conditions, Tg4510 mice show disrupted 
activity rhythms (Stevanovic et al., 2017). Thus, both our Drosophila model and Tg4510 mice 
recapitulate the dampening of circadian behaviour found in AD patients (Volicer et al., 2001; 
Coogan et al., 2013). However, PLB2Tau mice (express human 2n4r tauP301L and 2n4r tauR460W 
under the control of the forebrain-specific CaMKII promoter) show normal activity rhythms, 
despite abnormalities in sleep EEGs (Koss et al., 2016). We have shown that pan-neuronal 
expression of 2n4r tauWT and 0n4r tauR406W moderately shortens lifespan (Supplementary 
Figure 3.1). This is consistent with previous reports (Wittmann et al., 2001; Gorsky et al., 
2016).  
 
Pan-neuronal wild-type tau expression in Drosophila has been previously associated with 
locomotor activity deficits (Ali et al., 2011). In addition, motor deficits are a frequent 
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tau expression to the forebrain (under the control of the CaMKII promotor) (Koss et al., 
2016). We found normal levels of activity in Elav>0n4r tauR406W flies up to 35-days of age 
(Figure 3.3D). This indicates that the behavioural arrhythmicity is not an artifact of reduced 
activity levels. Interestingly, we found age-induced hyperactivity in Elav>2n4r tauWT flies 
(activity levels were normal in young flies, but elevated in aged flies) (Figure 3.3D). 
Therefore, Elav>2n4r tauWT expression reverses the age-related decline in levels of activity 
normally observed in Drosophila. Furthermore, we found age-independent hyperactivity in 
Elav>0n4r tauWT flies (Supplementary Figure 3.2D). Thus, tau expression can affect the 
overall amount of activity independently of the distribution of activity; for example, 
Elav>0n4rR406W flies are arrhythmic but have normal activity levels, whereas Elav>0n4r tauWT 
flies are rhythmic but are hyperactive. These results show isoform-specific effects of tau to 
produce behavioural arrhythmicity and hyperactivity when expressed pan-neuronally. 
However, AD patients do not usually differ from healthy controls concerning overall activity 
levels (van Someren et al., 1996; Harper et al., 2004). Although AD patients often exhibit 
other behavioural symptoms including restlessness, wandering, agitation and pacing, and 
perhaps these manifest as hyperactivity in our Drosophila model. To the best of our 
knowledge, this is the first study to show that human tau expression makes flies hyperactive 
in constant conditions.  
 
3.4.3   Adult-onset pan-neuronal tau expression is insufficient to trigger circadian 
abnormalities 
 
We next investigated whether adulthood restricted ubiquitous neuronal tau expression 
(using Elav-GS) is sufficient to cause circadian behavioural deficits. We found that neither 
2n4r tauWT nor highly toxic phosphorylation-resistant 2n4r tauS11A expression had any effect 
on circadian locomotor behaviour in either LD or DD conditions (Figure 3.4 and 
Supplementary Figure 3.3). The lack of a phenotype in ElavGS>2n4r tauWT and ElavGS>2n4r 
tauS11A flies is likely due to insufficient tau expression levels, it is possible that increasing the 
concentration of RU486, longer exposure to RU486 or introducing additional copies of 
Gal4/UAS might induce a phenotype. On the other hand, Tabuchi et al. (2015) showed that 
adulthood restricted pan-neuronal Aβarctic expression (via Elav-GS) reduces and fragments 
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and 2n4r tauS11A were insufficiently potent to produce a sleep loss phenotype 
(Supplementary Figure 3.3). However, this discrepancy could be related to differences in the 
genetic background or experimental protocol. During the course of this work, Dissel et al. 
(2017) showed that adulthood restricted ubiquitous tau expression (using Daughterless-GS) 
reduces daytime sleep. This inconsistency could be due to differences in the expression 
levels of the Elav-GS and Daughterless-GS drivers.  
 
3.4.4   Tau expression in the clock system affects activity and sleep in LD 
 
Next, we investigated how tau expression restricted to the clock system would affect 
circadian locomotor behaviour. Human tau (wild-type or R406W) expression in the clock 
system affects activity and sleep in LD conditions. Tau expression in PDF neurons (using Pdf-
Gal4), or in timeless clock neurons (using tim-Gal4), caused a substantial increase in night-
time activity and decrease in night-time sleep in an age-independent manner (Figure 3.5C, 
Figure 3.6C and Figure 3.7D,H). Pdf>2n4r tauWT and Pdf>0n4r tauR406W expression produced 
similar night-time activity and sleep phenotypes (Supplementary Figure 6B,D). The elevated 
night-time activity in Pdf>tau flies is not caused by loss of PDF signalling as Pdf01 mutants 
(which lack the PDF peptide) have an advanced evening peak of activity, which results in an 
increase in daytime activity (Renn et al., 1999). Tim>2n4r tauWT and tim>0n4r tauR406W 
expression produced similar night-time activity and sleep phenotypes in young flies. As the 
flies aged, levels of night-time activity and sleep were well maintained in tim>0n4r tauR406W 
flies, but not in tim>2n4r tauWT flies. As a result, the night-time activity and sleep 
phenotypes were milder in tim>2n4r tauWT flies than in tim>0n4r tauR406W flies 
(Supplementary Figure 5B,D). 
 
Elav>2n4r tauWT and Pdf>2n4r tauWT expression caused similar night-time activity and sleep 
phenotypes (Supplementary Figure 8B,D). In 5-day old flies, we found similar night-time 
activity and sleep phenotypes in Elav>0n4r tauR406W and Pdf>tauR406W flies. Whereas, in 25-
day old flies, we found a stronger night-time activity phenotype in Pdf>0n4r tauR406W flies 
compared to Elav>0n4r tauR406W flies. Elav>0n4r tauR460W and Pdf>0n4r tauR460W expression 
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Furthermore, suppression of tau expression exclusively in the PDF neurons rescued the 
night-time activity and sleep phenotypes in flies pan-neuronally expressing tau (Figure 
3.11B,C). Thus, tau acts in the PDF neurons to promote night-time activity and suppress 
night-time sleep. We found most parental controls showed a small, but significant, age-
related reduction in night-time activity, but no age-related differences in daytime activity 
(Figure 1B,C, Figure 5B,C and Figure 6B,C). However, other studies have reported the 
opposite (Metaxakis et al., 2014). Most parental controls showed no age-related differences 
in daytime and night-time sleep (Figure 2B,D and Figure 7C,D,G,H). On the other hand, 
previous studies have reported an age-related reduction in both daytime and night-time 
sleep (Koh et al., 2006; Vienne et al., 2016). 
 
Different tau proteins (2n4r tauWT and 0n4r tauR406W) differentially affected daytime activity 
and sleep when expressed in the clock system. Both Pdf>2n4r tauWT and tim>2n4r tauWT 
expression had no effect on daytime activity (Figure 3.5B). In contrast, tim>0n4r tau R460W 
expression affected daytime activity in an age-dependent manner; in young flies daytime 
activity was reduced, whereas in aged flies daytime activity was increased. A similar, but 
weaker, daytime activity phenotype was observed in Pdf>0n4r tauR460W flies. Tim>0n4r 
tauR460W and Pdf>0n4r tauR406W flies showed a significant age-related reduction in daytime 
activity levels (Figure 3.6B). Whereas, no age-related differences in daytime activity levels 
were seen in tim>2n4r tauWT, Pdf>2n4r tauWT and control flies (Figure 3.5B and Figure 3.6B). 
However, an increase in activity during the active phase as a function of age has not been 
previously reported in either AD patients or in AD mice models. Tim>2n4r tauWT and 
Pdf>0n4r tauR406W expression had no effect on daytime sleep. In comparison, tim>0n4r 
tauR460W expression produced a small gain in daytime sleep in young flies and a large loss of 
daytime sleep in aged flies. Similarily, Pdf>2n4r tauWT expression produced a small gain in 
daytime sleep in young flies. In both tim>0n4r tauR406W and Pdf>2n4r tauWT flies levels of 
daytime sleep decreased with age (Figure 3.7). We found sleep gain does not always 
coincide with reduced activity in tau-expressing flies. For example, in 5-day old tim>2n4r 
tauWT flies levels of daytime activity were normal, but levels of daytime sleep were 
increased (Figure 3.5B and Figure 3.7C). On the other hand, sleep loss does not always 
coincide with increased activity. For example, in 25-day old Elav>2n4r tauWT flies levels of 
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Figure 3.2C). Taken together, these data show tau expression in the clock system resulted in 
age-dependent daytime activity and sleep phenotypes, and age-independent night-time 
activity and sleep phenotypes. In both tim>tau and Pdf>tau flies the daytime activity and 
sleep phenotypes were weaker than the night-time activity and sleep phenotypes.  
Therefore, tau expression restricted to the clock system (in young flies) better recapitulates 
the sleep-wake cycle disturbances characteristic of AD (increased daytime naps, reduced 
and fragmented night-time sleep and increased night-time wakefulness) than pan-neuronal 
tau expression, which produced daytime and night-time sleep loss (Figure 3.2). Thus, tau 
expression in the clock neurons promotes daytime sleep and tau expression in other parts of 
the brain blocks these sleep-prompting effects. These data suggest that the sleep-wake 
cycle disturbances in AD are, at least in part, due to tau abnormalities in the SCN. 
 
3.4.5   Tau expression in the clock system is sufficient to produce behavioural arrhythmia 
in DD  
 
Surprisingly, flies were rhythmic when we expressed tau only in the PDF neurons. Whereas, 
when we expressed tau in all clock cells, the flies became behaviourally arrhythmic. Neither 
Pdf>2n4r tauWT nor Pdf>0n4r tauR460W expression caused progressive behavioural 
arrhythmia (Figure 3.8A,B, Fig 3.9A,B and Supplementary Figure 3.6E). Tim>2n4r tauWT and 
tim>0n4r tauR406W expression had similar effects on circadian behavioural rhythms. We 
found a similar age-related decline in overall rhythmicity in tau-expressing and control flies 
(Figure 3.8D, Figure 3.9D and Supplementary Figure 5E). Flies expressing tau in the timeless 
clock neurons, but not the tim-positive glial cells, were more rhythmic than flies expressing 
tau in all clock cells as evidenced by increased overall rhythmicity (in 25-day old flies, but 
not in 5-day old flies) and a reduced arrhythmic sub-population (Figure 3.12B and Table 3.1). 
These results suggest glia are involved in regulating locomotor activity rhythms (Suh et al., 
2007; Ng et al., 2011). It has been proposed glial cells regulate PDF transport or release from 
sLNvs projections (Ng et al., 2011), it is possible tau may interfere with these processes. 
Furthermore, pan-clock tau expression had more a more severe effect on circadian 
behaviour than pan-neuronal tau expression (Supplementary Figure 7), it is possible that 
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Suppression of tau expression exclusively in the PDF neurons was insufficient to rescue the 
behavioural arrhythmia in flies pan-neuronally expressing tau (Figure 3.11D,E). Thus, tau-
evoked behavioural arrhythmia in DD is independent of the PDF neurons. Another possibility 
is that soluble tau migrates into the PDF neurons. However, this is unlikely as tau failed to 
migrate into the PDF neurons and induce night-time activity and sleep phenotypes in LD 
conditions (Figure 3.11B,C). Taken together, these experiments highlight the contribution of 
non-PDF clock neurons in mediating tau-evoked circadian behavioural arrhythmia. Clock 
neurons communicate with non-clock output neurons to give rise to robust locomotor 
activity rhythms (reviewed in Dubowy and Sehgal, 2017). For example, DN1 neurons make 
synaptic connections with a group of cells in the pars intercerebralis (PI) that express the 
neuropeptide, diuretic hormone 44 (DH44). DH44 is essential for normal free-running 
behaviour (Cavanaugh et al., 2014; King et al., 2017). It is possible that tau mediates 
behavioural arrhythmia in DD by disrupting the communication of the DN1 neurons or other 
non-PDF clock neurons with output neurons, such as DH44-positive PI cells. Several studies 
have shown pan-clock Aβ expression produces behavioural arrhythmicity. On the other 
hand, Aβ expression exclusively in the PDF neurons is insufficient to cause circadian 
behavioural arrhythmia (Chen et al., 2014; Long et al., 2014). Taken together, these findings 
suggest the primary target for both tau- and Aβ-evoked behavioural arrhythmia is the non-
PDF clock neurons. Similarly, other studies have found a blockage in the communication 
between the central clock and output neurons in both a mice model of HD (Pallier et al., 
2007) and AD patients (Wu et al., 2007; Cermakian et al., 2011).  
 
3.4.6   Tau expression in the clock system prolongs the free-running period  
 
Tau expression restricted to the clock system lengthened the free-running period (Figure 
3.8, Figure 3.9 and Table 3.1). Tim>tau and Pdf>tau expression produced similar period-
lengthening effects (Figure 3.8C, Figure 3.9C, Supplementary Figure 3.5F and Supplementary 
Figure 3.6F). Period lengths in tim>tau flies varied greatly (Figure 3.8C, Figure 3.9C and Table 
3.1). These long-period rhythms are not caused by the loss of PDF signalling, because killing 
the PDF neurons (using hid) results in short-period rhythms. Similarily, flies mutant for PDF 
and the PDF receptors show short-period rhythms (Renn et al., 1999). However, we see the 
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caused by blockade of chemical synaptic transmission, because Pdf>TNT flies exhibit robust 
behaviour in DD (Umezaki et al., 2011). Pan-neuronal tau expression had no effect on the 
period length of rhythms (Fig 3.3C and Supplementary Fig 3.2C). The period length of 
rhythms was normal in Elav, Pdf-Gal80>0n4r tauR460W flies (Fig 3.11F). We show tau 
expression exclusively in the PDF neurons has a period-lengthening effect. Whereas, tau 
expression in the non-clock neurons blocks the period-lengthening effect of tau expression 
in the PDF neurons. Similarly, Tg4510 mice show long-period rhythms (Stevanovic et al., 
2017). However, period lengths were normal in PLB2 mice (Koss et al., 2016). 
 
3.4.7   Tau expression causes hyperactivity in DD 
 
Tau expression in the clock system produces hyperactivity in DD (Figure 3.8D and Figure 
3.9D). Different tau isoforms have differential effects on levels of activity in DD. Pdf>2n4r 
tauWT and Pdf>0n4r tauR406W expression produced a similar increase in activity levels. As the 
flies aged, the elevated activity levels were stable in Pdf>2n4r tauWT and Pdf>0n4r tauR406W 
flies (Supplementary Figure 3.6G). Parental controls exhibited a small, but significant, age-
related reduction in levels of activity, which was inhibited by PDF>tau expression (Figure 
3.8D, Figure 3.9D and Supplementary Figure 3.6G). Tau expression exclusively in the PDF 
neurons has an activity-promoting effect in DD conditions. Tim>2n4r tauWT and tim>0n4r 
tauR406W expression differentially effected levels of activity in DD. In 5-day old flies, Tim>2n4r 
tauWT expression produced a mild increase in activity levels, whereas tim>0n4r tauR406W 
expression produced a strong increase in activity levels. As the flies aged, the elevated 
activity levels were well maintained in tim>0n4r tauR460W flies, but not in tim>2n4r tauWT 
flies (Figure 3.8D, Figure 3.9D and Supplementary Figure 3.5G). Thus, tim>2n4r tauWT 
expression results in a substantial age-related reduction in activity levels in both LD 
(restricted to the dark phase) and DD conditions (Figure 3.5C and Figure 3.8D). Tau 
expression in the non-PDF clock neurons blocks the activity-promoting effects of tau 
expression in the PDF neurons in aged flies. Differences in activity levels in tim>tau flies 
cannot be attributed to the high proportion of arrhythmic flies, because activity levels in 
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We found isoform-specific effects of ubiquitous neuronal tau expression on overall daily 
locomotor activity in DD. Elav>2n4r tauWT expression resulted in age-induced hyperactivity, 
whereas Elav>0n4r tauR406W expression had no effect on activity levels (Figure 3.3D). These 
results suggest that tau expression, in other parts of the brain, blocks the activity-promoting 
effects of tau expression in the PDF neurons. For example, communication between the 
master pacemaker and the brain regions involved in locomotion control (i.e. the ellipsoid 
body) could be inhibited by tau. In DD conditions, Tg4510 mice show normal daily activity 
levels (Stevanovic et al., 2017). Currently, activity levels in constant conditions have not 
been measured in other transgenic tau mice. It is possible that in mouse models of 
tauopathy, tau expression in the SCN has an activity-promoting effect, but this effect is 
inhibited by tau expression in other parts of the brain. It is worth noting that tim>2n4r 
tauS11A expression caused behavioural arrhythmia without affecting activity levels 
(Supplementary Figure 3.4). This lends further support to the idea that tau expression can 
affect the overall amount of activity, independently of the distribution of activity.  
 
Collectively, these results show pan-clock human tau expression causes progressive 
behavioural arrhythmia and hyperactivity and prolongs the free-running period in DD. In 
contrast, human tau expression exclusively in PDF neurons produces hyperactivity and 
lengthens the free-running period, but is insufficient to induce progressive behavioural 
arrhythmia in DD (Figure 3.8 and Figure 3.9). 
 
3.4.8   Circadian and sleep disruption is due to neuronal dysfunction in the clock cells 
 
Because tau expression in the clock system causes abnormalities in circadian locomotor 
behaviour (in both LD and DD conditions), we investigated the status of the master 
pacemaker neurons. We found no obvious loss of PDF neurons in either Pdf>tau or tim>tau 
flies up to 25-days of age (Figure 3.10). This indicates that circadian behavioural rhythm 
degradation in tim>tau flies occurs without neuronal death in the master pacemaker. These 
results support the idea that tau expression outside of the PDF neurons is of primary 
importance in tau-evoked behavioural arrhythmia in DD. This also suggests that the 
circadian behavioural abnormalities in Pdf>tau flies (elevated night-time activity and night-
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degeneration, in the master pacemaker neurons. A growing body of evidence shows that 
human tau expression causes neuronal dysfunction in Drosophila (Mudher et al., 2004; Chee 
et al., 2005; Mershin et al., 2010; Papanikolopoulou et al., 2010). Recent work undertaken in 
our laboratory has demonstrated that expression of human wild-type or mutant tau in the 
fly eye produces neuronal and synaptic dysfunction in the absence of neuronal death 
(Chapter 2).  
 
Recent work by Julienne et al. (2017) has shown electrophysiological abnormalities in the 
lLNvs coincide with behavioural arrhythmicity in a Drosophila model of PD. Specifically, the 
lLNvs are hyperactive and do not show a day/night difference in firing rate. We suggest that 
electrophysiological abnormalities in the PDF neurons underlie tau-evoked elevated night-
time activity, daytime sleep gains and night-time sleep loss in LD and hyperactivity in DD. 
Whereas, electrophysiological abnormalities in the non-PDF clock neurons (possibly the 
DN1s) underlie tau-evoked progressive behavioural arrhythmia in DD. In support of this, 
Sheeba et al. (2008) showed that hyperexcitation of the lLNvs neurons leads to sleep loss in 
Drosophila. Similarly, in a Drosophila model of human Aβ toxicity, daytime sleep loss 
coincides with hyperexcitability of the lLNvs neurons (Gerstner et al., 2017). Therefore, it is 
possible that electrophysiological abnormalities in the clock neurons are common to both 
tau and Aβ pathology. Flies were not aged past 35 days, degeneration of PDF neurons may 
occur in older flies. Furthermore, it is likely that there are changes in the ultrastructure of 
the clock neurons in tau-expressing flies; like which have been reported in several different 
neuronal populations in tau-expressing mice (Yoshiyama et al., 2007; Polydoro et al., 2009; 
Sydow et al., 2011; Jackson et al., 2017). However, this was beyond the scope of this 
investigation.  
 
In summary, we show human tau expression (either wild-type or R406W) in Drosophila 
recapitulates the sleep-wake cycle and circadian rhythm disturbances characteristic of AD. 
In this study, we show a role for the PDF neurons in tau-evoked elevated night-time activity, 
daytime sleep gains and night-time sleep loss in LD. We further establish a role for the non-
PDF clock neurons and tim-positive glial cells in tau-evoked progressive behavioural 
arrhythmicity in DD. Thus, distinct groups of cells mediate different tau-evoked circadian 
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not coincide with structural degeneration of the PDF neurons. Additionally, tau expression 
exclusively in the PDF neurons lengthens the circadian free-running period and makes the 
flies hyperactive in DD. Finally, we show tau expression in adult clock neurons is sufficient to 
induce behavioural arrhythmia. Our fly model provides an opportunity to study the 
mechanisms that underlie AD-linked circadian behavioural abnormalities. Further 
understanding, will facilitate the development of novel therapeutics that could improve 
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Figure 3.14: Tau expression in the fly brain results in circadian 
behavioural abnormalities in LD and DD conditions. (i) Scheme 
showing tau expression in all neurons results in elevated night-time 
activity (age-independent) and daytime and night-time sleep loss 
(age-independent) in LD conditions, and progressive behavioural 
arrhythmia in DD conditions. (ii) Scheme showing tau expression in 
all clock cells results in elevated night-time activity (age-
independent), daytime sleep gains (age-dependent) and night-time 
sleep loss (age-independent) in LD conditions, and progressive 
behavioural arrhythmia and hyperactivity in DD conditions. (iii) 
Scheme showing tau expression in PDF neurons results in elevated 
night-time activity (age-independent), daytime sleep gains (age-
dependent) and night-time sleep loss (age-independent) in LD 
conditions, but no progressive behavioural arrhythmia in DD 
conditions. (iv) Scheme showing tau expression in all neurons apart 
from PDF neurons has no effect on night-time activity and daytime 
and night-time sleep, but causes progressive behavioural 
arrhythmia in DD conditions. Tau expression in ii and iii also 






Genotype  Age 
(d)  







   median mean ± 
SEM 
median mean ± 
SEM 
 median mean ± 
SEM 
  
Elav-Gal4  5 60 574 634 ± 43 23.7 23.7 ± 0.04 100 0.66 0.69 ± 0.04 94  
Elav-Gal4  25 84 330 410 ± 34 23.6 23.6 ± 0.10 100 0.46 0.51 ± 0.03 93  
UAS-2n4r tauWT  5 115 529 597 ± 31 23.7 23.7 ± 0.03 100 0.57 0.60 ± 0.02 96  
UAS-2n4r tauWT  25 71 226 293 ± 28  23.6 23.6 ± 0.06 100 0.46 0.49 ± 0.03 92  
Elav-Gal4/UAS-2n4r tauWT  5 71 156 237 ± 29 23.5 23.5 ± 0.05 98  0.71 0.74 ± 0.03 89  
Elav-Gal4/UAS-2n4r tauWT 25 97 58 118 ± 15 23.9 24.0 ± 0.15 84 0.61 0.83 ± 0.06 88  
UAS-0n4r tauR406W  5 88 454 527 ± 34 23.6 23.8 ± 0.02 99 0.66 0.68 ± 0.04 95   
UAS-0n4r tauR406W  25 54 346 382 ± 35 23.5 23.8 ± 0.05 98 0.41 0.46 ± 0.04 89  
Elav-Gal4/UAS-0n4r tauR406W  5 96 81 142 ± 18 23.6 23.9 ± 0.09 95 0.69 0.71 ± 0.03 86  
Elav-Gal4/UAS-0n4r tauR406W  25 79 65 81 ± 8 23.4 24.0 ± 0.12 86 0.50 0.59 ± 0.04 59  
UAS-0n4r tauWT  5 32 575 625 ± 47 575 23.8 ± 0.05 100 0.77 0.80 ± 0.05 100  
UAS-0n4r tauWT  25 44 281 342 ± 35 281 24.0 ± 0.06 100 0.91 0.89 ± 0.04 98  
Elav-Gal4/UAS-0n4r tauWT  5 46 601 643 ± 59 601 23.8 ± 0.06 100 1.31 1.44 ± 0.10 96  
Elav-Gal4/UAS-0n4r tauWT 25 44 529 546 ± 66 529 24.2 ± 0.14 100 1.53 1.59 ± 0.07 92  
Elav-GeneSwitch-Gal4/UAS-
2n4r tauWT (vehicle control)  
12 46 452 564 ± 50 23.4 23.5 ± 0.04 100 0.29 0.31 ± 0.02 96  
Elav-GeneSwitch-Gal4/UAS-
2n4r tauWT (RU486) 
12 68 475 538 ± 35 23.3 23.5 ± 0.04 100 0.33 0.34 ± 0.02 93  
Elav-GeneSwitch-Gal4/UAS-
2n4r tauS11A (vehicle control) 
12 16 142 302 ± 44 23.7 23.7 ± 0.06 100 
 
0.23 0.25 ± 0.04 89  
Elav-GeneSwitch-Gal4/UAS-
2n4r tauS11A (RU486) 
12 29 222 284 ± 45 23.8 23.8 ± 0.05 100 0.27 0.30 ± 0.04 85  
tim-Gal4 5 92 335 447 ± 33 23.8 23.8 ± 0.03 100 0.59 0.66 ± 0.03 96  
tim-Gal4  25 67 275 317 ± 32 23.6 23.6 ± 0.06 100 0.53 0.59 ± 0.02 87  
tim-Gal4/2n4r tauWT  5 46 60 74 ± 7 24.1 24.7 ± 0.25 95 1.15 1.10 ± 0.06 100  
tim-Gal4/2n4r tauWT  25 77 24 30 ± 2 24.7 25.1 ± 0.35 70 0.57 0.61 ± 0.04 96  





Pdf-Gal4  25 60 228 303 ± 33 23.8 23.8 ± 0.06 100 0.42 0.50 ± 0.04 89  
Pdf-Gal4/2n4r tauWT  5 55 519 533 ± 29 24.5 24.5 ± 0.05 100 1.00 1.07 ± 0.05 98  
Pdf-Gal4/2n4r tauWT  25 31 199 230 ± 25 24.5 24.5 ± 0.06 100 0.90 0.97 ± 0.07 97  
tim-Gal4/UAS-0n4r tauR406W  5 88 68 86 ± 7 24.2 24.2 ± 0.13 98 0.81 0.82 ± 0.03 97  
tim-Gal4/UAS-0n4r tauR406W  25 50 37 50 ± 5  24.7 24.9 ± 0.29 98 0.84 0.93 ± 0.05 98  
Pdf-Gal4/UAS-0n4r tauR406W  5 109 189 233 ± 16  24.3 24.3 ± 0.03 100 0.83 0.85 ± 0.02 97  
Pdf-Gal4/ UAS-0n4r tauR406W  25 27  183 183 ± 20 24.3 24.3 ± 0.06 100 0.99 1.03 ± 0.05 84  
Elav-Gal4, Pdf-Gal80  5 48 556 604 ± 63 23.4 23.4 ± 0.04 100 0.90 0.94 ± 0.07 100  
Elav-Gal4, Pdf-Gal80/UAS-
0n4r tauR406W  
25 32 67 105 ± 21 23.7 23.8 ± 0.14 100 0.71 0.85 ± 0.08 91  
Tim-Ga4, repo-Gal80  5 32 575 600 ± 52 23.7 23.7 ± 0.06 100 0.61 0.62 ± 0.04 100  
Tim-Ga4, repo-Gal80  25 32 226 278 ± 31 23.5 23.5 ± 0.09 100 0.47 0.49 ± 0.04 100  
Tim-Ga4, repo-Gal80/UAS-
2n4r tauWT  
5 49 78 87 ± 10 24.1 24.5 ± 0.20 96 0.50 0.54 ± 0.03 100  
Tim-Ga4, repo-Gal80/UAS-
2n4r tauWT  
25 63 45 53 ± 5 24.3 24.4 ± 0.21 95 0.35 0.39 ± 0.02 98  
tim-Gal4, tub-Gal80ts (20 °C) 3-5 40 189 216 ± 17 24.1 24.0 ± 0.10 100 0.87 0.95 ± 0.05 93  
tim-Gal4, tub-Gal80ts (30 °C) 3-5 40 468 468 ± 34 23.5 23.6 ± 0.08 100 0.76 0.75 ± 0.03 93  
tim-Gal4, tub-Gal80ts/UAS-
2n4r tauWT(20 °C) 
3-5 85 257 265 ± 13 23.8 23.8 ± 0.03 100 0.75 0.80 ± 0.03 99  
tim-Gal4, tub-Gal80ts/UAS-
2n4r tauWT(30 °C) 
3-5 85 229 245 ± 14 24.5 24.6 ± 0.08 100 0.75 0.77 ± 0.02 99  
UAS-2n4r tauS11A  5 33 412 517 ± 61 23.6 23.6 ± 0.07 100 0.47 0.53 ± 0.04 96  
UAS-2n4r tauS11A  25 25 335 342 ± 32 23.6 23.6 ± 0.06 100 0.43 0.46 ± 0.04 96  
tim-Gal4>UAS-2n4r tauS11A  5 53 39 54 ± 6 23.7 24.1 ± 0.25 82 0.43 0.60 ± 0.05 98  
tim-Gal4>UAS-2n4r tauS11A  25 37 22 31 ± 4  24.5 
 
25.4 ± 0.80  62 0.37 0.46 ± 0.04 93  
 
Table 3.1: Power (PN) and period length of rhythms was determined by Lomb-Scargle periodogram analysis. Flies were defined as rhythmic based upon the presence of a 
peak above the 0.05 significance line (usually at 12.5 PN). In flies with complex rhythms (more than a single peak above the 0.05 significance line), the largest peak was 





activity counts per min across 24 h. Survival percentage: number of flies which survived to the end of the experiment/ number of flies which started the experiment as a 






Supplementary Figure 3.1: Pan-neuronal tau expression significantly reduces lifespan. Survival curves of tau-
expressing and control adult male flies raised and maintained at 25 °C. (A) Elav>2n4r tauWT flies show a 
significant reduction in lifespan compared with the UAS control. (B) Elav>0n4r tauR406W flies show a significant 
reduction in lifespan compared with the UAS control. ***p<0.0001; Log-rank (Mantel-Cox) test. (C) Median 















Supplementary Figure 3.2: Normal locomotor behaviour in Elav>0n4r tauWT flies. (A) Average daily activity 
histograms and representative double-plotted actograms for seven days of DD conditions are shown for 5- and 
25-day old Gal4 control (left column) and Elav>0n4r tauWT (right column) flies. Flies were entrained in standard 
LD cycles for three days and then monitored in DD for seven days. Gal4 control flies maintain robust rhythms 
of daytime activity and night-time inactivity, with a period of just under 24 h. Elav>0n4r tauWT flies exhibit 
robust rhythms with a normal period. (B) No differences in power are found in Elav>0n4r tauWT flies relative to 
controls. (C) No differences in period length are found in Elav>0n4r tauWT flies relative to controls. (C) 
Substantial increase in activity levels in DD is found in Elav>0n4r tauWT flies relative to controls. Graphs show 
median with second and third quartiles and 10th and 90th percentiles. n = 32-84 flies per genotype/age from 2-
6 independent experiments. ns p>0.05; *p<0.05; **p<0.001; ***p<0.0001. (B,D) Multiple comparisons 
between different genotypes of the same age (asterisks in black) and different ages of the same genotype 
(number symbols in red) by 2-way ANOVA and post-hoc Tukey HSD tests with log-transformed data. (C) 
Multiple comparisons between different genotypes of the same age (asterisks in black) by Kruskal-Wallis 
ANOVA and post-hoc Dunn’s tests. Comparisons between different ages of the same genotype (number 









Supplementary Figure 3.3: Activity 
and sleep in ElavGS>2n4r tauWT and 
ElavGS>2n4r tauS11A flies. (A) 
Average daily sleep profile for three 
days of LD conditions are shown for 
RU486- and vehicle-fed ElavGS>2n4r 
tauWT flies. Mean ± SEM. (B) 
Quantification of daytime and night-
time activity for RU486- and vehicle-
fed ElavGS>2n4r tauWT flies. (C) 
Quantification of daytime and night-
time sleep for RU486- and vehicle-
fed ElavGS>2n4r tauWT flies. n = 46-
68 flies per group from 3-4 
independent experiments. D) 
Quantification of daytime and night-
time activity for RU486- and vehicle-
fed ElavGS>2n4r tauS11A flies. (E) 
Quantification of daytime and night-
time sleep for RU486- and vehicle-
fed ElavGS>2n4r tauS11A flies. Graphs 
show median with second and third 
quartiles and 10th and 90th 
percentiles. n = 16-29 flies per group 
from a single experiment. ns p>0.05; 
two-tailed Student’s t-tests with log-
transformed data for (B,D); Mann-















Supplementary Figure 3.4: Phospho-resistant 2n4r tauS11A expression in the clock system disrupts normal 
circadian locomotor rhythms. (A) Average daily activity histograms and representative double-plotted 
actograms for nine days of DD conditions are shown for 5- and 25-day old UAS control (left column) and 
tim>2n4r tauS11A (right column) flies. Flies were entrained in standard LD cycles for three days and then 
monitored in DD for nine days. UAS control flies maintain robust rhythms of daytime activity and night-time 
inactivity, with a period of just under 24 h. 5-day old tim>2n4r tauS11A flies show very weak rhythms with a 
normal period or are arrhythmic. 25-day old tim>2n4r tauS11A flies show very weak rhythms with a long period 
(>24 h) or are arrhythmic. (B) Severely reduced power is found in tim>2n4r tauWT and tim>2n4r tauS11A flies 
relative to controls. See Table 3.1 for the percentage of rhythmic flies. (C) No differences in period length are 
found in 5-day old tim>2n4r tauS11A flies relative to controls. Increase in period length is found in tim>2n4r 
tauWT and 25-day old tim>2n4r tauS11A flies relative to controls. (D) Substantial increase in activity levels in DD is 
found in 5-day old tim>2n4r tauWT flies relative to controls. No differences in activity levels in DD are found in 
tim>2n4r tauS11A and 25-day old tim>2n4r tauWT flies relative to controls. Graphs show median with second and 
third quartiles and 10th and 90th percentiles. n = 25-115 flies per genotype/age from 1-6 independent 
experiments. ns p>0.05; *p<0.05; **p<0.001; ***p<0.0001. (B,D) Multiple comparisons between different 
genotypes of the same age (asterisks in black) and different ages of the same genotype (number symbols in 
red) by 2-way ANOVA and post-hoc Tukey HSD tests with log-transformed data. (C) Multiple comparisons 
between different genotypes of the same age (asterisks in black) by Kruskal-Wallis ANOVA and post-hoc 
Dunn’s tests. Comparisons between different ages of the same genotype (number symbols in red) by Mann-












Supplementary Figure 5: Effects of tim>2n4r tauWT and tim>0n4r tauR460W expression on circadian locomotor 
behaviour. (A-B) Quantification of daytime and night-time activity. Reduced daytime activity is found in 5-day 
old tim>0n4r tauR460W flies relative to age-matched tim>2n4r tauWT flies. Increased daytime activity is found in 
25-day old tim>0n4r tauR460W flies relative to age-matched tim>2n4r tauWT flies. No differences in night-time 
activity are found between 5-day old tim>2n4r tauWT and tim>0n4r tauR406W flies. Increased night-time activity 
is found in 25-day old tim>0n4r tauR406W flies relative to age-matched tim>2n4r tauWT flies. (C-D) Quantification 
of daytime and night-time sleep. Increased daytime sleep is found in 5-day old tim>0n4r tauR460W flies relative 
to age-matched tim>2n4r tauWT flies. Reduced daytime sleep is found in 25-day old tim>0n4r tauR460W flies 
relative to age-matched tim>2n4r tauWT flies. No differences in night-time sleep are found between 5-day old 
tim>2n4r tauWT and tim>0n4r tauR406W flies. Reduced night-time sleep is found in 25-day old tim>0n4r tauR406W 
flies relative to age-matched tim>2n4r tauWT flies. n = 57-115 flies per genotype/age from 3-6 independent 
experiments. (E) No differences in power are found between tim>2n4r tauWT and tim>0n4r tauR406W flies. (F) No 
differences in period length are found between tim>2n4r tauWT and tim>0n4r tauR406W flies. (G) Increased 
activity levels in DD are found in 5-day old tim>2n4r tauWT flies relative to age-matched tim>0n4r tauR460W flies. 
In contrast, increased levels of activity in DD are found in 25-day old tim>0n4r tauR406W flies relative to age-
matched tim>2n4r tauWT flies. n = 46-115 flies per genotype from 3-6 independent experiments. All graphs 
show median with second and third quartiles and 10th and 90th percentiles. ns p>0.05; *p<0.05; **p<0.001; 
***p<0.0001. (A,B,E,G) Multiple comparisons between different genotypes of the same age (asterisks in black) 
and different ages of the same genotype (number symbols in red) by 2-way ANOVA and post-hoc Tukey HSD 
tests with log-transformed data. (C,D,F) Multiple comparisons between different genotypes of the same age 
(asterisks in black) by Kruskal-Wallis ANOVA and post-hoc Dunn’s tests. Comparisons between different ages of 











Supplementary Figure 6: Effects of Pdf>2n4r tauWT and Pdf>0n4r tauR460W expression on circadian locomotor 
behaviour. (A-B) Quantification of daytime and night-time activity. No differences in daytime and night-time 
activity between Pdf>2n4r tauWT and Pdf>0n4r tauR460W flies, with the exception of increased night-time 
activity in 25-day old Pdf>0n4r tauR460W flies compared to age-matched Pdf>2n4r tauWT flies. (C-D) 
Quantification of daytime and night-time sleep. No differences in daytime and night-time sleep between 
Pdf>2n4r tauWT and Pdf>0n4r tauR460W flies. n = 28-115 flies per genotype from 2-6 independent experiments. 
No differences in power (E), period length (G) and activity in DD (G) are found between Pdf>2n4r tauWT and 
Pdf>0n4r tauR460W flies. n = 27-115 flies per genotype from 2-6 independent experiments. All graphs show 
median with second and third quartiles and 10th and 90th percentiles. ns p>0.05; *p<0.05; **p<0.001; 
***p<0.0001. (A,B,E,G) Multiple comparisons between different genotypes of the same age (asterisks in black) 
and different ages of the same genotype (number symbols in red) by 2-way ANOVA and post-hoc Tukey HSD 
tests with log-transformed data. (C,D,F) Multiple comparisons between different genotypes of the same age 
(asterisks in black) by Kruskal-Wallis ANOVA and post-hoc Dunn’s tests. Comparisons between different ages of 
the same genotype (number symbols in red) by Mann-Whitney U-tests.  
 
 
Supplementary Figure 7: Comparing the effects on circadian rhythmicity of expressing 2n4r tauWT (A) or 0n4r 
tauR460W (B) to various extents. Elav-Gal4: all neurons; tim-Gal4: all clock cells; Pdf-Gal4: PDF clock neurons; 
tim-Gal4, repo-Gal80: all clock neurons; Elav-Gal4, Pdf-Gal80: all neurons except PDF neurons. (A) n = 31-82 
flies per genotype from 2-6 independent experiments. (B) n = 27-109 flies per genotype from 2-4 independent 
experiments. All graphs show median with second and third quartiles and 10th and 90th percentiles. ns p>0.05; 
*p<0.05; **p<0.001; ***p<0.0001.Multiple comparisons between different genotypes of the same age 
(asterisks in black) and different ages of the same genotype (number symbols in red) by 2-way ANOVA and 











Supplementary Figure 8: Comparing the effects on activity and sleep of expressing 2n4r tauWT (A-D) or 0n4r 
tauR046W (E-H) to various extents. (A-B) Percentage change in daytime and night-time activity between 
experimental genotypes (Elav>2n4r tauWT, tim>2n4r tauWT and Pdf>2n4r tauWT) in comparison to relevant Gal4 
and UAS control genotypes. (C-D) Percentage change in daytime and night-time sleep between experimental 
genotypes (Elav>2n4r tauWT, tim>2n4r tauWT and Pdf>2n4r tauWT) in comparison to relevant Gal4 and UAS 
control genotypes. (E-F) Percentage change in daytime and night-time activity between experimental 
genotypes (Elav>0n4r tauR406W, tim>0n4r tauR406W, Pdf>0n4r tauR406W and Elav, Pdf-Gal80>0n4r tauR406W) in 
comparison to relevant Gal4 and UAS control genotypes. (G-H) Percentage change in daytime and night-time 
sleep between experimental genotypes (Elav>0n4r tauR406W, tim>0n4r tauR406W, Pdf>0n4r tauR406W and Elav, 
Pdf-Gal80>0n4r tauR406W) in comparison to relevant Gal4 and UAS control genotypes. All graphs show mean ± 
SEM. ns p>0.05; *p<0.05. Multiple comparisons between experimental genotypes by 2-way ANOVA and post-























Chapter 4:   Investigating the spatial resolution of Drosophila motion vision 
through optomotor behaviour in a flight simulator system 
 
The work presented in this chapter was previously published in Juusola, M., Dau, A., Song, 
Z., Solanki, N., Rien, D., Jaciuch, D., Dongre, S. A., Blanchard, F., de Polavieja, G. G., Hardie, R. 
C.; Takalo, J. (2017). Microsaccadic sampling of moving image information provides 
Drosophila hyperacute vision. eLife. Figure 10, Figure Supplement 10 and Appendix 10. All 
experiments in this chapter were performed by myself. This chapter was written by myself. 
 
4.1   Introduction 
 
The Drosophila compound eye is composed of ~750 unit eyes called ommatidia arranged in 
a hexagonal array. Each ommatidium is physically separate from its neighbours, containing a 
lens and eight photoreceptors. The outer R1-R6 photoreceptors are arranged in a trapezoid 
and the inner R7+R8 photoreceptors lie centrally, on top of one another. Because of the 
Drosophila eyes neural superposition principal, R1-R6 photoreceptors from neighbouring 
ommatidia point in the same direction. Pooling the output of R1-R6 photoreceptors that 
point in the same direction increases sensitivity (~sixfold) without loss of spatial resolution 
(Paulk et al., 2013).  
 
Visual acuity is the minimum resolvable angle. The acuity of a Drosophila eye is limited by its 
photoreceptor spacing, which essentially matches its interommatidial angle (~4.5°). For 
example, to be able to resolve a black-and-white grating, one ommatidium must look at a 
black stripe and the neighbouring ommatidium must look at the adjacent white stripe. If a 
single ommatidium looks at both a black and a white stripe it will be seen as a single grey 
stripe. To resolve two objects requires at least three ommatidia, one for each of the objects 
and one for the gap between the objects (Land, 1997). If a single ommatidium looks at two 
objects they will be seen as a single object. Animals view the world through a pattern of 
slow fixations with fast saccades that shift the direction of gaze. These moments may be 
made by either the eye, head or body. According to the classic ideas, animals would keep 





integration time. However, fast photoreceptor adaptation could cause perceptual fading 
during fixation. Therefore, it was thought that photoreceptor sampling would occur only 
when the gaze is stabilised, whereas during saccades the animal would be effectively blind. 
Thus, eyes would sample information through a series of more or less stationary images 
(Land, 1999).  
 
However, recent findings in our lab suggest that photoreceptors in fact exploit saccadic light 
modulation to enhance visual acuity. Juusola et al. (2017) found photoreceptors encoding 
capacity is maximised to fast high contrast bursts that are similar to saccadic light input. 
Photoreceptors transfer two-to-four times more information to fast high contrast bursts 
than to Gaussian white-noise and naturistic stimuli. This high information transfer rate is 
because of the darker intervals in the bursty light stimulus, which relieve photoreceptors 
refractory microvilli. Thus, they are able to approach close to 100 percentage encoding 
efficiency. The authors further found that rapid photomechanical contractions reduce 
motion-blur during saccades and reduce adaptation during fixation to improve the 
resolvability of saccadic visual inputs beyond the theoretical motion-blur limit. Collectively, 
refractory sampling and photomechanical contractions actively modulate light input, and 
thereby reduce adaption during gaze stabilisation that could otherwise fade vision. Jointly 
these processes allow photoreceptors to encode visual information in both space and time. 
Therefore, when the authors incorporated refractory sampling and photomechanical 
contractions into a biophysically-realistic model, it predicted Drosophila see ≥ four-fold finer 
detail than suggested by the classic theories. To test this experimentally, we investigated 
the spatial resolution of Drosophila motion vision through optomotor behaviour in a flight 
simulator system. We show Drosophila possess hyperacute motion vision and in accordance 
with the model predictions respond to patterns with ~1° spatial resolution.  
 
4.2   Material and Methods  
 
In all experiments, 1- to 3-day-old wild-type “Berlin” female flies were used. Flies were kept 
in bottles at a low population density to prevent overcrowding and maximise size. Following 
cold-anaesthesia (lasting three-five minutes) a small triangle-shaped copper-wire hook was 





(four-six pm). After preparation, flies were left overnight individually in small moist 
chambers with sugar to recover. A bespoke flight simulator system was used to study 
Drosophila’s optomotor behaviour (Wardill et al., 2012). A fly was connected by its small 
triangular hook to a small metal clamp. The metal clamp was then connected to the torque 
meter (Tang and Guo, 2001). A fly connected to the torque meter was placed inside the 
centre of a white cylinder. Inside it, we placed a laser printed transparency containing a 
black-and-white vertical grating. The grating forms a continuous (360°) scene around the fly. 
Bright homogenous illumination of the arena was provided by a ring–shaped light tube 
(Philips, 350-900 nm). The scene was rotatable by the use of a stepping motor. We used an 
eight second stimulus which consisted of two seconds of counterclockwise rotation and two 
seconds of clockwise rotation separated by two seconds when the arena was still – 
preceded and concluded by one second when the arena was still. The eight second stimulus 
was repeated ~20 times. Data from any flies who failed to fly for the entire duration of the 
experiment (~three minutes) was excluded. At least 10 flies were tested per experiment. All 
experiments were performed in a dark room at ~23 °C. 
 
4.3   Results and Discussion  
 
We investigated the visual acuity of Drosophila motion vision through their optomotor 
behaviour in a flight simulator system. Drosophila were connected to a torque meter in the 
centre of a white cylinder. Inside it, we placed a black-and-white vertical grating which 
formed a continuous (360°) scene around the fly. The scene was rotatable via the use of a 
stepping motor. We measured flies yaw torque responses to an eight second stimulus – 
preceded and concluded by a one second pause, the panorama was rotated anticlockwise 
for two seconds then clockwise for two seconds, separated by a two second pause - which 
was repeated ~20 times. When presented with scene rotations, flies attempt to follow them 
producing yaw torque responses (optomotor responses to the left or to the right), to 
attempt to minimise retinal slippage. The strength of the fly’s response is thought to be 
proportional to the strength of their perception. For example, if a fly can comfortably 
resolve the grating they will be able to accurately follow the scene rotations. Whereas, if a 
fly is unable to resolve the grating they will fail to follow the scene rotations, resulting in 





We recorded optomotor responses of wild-type flies to black-and-white vertical gratings of 
three different spatial resolutions (wavelength: 1.16°, 2.88° and 14.4°), rotating slowly at 
75°/s. The flies responded most strongly to the 14.4° bar panorama. The white cylinder 
alone (no apparent visual features) did not evoke a response, and thus provided the 
baseline response level. The 3.9° bar panorama evoked a strong response. The maximum 
response (peak-to-peak) to the 3.9° bar panorama was 70 % of the maximum response to 
the 14.4° bar panorama. Similarly, the 1.2° bar panorama also evoked a strong response. 
The maximum response to 1.2° bar panorama was 50 % of the maximum response to 14.4° 
bar panorama. The response to both the 3.9° and 1.2° bar panoramas was significantly 
stronger than the response to the white panorama (Figure 4.1). The population response of 
10 flies is shown in Figure 4.1, whereas, the responses of individual flies is shown in Figure 
4.2. Responses vary in strength between different flies. However, all flies tested responded 
to the 3.9° and 1.2° bar panoramas – much stronger response than to the white panorama. 
The strength of the responses to the different patterns was consistent amongst all the flies – 
response to 14.4° bars > 3.9° bars > 1.2° bars > no bars (Figure 4.2).  
 
It is not possible to test optomotor responses of flies to black-and-white vertical gratings 
rotating at <75°/s, because the stepping motor is unable to rotate the arena smoothly and 
uniformly at <75°/s. It is also not possible to test patterns with a wavelength <1°, because 
printers are unable to print on transparent film at high enough resolution. These results 
demonstrate flies possess hyperacute (<4.5° interommatidial angle) motion vision and see 
















Figure 4.1: Optomotor behaviour in the flight simulator indicates Drosophila possess hyperacute motion 
vision. (A) Optomotor responses of tethered flying Drosophila to black-and-white vertical gratings of three 
different spatial resolutions (wavelength; 14.4°, 3.9° and 1.2°) and the white cylinder alone rotating slowing at 
75°/s. The 14.4°, 3.9° and 1.2° bar panoramas evoke strong optomotor responses. The white panorama does 
not evoke an optomotor response. (B) Flies optomotor responses are strongest to the 14.4° bar panorama. The 
response to the white panorama established the baseline response level. The response to 3.9° and 1.2° bar 
panoramas is significantly stronger than the response to the white panorama. ***p<0.001; 1-way ANOVA 
followed by post-hoc Tukey HSD tests. Mean of 10 flies. Individual flies are shown in Figure 4.2 
 
Next, we asked if we could find the limit of Drosophila motion vision through optomotor 
behaviour in the flight simulator system. We recorded optomotor responses of wild-type 
flies to black-and-white vertical gratings of three different spatial resolutions (wavelength: 
1.16°, 2.88° and 14.4°), rotating at 75, 150, 300 or 400°/s. Flies responded very strongly to 
the 14.4° bar panorama rotated at all the different speeds tested. Increasing the speed of 
the 14.4° bar panorama had little effect on the size of the response. In contrast, increasing 
the speed caused a dramatic reduction in strength of the response to the 3.9° bar 
panorama. Strong response to the 3.9° bar panorama rotating at 75°/s and 150°/s – 70 % of 
the maximum response to the 14.4° bar panorama . Weak response to the 3.9° bar 
panorama rotating at 300°/s – 20 % of the maximum response to the 14.4° bar panorama. 
No response to the 3.9° bar panorama rotating at 400°/s – does not significantly differ from 





in the strength of the response to the 1.2° bar panorama. Strong response to the 1.2° bar 
panorama rotating at 75 – 60 % of the maximum response to the 14.4° bar panorama. 
However, no response to the 1.2° bar panorama rotating at 150, 300 or 400°/s – does not 
significantly differ from the response to the white panorama rotating at the same speed 
(Figure 4.3). 
 
Very weak response to the white panorama, which was similar at all the different speeds 
tested – 10 % of the maximum response to the 14.4° bar panorama. It is not spontaneous 
activity because it is consistent and coupled to the optomotor stimuli. Therefore, we 
performed two control experiments to ensure there were no unbeknown visual features in 
the white cylinder that was affecting optomotor behaviour. First, we tested the optomotor 
response of wild-type flies to the 14.4° bar panorama rotating at 75°/s in darkness 
(surrounding ring-shaped light turned off). The 14.4° bar panorama in darkness evoked a 
very weak response, similar to the response evoked by the lit white panorama. Next, we 
tested the optomotor response of blind hdcJK910 flies (photoreceptors lack the 
neurotransmitter, histamine) (Burg et al., 1993) to the 14.4° bar panorama and white 
panorama rotating at 75°/s. As expected the responses of hdcJK910 flies to the 14.4° bar 
panorama and white panorama were essentially identical. Responses of hdcJK910 flies to 
either the 14.4° bar panorama or the white panorama were similar to the response of wild-
type flies to the white panorama. Thus, the weak optomotor responses evoked by the white 
panorama are not due to inadvertent visual features, but probably due to airflow on the 
halters (Figure 4.4) (Mureli and Fox, 2015).  
 
Drosophila have been used to study vision for over a hundred years (Paulk et al., 2012), but 
to date no study has tested the limit of the spatial resolution of Drosophila motion vision. 
This is probably because of the long held belief that Drosophila possess coarse vision, as 
determined by the 4.5~ interommatidial angle (Land, 1997). Buchner (1976) used a trackball 
system coupled with microscope-mediated local grating stimulation to probe Drosophila 
motion vison through optomotor behaviour. However, they did not test whether flies 
responded to a grating with a spatial resolution of <4.5°. Moreover, it is reasonable to 
assume the microscope-mediated local grating and panoramic high resolution black-and-






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.4: Control measurements of optomotor behaviour in the flight simulator system. (A) Very weak 
response of wild-type flies to the white panorama. Similar weak response of wild-type flies to the 14.4° bar 
panorama in darkness. Also similar weak responses of blind hdcJK910 flies to the 14.4° bar and white panoramas. 
(B) The maximum responses of wild-type flies to the 14.4° bar panorama in darkness and hdcJK910 flies to the 
14.4° bar or white panorama does not significantly differ from the maximum response of wild-type flies to the 


















Chapter 5:   Final Discussion 
 
Tauopathies are a group of diseases characterised by the aggregation of 
hyperphosphorylated tau protein into neurofibrillary tangles (NFTs) and slow and 
progressive neurodegeneration. Abnormal post-translational modifications (PTMs), 
misfolding and aggregation of tau are common to all tauopathies. However, the brain 
regions the aggregates deposit in and their constituent tau isoform vary according to the 
disease. Different tauopathies have distinct clinical profiles, which range from cognitive to 
motor deficits (reviewed in Wang and Mandelkow, 2016). The vast majority of research has 
focused on NFT formation and neuronal death, because of the long held belief that the NFTs 
exert neurotoxicity. 
 
However, mounting evidence suggests that the NFTs are relatively inert and instead the 
soluble tau species are neurotoxic. Human histopathological studies have shown clinical 
symptoms precede aggregate formation and neuronal death (reviewed in Arendt et al., 
2009). Thus, a period of cellular dysfunction often precedes cell loss. This offers an exciting 
opportunity for therapeutic intervention before unrepairable neuronal damage. Therefore, 
a current priority is to develop tools and techniques to identify affected individuals earlier. 
As such, further understanding of the mechanisms underlying tau-mediated neuronal 
dysfunction is urgently needed. To achieve this we need to develop animal models that 
faithfully recapitulate the early stages of tauopathies, in which one is able to express 
different tau proteins in specific neuronal populations and robustly assay neuronal function 
and death.  
 
Many transgenic tau mice have been produced that express various different tau proteins to 
varying extents in the brain. These transgenic tau mice exhibit a myriad of behavioural 
abnormalities and neuronal and synaptic dysfunction (Kimura et al., 2007; Yoshiyama et al., 
2007; Polydoro et al., 2009; Hoover et al., 2010; Sydow et al., 2011; Tai et al., 2012). 
However, it is a confusing and contradictory picture as to whether the neuronal dysfunction 
in transgenic tau mice coincides with neuronal death, precedes neuronal death, or occurs in 





expression systems and express different tau proteins, it is difficult to make direct 
comparisons between them.  
 
A key question is whether different 4r tau isoforms cause similar results when studied in 
isolation in the same neuronal population. In Chapter 2 to answer this question we 
expressed different human tau proteins in the Drosophila eye (using the Gal4/UAS system) 
and monitored age-related changes in function and structure. The Drosophila eye permits 
rapid and reproducible measures of function using electrophysiology (electroretinograms 
(ERGs)) or behaviour (optomotor responses), and structure using the corneal neutralisation 
technique.  
 
We show that 0n4r tau expression in the developing eye causes progressive adult-onset 
neuronal dysfunction as shown by the progressive loss of the ERG response (Figure 2.1) and 
abnormal optomotor behaviour in the flight simulator system (Figure 2.5), without neuronal 
death as shown by the normal number and organisation of photoreceptor rhabdomeres 
(Figure 2.2). On the other hand, 2n4r tau expression in the developing eye causes 
progressive age-related neuronal dysfunction as shown electrophysiologically (Figure 2.3) 
and behaviourally (Figure 2.5), which precedes neuronal death as shown by the progressive 
loss of photoreceptor rhabdomeres (Figure 2.4). Thus, lGMR>2n4r tau expression produces 
temporally separable neuronal dysfunction and neuronal death.  
 
lGMR>0n4r tau and lGMR>2n4r tau expression differentially affect the ERG response in 
young flies. We found normal ERG responses and optomotor behaviour in the flight 
simulator system in 0n4r tau-expressing flies up to 5-days of age (Figure 2.1 and Figure 2.5). 
Whereas, we found tiny ON transients in ERG responses in 2n4r tau-expressing flies early in 
life, indicating severe synaptic transmission defects (Figure 2.3). Thus, synaptic transmission 
is more sensitive to 2n4r tau expression than 0n4r tau expression. These results suggest tau 
influences synaptic transmission via its N-terminal domain, as has been suggested by others 
(Zhou et al., 2017). On the other hand, lGMR>0n4r tau and lGMR>2n4r tau expression 
produces a similar effect on the ERG response in aged flies (30-day old). ERG responses 
showed a lack of transients (reflect synaptic transmission) and a substantial reduction in 





2.1 and Figure 2.3). These results suggest isoform-specific effects are more dramatic early in 
the disease process.  
 
We further show that 2n4r tau expression in the adult Drosophila eye causes progressive 
neuronal dysfunction as evidenced by the progressive loss of the ERG response (Figure 2.7), 
without neuronal death as evidenced by the normal number and organisation of 
photoreceptor rhadomeres (Figure 2.9). Thus, adult 4r tau-mediated structural 
degeneration, unlike function degeneration, requires a neurodevelopmental component. 
We further suggest a role for tau phosphorylation, by the PAR1 kinase, in tau-mediated 
neuronal dysfunction. Tau with mutations at the PAR1 phosphorylation sites is unable to 
cause neuronal dysfunction in the Drosophila eye (Figure 2.10). Our results suggest tau is an 
important downstream mediator of Aβ-dependent neuronal dysfunction. Aβ42 expression 
alone is insufficient to cause neuronal dysfunction, but coexpression of Aβ42 with 2n4r 
tauWT potently exacerbates tau-mediated neuronal dysfunction (Figure 2.11).  
 
Circadian rhythm disruption is common in tauopathies. The vast majority of individuals with 
Alzheimer’s Disease (AD), Frontotemporal dementia (FTD) or Parkinson’s Disease (PD) will 
experience circadian rhythm disturbances, typically early in the disease process. In fact, 
circadian disruption often occurs before the onset of traditional clinical symptoms, such as 
memory and motor deficits. Manifestation varies according to the disease, but typically 
night-time activity levels and daytime sleepiness are increased and night-time sleep levels 
are reduced (for review see Musiek et al., 2015). It is important to delineate the effects of 
tau and Aβ pathology on circadian dysfunction in AD, where they are both present. Animal 
models that are susceptible to sophisticated genetic manipulation and recapitulate the key 
features of circadian dysfunction in the human disease are urgently needed. Drosophila are 
a very well established model for studying circadian rhythms and sleep (reviewed in Dubowy 
and Sehgal, 2017). 
 
Pan-neuronal 2n4r tauWT and 0n4r tauR406W expression (using Elav-Gal4) causes a shortened 
lifespan. Elav>2n4r tauWT and Elav>0n4r tauR406W expression produced a similar reduction in 
lifespan (Supplementary Figure 3.1). Pan-neuronal 2n4r tauWT and 0n4r tauR460W expression 





time sleep levels in LD conditions. The night-time activity and sleep phenotypes in Elav>2n4r 
tauWT and Elav>0n4r tauR406W flies are similar. The night-time activity and sleep phenotypes 
are neither progressive nor age-dependent (Figure 3.1 and Figure 3.2).  
 
Pan-neuronal 2n4r tauWT and 0n4r tauR406W expression produces progressive behavioural 
arrhythmia in DD conditions (Figure 3.3). Pan-neuronal 2n4r tauWT, but not 0n4r tauR406W, 
expression causes age-induced hyperactivity in DD (Figure 3.3). Whereas, Elav>0n4 tauWT 
expression produces hyperactivity in an age-independent manner (Supplementary Figure 
3.2). Typically overall activity levels are unaffected in AD and FTD patients (van Someren et 
al., 1996; Harper et al., 2004). We are the first to show human tau expression is capable of 
producing hyperactivity in constant conditions. However, many studies have found 
hyperactivity in mouse models of β-amyloidosis in free-running conditions (Ambree et al., 
2006; Gil-Bea et al., 2007; Gorman and Yellon, 2010; Roh et al., 2012). Pan-neuronal 0n4r 
tauWT, unlike 2n4r tauWT and 0n4r tauR406W, expression fails to cause progressive behavioural 
arrhythmia (Supplementary Figure 3.2). Collectively, these results show isoform-specific 
effects of ubiquitous neuronal tau expression to induce progressive behavioural arrhythmia 
and hyperactivity. These data show tau influences the amount of activity independently of 
the distribution of activity.  
 
Next, we investigated the effects of restricting tau expression to the clock system, either in 
all clock cells (using tim-Gal4) or exclusively in PDF clock neurons (using Pdf-Gal4). PDF clock 
neurons are considered to be the master pacemaker as they synchronise the oscillations of 
all the clock neurons, so that they oscillate in phase with each other (Stoleru et al., 2005; 
Lear et al., 2009; Yoshii et al., 2009; Yao and Shafter, 2014). Tim>tau and Pdf>tau expression 
produces increased night-time activity levels and daytime sleep levels, and reduced night-
time sleep levels (Figure 3.5, Figure 3.6 and Figure 3.7). Tim>2n4r tauWT and tim>0n4r 
tauR406W expression produce similar night-time activity and sleep phenotypes 
(Supplementary Figure 3.5). Additionally, Pdf>2n4r tauWT and Pdf>0n4r tauR406W expression 
also produce similar night-time activity and sleep phenotypes (Supplementary Figure 3.6). 
Elav>, tim> and Pdf>tau expression cause similar night-time activity and sleep phenotypes 






Tim>2n4r tauWT and tim>0n4r tauR406W expression differentially affect daytime activity and 
sleep (Supplementary Figure 3.5). Tim>2n4r tauWT expression has no effect on daytime 
activity and sleep (Figure 3.5 and Figure 3.7). Whereas, tim>0n4r tauR406W expression 
produces age-dependent daytime activity and sleep phenotypes (Figure 3.6 and Figure 3.7). 
Similarily, Pdf>2n4r tauWT and Pdf>0n4r tauR406W expression differentially affect daytime 
activity and sleep (Figure 3.5, Figure 3.6, Figure 3.7 and Supplementary Figure 3.6). Thus, 
2n4r tauWT and 0n4r tauR406W expression in the clock system produces isoform-specific 
effects on daytime activity and sleep, but not on night-time activity and sleep. Regardless of 
isoform, tau has a more significant effect on activity and sleep levels during the night, than 
the day. These data show tau expression can influence levels of daytime activity and sleep 
independently of levels of night-time activity and sleep. Thus, these results suggest distinct 
neural circuits control daytime and night-time activity and sleep levels.  
 
Tau (2n4r and 0n4r isoforms) expression in all clock neurons causes progressive behavioural 
arrhythmia, prolongs the period length of rhythms and induces hyperactivity in free-running 
conditions. On the other hand, tau (2n4r and 0n4r isoforms) expression exclusively in the 
PDF neurons lengthens the free-running period and produces hyperactivity, but is 
insufficient to trigger progressive behavioural arrhythmia in DD conditions (Figure 3.8 and 
Figure 3.9). Thus, tau expression in all the clock neurons is the most clock-restricted domain 
that produces progressive behavioural arrhythmia in DD. The prolonged free-running period 
suggests changes in relative synchronisation between clocks. We found similar period-
lengthening effects and hyperactivity in tim>tau and Pdf>tau flies (Figure 3.8, Figure 3.9, 
Supplementary Figure 3.5 and Supplementary Figure 3.6). We found no overt neuronal loss 
in Pdf>tau and tim>tau flies (Figure 3.10). Thus, the circadian behavioural deficits are likely 
due to neuronal dysfunction rather than neuronal death.  
 
We further suggest a role for tim-positive glial cells in tau-mediated behavioural 
arrhythmicity. Flies expressing tau in the timeless clock neurons are more rhythmic than 
flies expressing in all the clock cells, including tim-positive glial cells (Figure 3.12). Others 
have shown a role of glial cells in regulating locomotor activity rhythms in Drosophila and 






Collectively, these results show distinct groups of neurons mediate different tau-evoked 
circadian behavioural abnormalities. The PDF neurons mediate tau-evoked elevated night-
time activity, daytime sleep gains and night-time sleep loss and in LD and tau-evoked 
hyperactivity in DD. In support of this, blocking tau expression exclusively in the PDF clock 
neurons rescues the elevated night-time activity and night-time sleep loss phenotype in tau-
expressing flies (Figure 3.11). Whereas, non-PDF clock neurons mediate tau-evoked 
progressive behavioural arrhythmia in DD. As such, blocking tau expression only in the PDF 
neurons is insufficient to rescue the progressive behavioural arrhythmia in tau-expressing 
flies (Figure 3.11). Taken together, these results show both the extent of tau expression and 
the identity of the tau species influence the circadian behavioural deficits. These results 
underlie the different manifestations of circadian rhythm disruption in distinct tauopathies, 
which are characterised by aggregates of unique tau species in specific brain regions.  
 
We show tau expression in specific groups of neurons has differential effects on circadian 
behaviour, which influence one another. For example, tau expression exclusively in the PDF 
neurons has an activity-promoting effect and period-lengthening effect in DD. Whereas, flies 
pan-neuronally expressing tau have normal activity levels and period lengths in DD. 
Therefore, tau expression in the non-PDF neurons blocks the activity-promoting effect and 
period-lengthening effect of tau expression in the PDF neurons. Thus, abnormal levels of tau 
proteins in different neuronal populations can have opposing effects. Therefore, it is 
possible that widespread tau expression in animal models may mask AD-linked circadian 
behavioural deficits. These results suggest, in tauopathies, the circadian behavioural deficits 
are as a result of interactions between the effects of tau abnormalities in distinct groups of 
neurons. In tauopathies, the clinical symptoms are contributed to by the identity of the tau 
species and its location. These results indicate that targeting tau abnormalities in specific 
brain regions may have dramatic effects on the clinical profile, despite the presence of tau 
abnormalities in other brain regions. Taken together, these results suggest that different 
therapeutic strategies may need to be developed for distinct tauopathies. To do this 
successfully, further understanding of the identify and location of tau species in tauopathies 
is required. Our model provides a platform to investigate the effects of expressing different 






Taken together, we show human tau expression in Drosophila is able to cause neuronal 
dysfunction in independent neuronal populations, in both the peripheral nervous system 
and central nervous system, with distinct properties. We show both 2n4r and 0n4r isoforms 
of tau cause neuronal and synaptic dysfunction in both photoreceptors and clock neurons as 
assayed both electrophysiologically and behaviourally. Tau-mediated neuronal dysfunction 
in both photoreceptors and clock neurons occurs in the absence of neuronal death as 
assayed using confocal microscopy. Thus, tau-mediated neuronal dysfunction is separable 
from neuronal death.  
 
In this thesis, we present two Drosophila models of tauopathy that recapitulate neuronal 
dysfunction in the absence of neuronal death seen in the early stages of the human disease. 
However, there are some key differences between the two models. The effects of human 
tau on retinal function and structure are progressive and age-related. Whereas, the effects 
of human tau on circadian locomotor behaviour are predominately neither progressive nor 
age-related. We demonstrate isoform-specific effects of tau-mediated neuronal dysfunction 
when expressed in either the Drosophila eye or clock system. The work presented in this 
thesis, will provide a platform for the future dissection of the mechanisms underlying tau-
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